Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29561,0.111246118819737,0.00212210791340587,0.107086787309462,0.115405450330013,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,28792,-0.325819075578416,0.00818745062410602,-0.341866478801664,-0.309771672355169,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,24917,-0.221250700261728,0.00543067141963339,-0.231894816244209,-0.210606584279246,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,29438,-0.121955086079446,0.00287518008883287,-0.127590439053559,-0.116319733105334,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29438,0.0997573438462036,0.00207046042560082,0.095699241412026,0.103815446280381,0
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24933,-0.100341913009248,0.00268642629636129,-0.105607308550116,-0.0950765174683797,3.70763545270793e-297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,29342,-0.0986513365043449,0.00271246825943623,-0.10396777429284,-0.0933348987158499,2.56221433564545e-283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9,Complement component C9,24946,0.126287878093516,0.00350919633449225,0.119409853277911,0.133165902909121,1.53778876435426e-276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29756,0.288225915973689,0.00806712413542362,0.272414352668259,0.30403747927912,8.87046448647778e-274
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24788,-0.130795798383887,0.003665967344414,-0.137981094378938,-0.123610502388835,6.4612495538579e-272
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,29344,-0.19412277808559,0.00600402578279399,-0.205890668619866,-0.182354887551314,2.25450042119192e-225
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYY,Peptide YY,24106,-0.207738176089978,0.00644240170653407,-0.220365283434785,-0.195111068745171,2.26766596998373e-223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,24946,0.0533237876214832,0.00165932134835516,0.050071517778707,0.0565760574642593,4.69755244048444e-222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,29029,0.113748602504583,0.00356539674991837,0.106760424874743,0.120736780134423,1.49239153617716e-219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29576,0.0573200770053779,0.00188727264579823,0.0536210226196134,0.0610191313911424,1.51086971862843e-199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29689,-0.280712405974464,0.0092557476241171,-0.298853671317734,-0.262571140631195,5.29775811904834e-199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29429,-0.102955717976916,0.00355574928620251,-0.109924986577873,-0.0959864493759592,8.72857834506574e-182
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,29502,0.0369624168591861,0.00132199027607119,0.0343713159180866,0.0395535178002856,8.28426638184846e-170
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,29484,-0.150113742311842,0.00538861765134156,-0.160675432908471,-0.139552051715212,1.33945811443494e-168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,29720,-0.120846188600779,0.00439524665844608,-0.129460872051333,-0.112231505150225,2.32626444939307e-164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,29720,0.0649905852846894,0.00237900216695955,0.0603277410374487,0.0696534295319301,2.60804302646528e-162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,29473,-0.110873902107101,0.00411723644718528,-0.118943685543584,-0.102804118670618,8.16752954843592e-158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,29669,-0.210299146709988,0.00791735990492186,-0.225817172123634,-0.194781121296341,1.18239711582641e-153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,29438,-0.0731353289306878,0.00275689894110865,-0.0785388508552607,-0.0677318070061148,2.92553042303475e-153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,29579,-0.0595724182876377,0.00228942097520311,-0.0640596833990358,-0.0550851531762396,1.32861757459796e-147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24840,0.0628808251362464,0.00246034716390115,0.0580585446950002,0.0677031055774927,3.11531407543342e-142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,24235,-0.0856976809114245,0.00341650261016698,-0.0923940260273518,-0.0790013357954973,4.23834192627868e-137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29752,0.104057089600239,0.0041638613690544,0.095895921316892,0.112218257883585,1.98689420045895e-136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29589,0.0625595094930828,0.00255224470896152,0.0575571098635182,0.0675619091226473,2.28053706181301e-131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,29395,-0.163551557819536,0.00681842244640541,-0.17691566581449,-0.150187449824581,6.23198342902323e-126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,24933,0.0941781198644359,0.00395719108208112,0.0864220253435569,0.101934214385315,8.19390579752387e-124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,29473,0.0740907658714653,0.00314850429756762,0.0679196974482327,0.0802618342946978,2.52839035855424e-121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,24946,0.0813020238288788,0.0034538048501865,0.0745325663225132,0.0880714813352443,3.35157225497334e-121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,24961,0.102980641246963,0.0045207656245706,0.0941199406228044,0.111841341871121,1.05994286870285e-113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29430,0.0478273603805502,0.00212285892262586,0.0436665568922035,0.0519881638688968,1.86668154851986e-111
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,24800,-0.106860958889089,0.00482208761416894,-0.11631225061286,-0.0974096671653179,9.16057980385514e-108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,29781,-0.0781067184820682,0.00354541604924835,-0.0850557339385949,-0.0711577030255414,1.05227731524277e-106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29213,-0.0437021752881977,0.00199553838542871,-0.047613430523638,-0.0397909200527574,1.83975068042606e-105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,24917,-0.133760318526942,0.00613238434349879,-0.1457797918402,-0.121740845213684,1.69460788110322e-104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFM,Afamin,24961,-0.0281606593862589,0.00130563231902047,-0.0307196987315391,-0.0256016200409788,3.04553554541193e-102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28911,-0.0745859796401239,0.0034692780512678,-0.0813857646206088,-0.067786194659639,9.98522513390456e-102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,29449,-0.0781187841174412,0.00366367690511743,-0.0852995908514714,-0.0709379773834111,4.02075319754955e-100
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FURIN,Furin,29561,-0.0475401056903517,0.00224815116562359,-0.0519464819749739,-0.0431337294057294,1.60494871847625e-98
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,28926,-0.112936399398215,0.00534435577198866,-0.123411336711313,-0.102461462085117,2.24863733658829e-98
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,29438,0.0406176621455235,0.00192383623073715,0.0368469431332787,0.0443883811577683,3.24824417178717e-98
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29815,0.0349248291280962,0.00165462528508724,0.0316817635693253,0.0381678946868672,3.56356921253712e-98
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28911,-0.118077883359438,0.00561458686639229,-0.129082473617567,-0.107073293101309,1.85421205955088e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29781,0.0366708395033492,0.00174627516045035,0.0332481401888665,0.0400935388178318,3.36721698090284e-97
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,29623,0.0384419896319153,0.00186613163388437,0.034784371629502,0.0420996076343287,1.25073342777079e-93
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,29438,0.0372409970447329,0.00181106899071294,0.0336913018229356,0.0407906922665303,2.67053038962243e-93
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,24376,-0.0396417268333439,0.00192813630553871,-0.0434208739921998,-0.035862579674488,3.90156097214529e-93
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24376,0.0421670384282498,0.00205494007306805,0.0381393558850364,0.0461947209714632,8.72526583872984e-93
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29540,0.0402904205221075,0.00197663465204675,0.0364162166040959,0.0441646244401192,1.0070851558005e-91
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24799,-0.116209681931208,0.00571110612693738,-0.127403449940005,-0.105015913922411,2.69557189127419e-91
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29561,0.0546589764088474,0.00269564112937421,0.0493755197952739,0.0599424330224208,8.56176018227658e-91
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28930,-0.107102445436554,0.00529356052467139,-0.11747782406491,-0.0967270668081982,2.13947725741145e-90
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29720,-0.0501576016980438,0.00248178411578659,-0.0550218985649855,-0.0452933048311021,3.2164273110999e-90
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,27437,-0.0550234112790851,0.00273641391281102,-0.0603867825481947,-0.0496600400099755,2.77593404071316e-89
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,29554,-0.0431159694805659,0.00219180022050771,-0.047411897912761,-0.0388200410483708,1.33821890067237e-85
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29531,-0.0434628592022582,0.00223517461310193,-0.047843801443938,-0.0390819169605784,1.0751798390034e-83
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,28769,-0.0668006872231434,0.0034639688562088,-0.0735900661813127,-0.0600113082649742,2.40617040072743e-82
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24574,-0.0338405089363395,0.00175491970559426,-0.0372801515593043,-0.0304008663133748,3.01567156278123e-82
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29421,-0.108989723955384,0.00565581262255381,-0.120075116695589,-0.0979043312151783,3.06414646064142e-82
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MME,Neprilysin,29344,-0.103140836286244,0.00539468878982867,-0.113714426314308,-0.0925672462581794,5.46632116091355e-81
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH1,Somatotropin,29428,0.225373286032487,0.0119255383935533,0.201999230781123,0.248747341283852,3.46865808807783e-79
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,29781,-0.0356047053385636,0.00190622650531736,-0.0393409092889856,-0.0318685013881415,2.06948004601771e-77
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28911,-0.0831176570238571,0.00445182647365459,-0.0918432369122201,-0.0743920771354941,2.45777408110042e-77
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23820,-0.0400943973107147,0.00215691410869046,-0.0443219489637479,-0.0358668456576814,1.38124802723648e-76
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28792,-0.0946478554407906,0.00514416291641624,-0.104730414756966,-0.0845652961246148,3.6091437064257e-75
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,29475,0.064553734978099,0.00353185681289139,0.0576312956248319,0.0714761743313661,3.21482346293849e-74
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),24479,0.218981179006352,0.012009051314453,0.195443438430024,0.242518919582679,8.44716294423534e-74
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29344,-0.0837410475251918,0.00465074590410973,-0.0928565094972469,-0.0746255855531367,4.28258262390352e-72
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29589,0.0402771827614107,0.00223778887670303,0.0358911165630728,0.0446632489597486,4.84215960321676e-72
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29589,0.0522395298097499,0.002942204124707,0.0464728097253242,0.0580062498941757,3.63489021548059e-70
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,29576,0.0515391934288657,0.00290367617169942,0.0458479881323349,0.0572303987253966,4.01339735204474e-70
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24887,0.0864538533418702,0.0049279896990303,0.0767949935317708,0.0961127131519696,1.72722311591998e-68
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,24402,0.0363880715380225,0.00207952763187594,0.0323121973795456,0.0404639456964993,3.85653714843749e-68
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,29720,0.0539840095255288,0.00310662083347498,0.0478950326919178,0.0600729863591397,2.65040700633605e-67
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELE,E-selectin,29815,-0.058731458016388,0.00338776575218943,-0.0653714788906793,-0.0520914371420967,5.33715272592918e-67
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,29572,-0.0756747489946452,0.00438915577974321,-0.0842774943229419,-0.0670720036663485,2.74666036781395e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,29720,-0.0391213015256403,0.00227555122354169,-0.043581381923782,-0.0346612211274986,6.35791995833209e-66
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,29187,0.0326689339964238,0.00190594527466878,0.028933281258073,0.0364045867347747,1.54977929553226e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29689,0.0249232318465093,0.00145825590131306,0.0220650502799357,0.0277814134130829,3.54691743563826e-65
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,29599,-0.0683385461408484,0.00401601181133369,-0.0762099292910624,-0.0604671629906343,1.25842008001315e-64
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29815,0.0389908501337904,0.00229513113827067,0.0344923931027799,0.0434893071648009,2.00993333915641e-64
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29438,0.0307323056549825,0.00181369334754606,0.0271774666937922,0.0342871446161727,4.2515944654966e-64
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,24324,-0.0428350178904721,0.00253038320089821,-0.0477945689642326,-0.0378754668167116,6.47389014198996e-64
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,29213,0.0385964962839572,0.00228946833671954,0.0341091383439869,0.0430838542239275,1.82190731017809e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,29540,-0.020594663741271,0.00122327064652937,-0.0229922742084686,-0.0181970532740735,2.63722042051388e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28792,-0.0669498239631395,0.0039798959425426,-0.074750420010523,-0.059149227915756,3.37698082628695e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,29561,-0.045413293315322,0.00270166518174864,-0.0507085570715493,-0.0401180295590947,4.09647829515042e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24224,-0.139033785942089,0.00828250689597088,-0.155267499458192,-0.122800072425987,6.95971708665101e-63
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,24190,-0.091524992668066,0.00546055724262173,-0.102227684863605,-0.0808223004725274,1.06200329593749e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24933,-0.0370381935032253,0.00221083985164809,-0.0413714396124555,-0.032704947393995,1.18637642676202e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29344,-0.0896096590028135,0.00535226033328552,-0.100100089256053,-0.0791192287495739,1.2577697282526e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29815,0.0358148341164944,0.00214382533640367,0.0316129364571432,0.0400167317758456,2.2779962613307e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,29815,-0.0587603302239307,0.00351771648595494,-0.0656550545364024,-0.051865605911459,2.35216419930056e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29473,-0.0381049755670735,0.00228407664774789,-0.0425817657966593,-0.0336281853374876,3.37114235543987e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24883,0.0548049174028286,0.00329281439248285,0.0483510011935623,0.061258833612095,7.25893424964817e-62
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29344,0.0454419007243023,0.00275456784082682,0.0400429477562817,0.0508408536923229,7.26337468386662e-61
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,24863,-0.0489464315601966,0.00297754638625717,-0.0547824224772607,-0.0431104406431326,2.11372259215703e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,29689,0.0413274159694529,0.00251714245162038,0.0363938167642769,0.0462610151746288,2.60788512072497e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29473,0.0298667434613564,0.00182791897433296,0.0262840222716638,0.033449464651049,9.51567265135379e-60
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,29627,-0.0531506807146237,0.00326076049148876,-0.0595417712779417,-0.0467595901513057,1.79012204526168e-59
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29720,0.0634284243933305,0.0039530136326198,0.0556805176733957,0.0711763311132653,1.07336786186473e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29429,-0.0299236481742144,0.00186925546123899,-0.0335873888782428,-0.026259907470186,1.95544947076328e-57
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,29213,-0.0556580881184453,0.00350795684913147,-0.062533683542743,-0.0487824926941477,1.8697761625895e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29031,-0.157106378192743,0.00991493564476908,-0.17653965205649,-0.137673104328995,2.60570599308072e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29689,0.0486805091611662,0.00308607031813476,0.0426318113376221,0.0547292069847104,7.89068874955105e-56
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,29539,-0.0324737233569639,0.00206233535230622,-0.0365159006474841,-0.0284315460664437,1.23107709512124e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,29745,0.0569717000637634,0.00363543547706055,0.0498462465287247,0.0640971535988021,3.95700758057867e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASN,Vasorin,29060,0.0289918536292406,0.00185583640762132,0.0253544142703028,0.0326292929881783,8.62226577006808e-55
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,24800,-0.116197193216844,0.0074664201142961,-0.130831376640864,-0.101563009792823,2.36238408717695e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24878,0.0155096290891208,0.000997859577906471,0.0135538243164241,0.0174654338618175,3.19994142741103e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTR,Transthyretin,24702,-0.0264770254173856,0.00170776074624568,-0.0298242364800271,-0.023129814354744,5.86276038779868e-54
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29438,0.03883669020263,0.0025259802632665,0.0338857688866276,0.0437876115186323,3.88367988136233e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,29438,-0.033301551713296,0.00217084922288182,-0.0375564161901443,-0.0290466872364476,6.59035760558813e-53
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24961,0.0268544297084433,0.00175418210483889,0.023416232782959,0.0302926266339275,1.15939559657646e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29561,-0.0358531738490413,0.00235160985445205,-0.0404623291637673,-0.0312440185343153,2.75948771731406e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29650,-0.0322243990582354,0.00211516739468498,-0.0363701271518179,-0.0280786709646528,3.27204496968405e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28548,-0.103676652567431,0.006806597370876,-0.117017583414348,-0.0903357217205138,3.49173543656276e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,28759,-0.0608298104638259,0.00400561430543802,-0.0686808145024844,-0.0529788064251674,6.94941656668251e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29669,-0.0430770073119814,0.00283881355796341,-0.0486410818855897,-0.0375129327383731,8.19543403820547e-52
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29531,0.0460727446045011,0.00304490190102159,0.0401047368784988,0.0520407523305035,1.57660589595735e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29537,0.0315040120228163,0.00208507634044159,0.0274172623955507,0.0355907616500818,2.19036135067779e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29213,-0.0332497639877044,0.00221190427734708,-0.0375850963713047,-0.0289144316041041,7.00695131908103e-51
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29344,-0.0821261194099895,0.00547541722692448,-0.0928579371747615,-0.0713943016452175,1.14818216098892e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,29689,-0.0374100741811115,0.00249522228323715,-0.0423007098562564,-0.0325194385059667,1.25675800025408e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,24376,-0.0405731272314616,0.00271604537738688,-0.0458965761711399,-0.0352496782917833,3.09880522728022e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,24235,-0.0644186141016315,0.00431480843788121,-0.0728756386398786,-0.0559615895633843,3.53452232977578e-50
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24376,-0.0375221228664117,0.00252805698978109,-0.0424771145663826,-0.0325671311664407,1.28636554245612e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24917,-0.0283153551956858,0.00191071743938555,-0.0320603613768815,-0.0245703490144901,1.78857990702305e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POSTN,Periostin,24933,0.0377611528277205,0.00255205826583396,0.0327591186266859,0.0427631870287551,2.50527529978253e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29556,0.0310375829098196,0.00210987643739455,0.0269022250925263,0.0351729407271129,8.20413684146635e-49
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,24235,-0.0531469704053034,0.00363514597912119,-0.0602718565243809,-0.0460220842862258,3.34582921901319e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,29296,-0.0743266876160413,0.0050861165890944,-0.0842954761306663,-0.0643578991014163,3.39927580558431e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24235,-0.0563733530533867,0.00385883257122794,-0.0639366648929934,-0.0488100412137799,3.9495843747052e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29473,-0.0418394208220307,0.00287236280857511,-0.0474692519268379,-0.0362095897172235,6.76379649642814e-48
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29576,0.019965612569096,0.00138056742648016,0.0172597004131949,0.0226715247249971,3.05889021870518e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28792,-0.0616876323574742,0.00426707120779652,-0.0700510919247554,-0.0533241727901931,3.33151478365764e-47
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24235,0.058936570429201,0.00410049277740621,0.0508996045854849,0.0669735362729172,1.18887478400576e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,29344,-0.0541728340634446,0.00378247044781986,-0.0615864761411715,-0.0467591919857177,2.284168995192e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,29430,0.0434882425361538,0.00303846522875323,0.0375328506877975,0.0494436343845101,2.61378896632588e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24788,-0.050580890862086,0.003533509596687,-0.0575065696715925,-0.0436552120525795,2.71328902666176e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,29720,-0.0444121356233297,0.00310707677195485,-0.0505020060963612,-0.0383222651502982,3.40178184001959e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24800,-0.0938807973594708,0.00658209425812311,-0.106781702105392,-0.0809798926135495,5.65425444693847e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29344,0.0230616198833264,0.00161856077765804,0.0198892407591166,0.0262339990075361,6.5454692718603e-46
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREH,Trehalase,24933,-0.0717077667758843,0.00504455428751285,-0.0815950931794095,-0.0618204403723591,1.11773974919615e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29385,-0.047967503624914,0.00338539400401513,-0.0546028758727837,-0.0413321313770443,2.01333146624719e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,24917,-0.0252213527882768,0.00178201035830346,-0.0287140930905516,-0.021728612486002,2.67027702394278e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29438,0.0277395864000582,0.00196122997292257,0.02389557565313,0.0315835971469865,2.86391108120413e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,29522,0.0370378139486778,0.00262508269141486,0.0318926518735047,0.0421829760238509,4.67204977017829e-45
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,29473,-0.059940195609039,0.00428090106064851,-0.0683307616879101,-0.051549629530168,2.11062515481712e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29492,0.0318569476112344,0.00227556407117129,0.0273968420317386,0.0363170531907301,2.17571874804303e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29449,0.0322885381554584,0.00231026349379985,0.0277604217076107,0.0368166546033061,3.020436275755e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,24900,0.0324668999511537,0.00232300096417625,0.0279138180613683,0.0370199818409392,3.19831059472218e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,29344,-0.0334779235682158,0.00240545950059169,-0.0381926241893756,-0.0287632229470561,6.84366724223148e-44
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,24235,-0.0561285699622031,0.00405577399413592,-0.0640778869907096,-0.0481792529336967,2.16379811339908e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29344,-0.0368493576874542,0.00266986910929612,-0.0420823011416746,-0.0316164142332338,3.386797181285e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,29344,-0.0425066110708463,0.00308341747747544,-0.0485501093266982,-0.0364631128149944,4.24427718175047e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,23783,0.0403425104264088,0.00292755921658688,0.0346044943618985,0.0460805264909191,4.90604120058322e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELL,L-selectin,24961,0.0215293273846792,0.00156438565729692,0.0184631314963772,0.0245955232729812,6.17884732076427e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,29429,-0.0363740528592976,0.00264872281379305,-0.041565549574332,-0.0311825561442633,8.76990794831218e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29815,0.0267419398770397,0.0019481310151433,0.0229236030873588,0.0305602766667206,9.44643745785634e-43
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29399,-0.0182787868299468,0.00134224229706456,-0.0209095817321933,-0.0156479919277002,4.19664001809205e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29429,0.0358409008240458,0.00263962270638435,0.0306672403195325,0.0410145613285591,7.22969353957373e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,29590,-0.062217930458709,0.00458925154325786,-0.0712128634834944,-0.0532229974339235,9.55971947538097e-42
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24360,-0.0428263897910335,0.00318624291811417,-0.0490714259105373,-0.0365813536715298,4.86934002820301e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,29344,-0.063169708065143,0.00470432657545613,-0.072390188153037,-0.053949227977249,5.47838635337361e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29344,0.038202740515465,0.00285087534276896,0.0326150248436379,0.0437904561872922,7.93629488407433e-41
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24788,-0.0342297570780853,0.00256001551096838,-0.0392473874795833,-0.0292121266765873,1.23723260014763e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSN,Gelsolin,24840,0.0171949032955207,0.00128655902338383,0.0146732476096884,0.019716558981353,1.3374225101291e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,29815,0.0147778017636949,0.00110623999966895,0.0126095713643437,0.016946032163046,1.38138080720146e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28638,-0.0495874079396712,0.00371575770572981,-0.0568702930429016,-0.0423045228364407,1.67053085727045e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,24961,-0.0321887983819371,0.00241176603436579,-0.0369158598092941,-0.0274617369545802,1.70814035090695e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,29438,-0.0504517913363541,0.00378186169985017,-0.0578642402680605,-0.0430393424046478,1.76527278711137e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,29781,-0.0272430378193558,0.00204559600142873,-0.0312524059821561,-0.0232336696565555,2.3770799292295e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24917,-0.0587712398694275,0.0044455902047421,-0.067484596670722,-0.050057883068133,9.14432223748314e-40
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAST,Gastrin,24840,-0.115341139504405,0.00878045859847464,-0.132550838357415,-0.0981314406513946,2.76508374914807e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24618,0.0369983211984851,0.0028204891626464,0.0314701624396981,0.042526479957272,3.52998238237243e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29374,-0.0474399803568069,0.00363640405185351,-0.0545673322984398,-0.040312628415174,8.60417926523599e-39
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,24552,-0.0208993357521943,0.00160875290914925,-0.0240524914541268,-0.0177461800502618,1.84294621456774e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28926,-0.0482099356621032,0.00372304267179593,-0.0555070992988232,-0.0409127720253831,3.03865293906799e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24961,0.0225024094275868,0.00174626247956999,0.0190797349676297,0.025925083887544,7.12592828298021e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,24376,-0.0454065545590545,0.00352695025689691,-0.0523193770625724,-0.0384937320555365,8.35759989081606e-38
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29720,-0.110877142628445,0.00863320548321533,-0.127798225375547,-0.0939560598813434,1.18450068336794e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24917,-0.0704579036425195,0.00550739865014235,-0.0812524049967985,-0.0596634022882405,2.3429973581019e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24106,-0.0485492842295706,0.00379542564683607,-0.0559883184973693,-0.0411102499617719,2.41917958336981e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,29540,0.0239104739981796,0.00187133965599988,0.0202426482724199,0.0275782997239394,2.76041644547079e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24863,-0.0498175860587304,0.00390223038603533,-0.0574659576153597,-0.0421692145021012,3.30472341316895e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,29463,0.0332124082728283,0.00260620598117887,0.0281042445497177,0.0383205719959389,4.24224506735747e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPN,Asporin,24917,0.0236209444587197,0.00185891675847939,0.0199774676121001,0.0272644213053393,7.05427177155383e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24376,-0.0332760305482704,0.00262339894157855,-0.0384178924737643,-0.0281341686227764,9.44179829899097e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,29473,0.0440172957356671,0.00347206644266138,0.0372120455080508,0.0508225459632834,9.82460390096969e-37
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,29634,-0.0494166550583873,0.00389874193475098,-0.0570581892504992,-0.0417751208662754,1.01321194289509e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,29815,0.0232146563810704,0.00184010183147356,0.0196080567913822,0.0268212559707586,2.13673648654144e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29561,-0.030491745488006,0.00242057572425277,-0.0352360739075414,-0.0257474170684705,2.72278787395099e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24376,-0.0419973036092327,0.00333741410650103,-0.0485386352579747,-0.0354559719604907,3.36105097688361e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24800,0.0254030624913875,0.00201932938845836,0.0214451768900091,0.0293609480927658,3.51165694197382e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29731,-0.0425423154969574,0.00338804630428274,-0.0491828862533516,-0.0359017447405632,4.51683904001404e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,29429,-0.0277669439405298,0.00221417425336909,-0.0321067254771332,-0.0234271624039263,5.53764090843186e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,29344,0.0238214885848555,0.00190154681121886,0.0200944568348665,0.0275485203348444,6.53198569752218e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28792,-0.0692943930859011,0.00553642151160542,-0.0801457792486477,-0.0584430069231545,7.55900421363772e-36
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,29815,-0.0496476877921671,0.003982034956156,-0.0574524763062329,-0.0418428992781014,1.37067559709418e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29344,-0.0572125579181274,0.00458941533219059,-0.0662078119692209,-0.0482173038670338,1.40502884899492e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEP,Leptin,29473,-0.0563489261223792,0.00453163789060006,-0.0652309363879553,-0.0474669158568031,2.08230675317229e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29623,-0.0395694209335882,0.00318231032370303,-0.0458067491680462,-0.0333320926991303,2.09002241310526e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,28472,-0.0337246073579765,0.00271352453452308,-0.0390431154456418,-0.0284060992703113,2.2660775932284e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24639,-0.0266525951521822,0.00214619547252099,-0.0308591382783233,-0.022446052026041,2.64514548027247e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24648,-0.0227566398179947,0.00184146178452945,-0.0263659049156724,-0.019147374720317,5.60487403311535e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28911,-0.0765150782794702,0.00619439878294355,-0.0886560998940396,-0.0643740566649009,5.80112743620154e-35
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24933,0.0178831319571369,0.00145345801365582,0.0150343542503715,0.0207319096639023,1.08906062335051e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29344,-0.0876865461676531,0.00713269830908472,-0.101666634853459,-0.0737064574818471,1.19337669784537e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,29482,-0.026149229016428,0.0021306071365515,-0.030325219004069,-0.0219732390287871,1.53359537940163e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24224,0.0268274419069422,0.0021876270418011,0.022539692905012,0.0311151909088723,1.80548894103944e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29815,0.0130475519776078,0.00107030612417195,0.0109497519742308,0.0151453519809849,4.21218192728032e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29438,-0.0435682200820801,0.00358666157293536,-0.0505980767650335,-0.0365383633991268,7.14824336317822e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,29429,-0.0391346157336678,0.0032270465183128,-0.0454596269095608,-0.0328096045577747,9.14099117485196e-34
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24376,-0.0618212800761221,0.00510226311796971,-0.0718217157873427,-0.0518208443649015,1.08051664685465e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,24863,-0.0432187226477736,0.0035694491901016,-0.0502148430603727,-0.0362226022351744,1.19243563983213e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,29506,0.030233447426643,0.00250090543317802,0.0253316727776141,0.035135222075672,1.44982104880575e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29429,-0.0417163382213098,0.00346113056026433,-0.0485001541194279,-0.0349325223231917,2.24700763734841e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,24946,-0.022242405917252,0.00185823642065453,-0.0258845493017348,-0.0186002625327691,6.31001084761526e-33
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,29720,-0.0213403372804775,0.00179399064553737,-0.0248565589457308,-0.0178241156152243,1.48176148404999e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29589,0.0242027875229465,0.00204049349205578,0.0202034202785171,0.0282021547673758,2.22840920761907e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29344,-0.0348884026086392,0.00294648217837502,-0.0406635076782543,-0.0291132975390242,2.84828918557131e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPTC,Opticin,29344,0.0359843808789908,0.00305144866780212,0.0300035414900987,0.041965220267883,5.03734537598961e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD248,Endosialin,24933,0.0319192286559709,0.00271321472679306,0.0266013277914565,0.0372371295204853,7.23493366893868e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29473,-0.0241377893516527,0.00205492484642928,-0.0281654420506541,-0.0201101366526513,8.68612294068395e-32
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29344,0.0156226103419154,0.00133454075521852,0.0130069104616871,0.0182383102221437,1.390339431377e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29344,-0.0685564391269119,0.00586022031568775,-0.0800424709456599,-0.0570704073081639,1.52260018097848e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,29561,0.0217194154230232,0.00185760292642799,0.0180785136872244,0.0253603171588221,1.64004537632464e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,29429,-0.0599065479170178,0.00512454695367928,-0.0699506599462292,-0.0498624358878064,1.68127855825787e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,29213,0.0201082406376077,0.00173774572195317,0.0167022590225794,0.0235142222526359,6.71633107590878e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29438,0.0280635487855405,0.0024265233822648,0.0233075629563015,0.0328195346147796,7.20193587362875e-31
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,29213,-0.0325469232135414,0.00282238424015629,-0.0380787963242477,-0.0270150501028351,1.06427665174512e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,29781,-0.0266685361873003,0.00232043497224056,-0.0312165887328917,-0.0221204836417088,1.66110293886549e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24917,-0.0461243168207023,0.00401665899010447,-0.0539969684413071,-0.0382516652000976,1.91064389476583e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,29815,-0.0469374507235416,0.00410298082042175,-0.0549792931315682,-0.0388956083155149,3.05754476292043e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,29782,0.0332037937625479,0.00291216689132556,0.0274959466555498,0.038911640869546,4.731314530017e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24840,-0.0664275607817951,0.00582768265368263,-0.0778498187830131,-0.0550053027805772,5.04507671456903e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,29473,-0.0520683720016879,0.00459060877847917,-0.0610659652075071,-0.0430707787958687,9.32926521071543e-30
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TF,Serotransferrin,24961,-0.0165294827920101,0.00145862301009175,-0.0193883838917899,-0.0136705816922303,1.07377517862018e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29720,0.0260153966188066,0.00230133817599502,0.0215047737938564,0.0305260194437569,1.43335458224311e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29561,-0.0167956790112868,0.00148947913352893,-0.0197150581130035,-0.0138762999095701,1.97557410675145e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,29688,-0.0431118342346396,0.00383612228212107,-0.0506306339075969,-0.0355930345616823,3.02681481598317e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,28348,0.0238926681571401,0.00212656046637088,0.0197246096430532,0.028060726671227,3.1522025310789e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNC,Tenascin,29589,0.0361374662882508,0.00322283508601101,0.0298207095196692,0.0424542230568323,4.03345314624168e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,24605,0.0818671141070613,0.00729982400496333,0.0675594590573332,0.0961747691567894,4.05305441788346e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,24376,0.0391397323991059,0.00350205161281429,0.0322757112379899,0.0460037535602219,6.2688415954003e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29429,0.0200072936993029,0.00179203845175023,0.0164948983338725,0.0235196890647334,6.95052978190857e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24917,-0.0425365942829037,0.0038140080075981,-0.050012049977796,-0.0350611385880114,8.12720662429452e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,24909,-0.0212111170064677,0.00190312174389883,-0.0249412356245094,-0.017480998388426,8.8183220167368e-29
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,29438,-0.0280984284315705,0.0025256414244386,-0.0330486856234701,-0.0231481712396708,1.07851466904668e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REN,Renin,29473,-0.0571496655279941,0.0051373459304642,-0.0672188635517039,-0.0470804675042842,1.08933794252633e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24224,-0.0335473236934086,0.00301698611224844,-0.0394606164734156,-0.0276340309134017,1.18339183104719e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29781,0.0214648941354556,0.00193265795220642,0.017676884549131,0.0252529037217802,1.32900777486476e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,29689,0.0219619429302732,0.00197751068565084,0.0180860219863976,0.0258378638741489,1.33784156966936e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29344,-0.026729020286544,0.00242341425823769,-0.0314789122326899,-0.0219791283403981,3.12990531393811e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,29344,0.0218140738943438,0.00198061227509135,0.0179320738351647,0.0256960739535228,3.72312931091314e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,29678,-0.0148583417166965,0.00135752716291887,-0.0175190949560175,-0.0121975884773755,7.92453808907183e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29492,0.0176680055313903,0.00161500513166601,0.0145025954733249,0.0208334155894556,8.40119752931518e-28
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29429,-0.067463735379745,0.00618019573507981,-0.0795769190205014,-0.0553505517389885,1.09102377523178e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28748,0.034012414096123,0.00312179105072276,0.0278937036367064,0.0401311245555396,1.37642179491897e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29468,0.0287335835265946,0.00263849676623257,0.0235621298647787,0.0339050371884104,1.44981872598291e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28590,-0.0144246152496411,0.00132495594387567,-0.0170215288996374,-0.0118277015996448,1.50817527772124e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28985,0.0219938310622452,0.00202501479427627,0.0180248020654637,0.0259628600590267,1.9954188806877e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29429,-0.0712737176402639,0.00657423455120885,-0.0841592173606333,-0.0583882179198945,2.46877407499828e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29344,0.0193715562816004,0.00179510820677789,0.0158531441963157,0.022889968366885,4.25462263658355e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29344,-0.070890879869004,0.00657022513321351,-0.0837685211301024,-0.0580132386079055,4.3283125555854e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,29589,-0.0389798055494682,0.00361303203493396,-0.0460613483379388,-0.0318982627609977,4.3736042525928e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24376,0.020533604995865,0.00190447575280839,0.0168008325203606,0.0242663774713694,4.83135801882183e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24946,-0.0161329614861808,0.00150047480383936,-0.0190738921017059,-0.0131920308706556,6.65006406153459e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29815,-0.0484381212187398,0.0045203874721192,-0.0572980806640935,-0.0395781617733862,9.63368954431285e-27
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29429,-0.0531181023076258,0.00496866179432632,-0.0628566794245053,-0.0433795251907462,1.26037725395537e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,29815,0.0170937872209556,0.00160629638499925,0.0139454463063571,0.0202421281355542,2.12525304865468e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,29469,0.0155763976693719,0.00146795027847317,0.0126992151235645,0.0184535802151793,2.95520156313134e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29561,0.0199976957877979,0.00188620766855268,0.0163007287574347,0.0236946628181612,3.24884702377105e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,29213,0.0241706580441795,0.00228141034422527,0.019699093769498,0.0286422223188611,3.5217556971638e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,29429,0.0245080400570794,0.00231465449861769,0.0199713172397888,0.0290447628743701,3.76721887674952e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28911,0.0153435759128909,0.00145004052197647,0.012501496489817,0.0181856553359648,4.05444977731635e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,29531,0.0224758324985361,0.00212874203104597,0.018303498117686,0.0266481668793862,5.17619941372e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,24933,-0.0802691560606863,0.00761098925784702,-0.0951866950060664,-0.0653516171153061,5.98147107766092e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,29752,0.0328471278270089,0.00311557878213101,0.0267405934140321,0.0389536622399857,6.08986638045436e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28590,-0.0613054091042783,0.00583926414506049,-0.0727503668285969,-0.0498604513799597,9.74312261497826e-26
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,29473,0.0186524299085774,0.00177823021526907,0.01516709868665,0.0221377611305048,1.07355984630379e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24106,-0.0441848462451953,0.00421398415129494,-0.0524442551817333,-0.0359254373086572,1.1463968467372e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24224,-0.0492647268571157,0.004705759987127,-0.0584880164318847,-0.0400414372823468,1.3595429232332e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,29815,0.0214670614674901,0.00205206902933814,0.0174450061699873,0.0254891167649928,1.4421605008877e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,28769,-0.0451430358466971,0.00435904501403182,-0.0536867640741995,-0.0365993076191947,4.34298023785041e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,29428,-0.0209460729742093,0.0020269900339219,-0.0249189734406962,-0.0169731725077224,5.48096564687395e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29296,-0.0179963110049472,0.0017446159658397,-0.021415758297993,-0.0145768637119014,6.62672610790385e-25
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29452,-0.0669151537747069,0.00654966609067781,-0.0797524993124354,-0.0540778082369784,1.83628584631022e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,29781,-0.031140245403216,0.00306199828245556,-0.0371417620368289,-0.0251387287696031,2.96003848969519e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,24933,0.0355197850295516,0.00349770918628176,0.0286642750244394,0.0423752950346639,3.50311614144635e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,29429,0.0298635695553331,0.00294147835493796,0.0240982719796547,0.0356288671310115,3.53785360144758e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28926,-0.0480850669824553,0.00474122733349364,-0.0573778725561028,-0.0387922614088077,3.95118775849172e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24840,-0.0521583914869649,0.00514415551428207,-0.0622409362949578,-0.042075846678972,4.11778936317054e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,29473,-0.0419035513950583,0.00413633877939027,-0.0500107754026632,-0.0337963273874534,4.42671433487258e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTD,Biotinidase,24961,-0.0141099067530187,0.00139755357903416,-0.0168491117679257,-0.0113707017381117,6.38716568829751e-24
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29689,0.0308353255051224,0.00307547137312598,0.0248074016137955,0.0368632493964493,1.27496649849352e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,29338,-0.0208563909876116,0.00208297288163364,-0.0249390178356135,-0.0167737641396097,1.46108224730095e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29438,0.0164173150705129,0.00164034349818672,0.013202241814067,0.0196323883269589,1.52590507283818e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29429,-0.0716071018614659,0.00716000292128684,-0.0856407075871881,-0.0575734961357437,1.64520529791495e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29377,0.0171931626971735,0.00172339943174392,0.0138152998109554,0.0205710255833916,2.10880445925263e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29815,0.0175647806978691,0.00176311363717353,0.0141090779690089,0.0210204834267292,2.42242759804662e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29383,0.0323510019893017,0.00324957679333222,0.0259818314743706,0.0387201725042329,2.59946040723747e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,29473,0.0208917279678727,0.0020987649866616,0.016778148594016,0.0250053073417294,2.6290307353061e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,29689,0.0201905408229936,0.00203035924870299,0.0162110366955358,0.0241700449504515,2.90348034739535e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28792,-0.0428240924094621,0.00431259260728336,-0.0512767739197375,-0.0343714108991867,3.35893121203913e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,29484,0.0184334440696158,0.0018570562760867,0.0147936137684858,0.0220732743707457,3.48357801136514e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28926,-0.040007714032193,0.0040356639234436,-0.0479176153221425,-0.0320978127422436,3.95792416616784e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29589,0.038948876207187,0.00394356187206715,0.0312194949379354,0.0466782574764386,5.70903214163688e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29429,-0.0570604957199286,0.00579378614884626,-0.0684163165716673,-0.0457046748681899,7.54254918278161e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24933,-0.0154691812034656,0.00157336511366374,-0.0185529768262465,-0.0123853855806847,9.02651937718827e-23
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,24224,-0.0296142234131376,0.00301764634650309,-0.0355288102522836,-0.0236996365739915,1.08382385880678e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29561,0.0158294274979783,0.00161841823454639,0.0126573277582674,0.0190015272376892,1.47300046735604e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29720,-0.0188829226627941,0.00193122842856937,-0.0226681303827901,-0.0150977149427982,1.518428055984e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29213,-0.0370565137867934,0.00379363314939311,-0.0444920347596039,-0.0296209928139829,1.67104042114625e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29689,-0.0343999652545045,0.0035220781536668,-0.0413032384356915,-0.0274966920733176,1.68755976481483e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29095,-0.0311822212886695,0.00319744478154376,-0.0374492130604952,-0.0249152295168437,1.9533356225506e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24106,-0.0240730153874389,0.00246812302794796,-0.0289105365222169,-0.0192354942526609,1.95960437329635e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,29213,-0.0582678173905101,0.00597633800232768,-0.0699814398750724,-0.0465541949059479,2.00082309643951e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29623,0.0133376617246248,0.00136822005895743,0.0106559504090682,0.0160193730401814,2.02965278420853e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,28790,-0.0326274233181244,0.00335724972275288,-0.0392076327747201,-0.0260472138615288,2.72125444956107e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,24523,-0.0183688414986635,0.00189531291575214,-0.0220836548135377,-0.0146540281837892,3.58366332457693e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29158,-0.0474971171205576,0.00490645330450888,-0.057113765597395,-0.0378804686437202,3.93891792101405e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,29815,-0.0287612800407786,0.00297322995406388,-0.0345888107507438,-0.0229337493308134,4.21517656607121e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,29561,-0.0348962893593312,0.00362130966639483,-0.0419940563054651,-0.0277985224131973,6.04705780990729e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,29438,-0.0152550541088742,0.00158645648590237,-0.0183645088212428,-0.0121455993965055,7.38422042030498e-22
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,24914,-0.0362596971120575,0.0037855766285124,-0.0436794273039418,-0.0288399669201732,1.07444716934787e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24840,-0.0305633984203282,0.00319197910373301,-0.0368196774636449,-0.0243071193770115,1.10967987771974e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29420,0.0143718496069877,0.00150591695985204,0.0114202523656777,0.0173234468482977,1.4826417589811e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,24235,-0.0388024267917318,0.00406860304081507,-0.0467768887517294,-0.0308279648317343,1.60333680545181e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,24917,-0.0191559013098971,0.00201284933589091,-0.0231010860082433,-0.0152107166115509,1.94219505674759e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28769,-0.0332026662291901,0.00349233920284874,-0.0400476510667736,-0.0263576813916065,2.10406057954889e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29344,-0.0729671719165215,0.00767976318498244,-0.0880195077590871,-0.057914836073956,2.22661244426895e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28792,-0.0457686710038653,0.00482058392126438,-0.0552170154895435,-0.0363203265181871,2.37961782421265e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29589,-0.029381667544029,0.0031043279998248,-0.0354661504236856,-0.0232971846643724,3.15369317087613e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24788,-0.0363965385030557,0.00385117156518496,-0.0439448347708182,-0.0288482422352932,3.65125025329794e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29397,0.0355631975380416,0.00376451622350545,0.0281847457399709,0.0429416493361123,3.73818070809873e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,29815,0.018742880029957,0.00198950004736862,0.0148434599371145,0.0226423001227995,4.78437133653637e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24788,-0.0441441900663991,0.00468505780187471,-0.0533269033580735,-0.0349614767747247,4.78443387319111e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29344,-0.0280326249215183,0.00297623766521913,-0.0338660507453478,-0.0221991990976888,4.88539556379366e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29589,0.0175637064337756,0.00186687195590142,0.0139046374002088,0.0212227754673424,5.40538280554016e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,24800,-0.0635824302241925,0.00676321184425856,-0.0768383254389393,-0.0503265350094457,5.84488651492869e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29755,-0.0242771004799036,0.00258677356382145,-0.0293471766649937,-0.0192070242948136,6.71895443005238e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXN,Paxillin,28769,-0.0326768712860407,0.00348186028757408,-0.0395013174496859,-0.0258524251223955,6.7470560788621e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,29697,0.0227147755903289,0.00242237419228085,0.0179669221734585,0.0274626290071994,7.24918799123789e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24815,-0.0691422533392038,0.00737309921212292,-0.0835935277949648,-0.0546909788834429,7.30522612995606e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29561,0.0267781527159308,0.00285908216289362,0.0211743516766593,0.0323819537552023,8.0512775373082e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29561,-0.015672207586808,0.00167475734842285,-0.0189547319897168,-0.0123896831838992,8.69084509671749e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24106,-0.0430777240254085,0.00460588785332251,-0.0521052642179206,-0.0340501838328964,9.26028805944858e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,28792,-0.0397255762113476,0.00425171799816748,-0.0480589434877558,-0.0313922089349393,9.97951289756128e-21
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24863,-0.039408925932229,0.00422302671255538,-0.0476860582888375,-0.0311317935756204,1.12394186216666e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24933,0.0208119234195622,0.00223028798367484,0.0164405589715595,0.0251832878675649,1.1281317977186e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28926,0.0252484100843877,0.0027090950857268,0.0199385837163632,0.0305582364524123,1.24506523285525e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29344,-0.0374214755856025,0.00401950676415619,-0.0452997088433486,-0.0295432423278564,1.36511236272565e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24840,0.0193649769348866,0.00208110770179809,0.0152860058393623,0.0234439480304109,1.44548504515266e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24376,0.0257708612296331,0.00277086664916289,0.0203399625972739,0.0312017598619924,1.50968825961488e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,24106,-0.0270753002409177,0.00291149383069148,-0.032781828149073,-0.0213687723327623,1.52805791304773e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29720,0.0206719260794123,0.0022234536503396,0.0163139569247466,0.0250298952340779,1.53732693214831e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,24946,-0.0456580760226975,0.00491538337496111,-0.0552922274376213,-0.0360239246077738,1.68371326972311e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29503,0.0308663680154305,0.00332956133502989,0.0243404277987719,0.0373923082320891,1.97692645265939e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,24376,-0.0170528801499311,0.00184197359251064,-0.0206631483912519,-0.0134426119086102,2.25086999952277e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,29720,-0.0404159181877025,0.00438142549817733,-0.04900351216413,-0.0318283242112749,3.0353083001475e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,29187,-0.023081719279395,0.00250233814555996,-0.0279863020446925,-0.0181771365140975,3.0476906444489e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29438,0.0177840545837443,0.00192940581180856,0.0140024191925995,0.0215656899748891,3.24149033997097e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,29395,-0.0569619532554127,0.00619757388559232,-0.0691091980711736,-0.0448147084396518,4.14081283004147e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,29720,0.0102784800936022,0.00112249442657014,0.0080783910175247,0.0124785691696797,5.67798490607237e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,24376,-0.039371047028165,0.00430499509099196,-0.0478088374065092,-0.0309332566498207,6.39097139259986e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,29344,-0.0832728800745869,0.0091289817465085,-0.101165684297744,-0.0653800758514302,7.84694328533107e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29720,-0.021062618478894,0.00231026195939128,-0.0255907319193009,-0.016534505038487,8.19742349965738e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29561,-0.0508783011989182,0.00559039139790108,-0.0618354683388043,-0.0399211340590321,9.49516932063175e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29561,0.0169649173540934,0.00186423845274422,0.0133110099867148,0.0206188247214721,9.56871589487318e-20
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29213,-0.0451383925527175,0.00496916531278471,-0.0548779565657755,-0.0353988285396595,1.11391711835635e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24917,0.0200857510742867,0.00221279576557543,0.0157486713737589,0.0244228307748146,1.19557301444976e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,29213,-0.0323999426265459,0.0035726746244023,-0.0394023848903744,-0.0253975003627174,1.27650950574679e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29815,0.017814589441673,0.00196795759197155,0.0139573925614087,0.0216717863219372,1.4825479813586e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29074,0.0232724311370274,0.00257520551106942,0.0182250283353313,0.0283198339387234,1.70579247125233e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,29438,-0.0272539476402986,0.00302292090343337,-0.033178872611028,-0.0213290226695692,2.07050384937485e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29781,-0.0465164018293861,0.00518699686106108,-0.0566829156770658,-0.0363498879817064,3.19526957269617e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29429,-0.0242784624860441,0.00271241182665715,-0.0295947896662921,-0.0189621353057961,3.72913262298039e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28769,-0.0319576140266966,0.0035728799583345,-0.0389604587450322,-0.024954769308361,3.95535044066349e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,29526,0.0168890187441113,0.00189758805173526,0.0131697461627102,0.0206082913255124,5.88328605432298e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29815,-0.0237041558278288,0.00266665126196289,-0.028930792301276,-0.0184775193543815,6.49923901350226e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29781,-0.0196707727095719,0.00221512746959394,-0.024012422549976,-0.0153291228691678,7.04052367174931e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,29344,-0.0434711507990368,0.00489763934157996,-0.0530705239085335,-0.0338717776895401,7.32035358590487e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,24376,0.0311158767601887,0.00350855552492774,0.0242391079313304,0.0379926455890471,7.90615520635943e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28949,0.0248278720607,0.00280055073445146,0.0193387926211751,0.0303169515002248,8.05432459305208e-19
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29603,-0.0613724002680747,0.0069564541693136,-0.0750070504399293,-0.04773775009622,1.18093016777873e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,29561,0.0178264150625482,0.00202194939161796,0.013863394254977,0.0217894358701194,1.24494448740748e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FST,Follistatin,29531,0.0300324294506344,0.00341316483813521,0.0233426263678893,0.0367222325333794,1.45409218894249e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,29429,-0.0564013921917805,0.00641968083678252,-0.0689839666318743,-0.0438188177516868,1.63663368378876e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,24224,0.0179635730317928,0.0020461064258614,0.0139532044371045,0.0219739416264812,1.75011306260722e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORT1,Sortilin,29428,-0.0220593969157165,0.00251376026299154,-0.02698636703118,-0.0171324268002531,1.79226350335787e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29650,-0.0181102975865735,0.00206742279050646,-0.0221624462559662,-0.0140581489171809,2.05727579078219e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29495,-0.0311891611957869,0.00356113335200124,-0.0381689825657093,-0.0242093398258644,2.08772004756833e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,29781,-0.0154910648471232,0.00177193372713035,-0.0189640549522986,-0.0120180747419477,2.3983734547778e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29473,-0.0512415497327046,0.00586844555362145,-0.0627437030178026,-0.0397393964476065,2.63858058531923e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24376,-0.0128922863345952,0.00147786584626933,-0.0157889033932831,-0.0099956692759073,2.86445117924446e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,24961,0.0179064260353428,0.00205500126741533,0.0138786235512088,0.0219342285194769,3.1235999460172e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24863,0.0153853930764405,0.00177143096157468,0.0119133883917542,0.0188573977611269,4.00589690900187e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,29429,-0.0475528980094914,0.00548153290371067,-0.0582967025007643,-0.0368090935182185,4.34042173663171e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,24376,-0.0193872992663176,0.00223561986498558,-0.0237691142016893,-0.0150054843309458,4.50596381456188e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29815,0.0160300862147244,0.00185511210257713,0.0123940664936732,0.0196661059357756,5.84420784892914e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,24933,0.0183291256935852,0.00212139764748134,0.0141711863045218,0.0224870650826486,5.94658285608177e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,24788,-0.0579306192830687,0.00670575286506877,-0.0710738948986035,-0.0447873436675339,6.00985106055772e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,24224,0.015396258702193,0.00178667503033432,0.0118943756427377,0.0188981417616482,7.26899857415707e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,29473,-0.0310691567239691,0.0036109295918799,-0.0381465787240537,-0.0239917347238845,8.06047131585349e-18
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24840,0.0393925216560357,0.00459939627139425,0.030377704964103,0.0484073383479684,1.14531004746793e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29296,-0.0437437939630033,0.00510947240350536,-0.0537583598738738,-0.0337292280521328,1.16962766354339e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28792,-0.0351358942797443,0.00410535784088057,-0.0431823956478702,-0.0270893929116184,1.1989531784775e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPS,Colipase,29395,0.0409864253122987,0.00479036771775544,0.031597304585498,0.0503755460390993,1.22436393341946e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,29429,0.0246740317794659,0.00288958297556356,0.0190104491473613,0.0303376144115704,1.41859758908688e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29473,0.0196482680590355,0.00230276039031589,0.0151348576940163,0.0241616784240546,1.50000124271247e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNST,Consortin,29473,-0.0623807448341161,0.00731394869345066,-0.0767160842732794,-0.0480454053949528,1.54562382354167e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,29815,0.0112689135934234,0.00132280913129086,0.00867620769609328,0.0138616194907535,1.68505262832909e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,29781,-0.0215687369089509,0.00254323284210329,-0.0265534732794733,-0.0165840005384284,2.33776417117465e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,28419,-0.0525330951585375,0.0061983995473315,-0.0646819582713072,-0.0403842320457677,2.4572524883666e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24917,-0.0429611389434478,0.00507241551214555,-0.0529030733472531,-0.0330192045396425,2.59720656990026e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29438,-0.0134005110919865,0.00158302197521336,-0.0165032341634047,-0.0102977880205683,2.67546570236873e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24933,-0.0288512103846086,0.00340853068363971,-0.0355319305245424,-0.0221704902446747,2.71412395595121e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29429,0.0300594860638466,0.00355661212422592,0.0230885263003638,0.0370304458273294,3.00107259707307e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24106,-0.0424664681445858,0.00502775221064307,-0.0523208624774462,-0.0326120738117254,3.17115606312264e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,29781,0.00507510378165772,0.000601065119288165,0.00389701614785292,0.00625319141546253,3.21718064040223e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29678,-0.0328103262057912,0.00389820159069305,-0.0404508013235496,-0.0251698510880328,4.0412467975015e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29561,-0.0150790565624125,0.00179377424409387,-0.0185948540808365,-0.0115632590439886,4.41795104126027e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29689,-0.0543683669318158,0.00647300021099738,-0.0670554473453707,-0.041681286518261,4.69089752624125e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24788,-0.0273509368233619,0.00325757632484567,-0.0337357864200594,-0.0209660872266644,4.8592787800476e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28792,-0.0361415285663735,0.00432244601683391,-0.044613522759368,-0.0276695343733791,6.47619726174359e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,29164,-0.0295979696897793,0.00354370796067589,-0.0365436372927041,-0.0226523020868546,6.99016632873925e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29492,-0.0280027918768397,0.00336059230646183,-0.0345895527975049,-0.0214160309561745,8.24112425677451e-17
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,24898,0.0201627964316863,0.00242964450304447,0.0154006932057191,0.0249248996576535,1.10571670662218e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24268,0.0192660661559789,0.00232217769368816,0.0147145978763501,0.0238175344356077,1.12689595382244e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29429,-0.0357272975954737,0.00430774410215729,-0.044170476035702,-0.0272841191552454,1.14373390219094e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,24933,0.0135272199935388,0.00163107701219599,0.0103303090496347,0.016724130937443,1.15526608907593e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24917,-0.0165358263397375,0.00199615362047612,-0.0204482874358707,-0.0126233652436043,1.25194673069699e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,29429,-0.0303712333997159,0.00366861470275551,-0.0375617182171167,-0.0231807485823151,1.29778792028319e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28792,-0.0378850789975102,0.00457653985653371,-0.0468550971163162,-0.0289150608787041,1.30507209447498e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29720,-0.0183433098757169,0.00221726974770687,-0.0226891585812223,-0.0139974611702114,1.36113157090369e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24800,-0.05964025626084,0.0072142399994962,-0.0737801666598525,-0.0455003458618275,1.44160810595792e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EZR,Ezrin,29689,-0.0133770499786393,0.00162199895709103,-0.0165561679345378,-0.0101979320227409,1.68688095576189e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29429,-0.0577639709340796,0.00700654238346623,-0.0714967940056734,-0.0440311478624858,1.72983850914978e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29429,-0.0365084729595069,0.00443003123061257,-0.0451913341715075,-0.0278256117475062,1.77601668076242e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29561,0.0135185359553095,0.00164332235294819,0.010297624143531,0.0167394477670879,2.00855221698927e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29781,-0.0210994556060362,0.00256663751110903,-0.0261300651278099,-0.0160688460842625,2.1052369895407e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29588,0.013468694473791,0.00163966619288066,0.0102549487357449,0.0166824402118371,2.22034543691465e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29213,-0.0394402208557485,0.00480605511536194,-0.0488600888818579,-0.0300203528296391,2.37278676600516e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28769,-0.0314843505455916,0.00384526912779697,-0.0390210780360736,-0.0239476230551095,2.76915769961433e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,29815,0.0145756365287466,0.00178096533093413,0.0110849444801157,0.0180663285773775,2.85119130846393e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,29429,-0.0450652245389721,0.00550898233365476,-0.0558628299129355,-0.0342676191650088,2.94393990377381e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,29656,0.0237520790653861,0.00290362306514545,0.018060977857701,0.0294431802730712,2.94708613469334e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29438,0.0242232580280715,0.00296198885911918,0.0184177598641979,0.030028756191945,2.99998583134402e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29561,-0.050439550990764,0.00616811269636956,-0.0625290518756483,-0.0383500501058796,3.01366229434381e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28962,-0.0242174649865148,0.0029638033024524,-0.0300265194593215,-0.0184084105137081,3.17989640818349e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29689,-0.036792916273796,0.00450405145131782,-0.0456208571183789,-0.027964975429213,3.2358979114963e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28769,-0.0281479432438653,0.00344596605767247,-0.0349020367169033,-0.0213938497708273,3.25260909807505e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28792,-0.0454782007157323,0.0055727871769086,-0.0564008635824731,-0.0345555378489914,3.46366609556703e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28792,-0.0271377300529788,0.00333868864273147,-0.0336815597927325,-0.0205939003132251,4.52815914543503e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,29815,-0.0244055527125798,0.00300333735844493,-0.0302920939351318,-0.0185190114900277,4.6015333768017e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28769,-0.0153645611962245,0.00189149074962003,-0.0190718830654798,-0.0116572393269693,4.72892462796404e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29473,0.0248971594414248,0.00307122414246018,0.0188775601222028,0.0309167587606468,5.40597622800005e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29344,0.0358994955423329,0.00444450641621273,0.0271882629665559,0.0446107281181099,6.87498999555921e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29344,-0.0676467803669287,0.0083834378807285,-0.0840783186131565,-0.0512152421207008,7.35023392070728e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29473,-0.0345355452367064,0.00428375049593201,-0.0429316962087331,-0.0261393942646796,7.78844997939316e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,28926,-0.0240600426195756,0.00298461572516376,-0.0299098894408966,-0.0182101957982547,7.83435437038814e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24235,-0.0377342320859006,0.00468449381509205,-0.046915839963481,-0.0285526242083202,8.30206356868716e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,24224,-0.0180240252232141,0.00223928134007829,-0.0224130166497675,-0.0136350337966606,8.72639609212254e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,29074,-0.0206773922894167,0.00257352591300971,-0.0257215030789157,-0.0156332814999176,9.7370303765458e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29727,0.0194469219203702,0.00242044741578533,0.0147028449854309,0.0241909988553094,9.74674573710789e-16
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,29213,0.0228805732268885,0.00285264836258781,0.0172893824362164,0.0284717640175606,1.08945709801137e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29473,0.017238987316519,0.0021543831223747,0.0130163963966646,0.0214615782363734,1.2706369256694e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29473,0.0424310988642468,0.00530575891844145,0.0320318113841015,0.052830386344392,1.31934869182006e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,29344,-0.0508760082706197,0.00637576986957947,-0.0633725172149954,-0.0383794993262439,1.52142907658502e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,28911,0.0126480486379094,0.00158565770723441,0.00954015953172998,0.0157559377440889,1.56029399654429e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANG,Angiogenin,29430,-0.0181639442567872,0.00227797799316022,-0.0226287811233812,-0.0136991073901932,1.59520962966544e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,24224,-0.0449424608766626,0.00564909112263416,-0.0560146794770256,-0.0338702422762997,1.85875469426325e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,29438,0.0129139508639789,0.00162674748018591,0.00972552580281451,0.0161023759251433,2.11862084051107e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24800,-0.0433168297551821,0.00549225629188622,-0.0540816520872791,-0.0325520074230852,3.22516083324089e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24096,-0.0388212448806569,0.00492502126663394,-0.0484742865632594,-0.0291682031980544,3.34549072973863e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24840,-0.0335834785104994,0.004262590675379,-0.0419381562342422,-0.0252288007867565,3.44422627778116e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,24106,-0.0360359791600151,0.0045750174831544,-0.0450030134269977,-0.0270689448930324,3.50299294972988e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29627,0.0182823483225456,0.00232950842767225,0.013716511804308,0.0228481848407832,4.36366233800227e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,29222,-0.0383361897670003,0.00489373379875493,-0.0479279080125599,-0.0287444715214406,4.89607494062052e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29429,-0.0295894582047394,0.00378290229634731,-0.0370039467055801,-0.0221749697038987,5.37698093763898e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,24376,-0.0370288213683351,0.00473368720881994,-0.0463068482976222,-0.0277507944390481,5.39168913079962e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29781,0.0134463706636547,0.00172118393233831,0.0100728501562716,0.0168198911710378,5.80038646854389e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24376,-0.0218014692084415,0.00279886328355711,-0.0272872412442135,-0.0163156971726696,7.00016455290956e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24909,0.00989194850054612,0.0012703209656159,0.00740211940793896,0.0123817775931533,7.12998529841142e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,28926,-0.0249615829759433,0.00320699435470634,-0.0312472919111678,-0.0186758740407189,7.29027287883498e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,28769,0.0389841250211841,0.00501676401751814,0.0291512675468486,0.0488169824955197,8.06027123089388e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,24946,0.0253809000867691,0.00327005377718333,0.0189715946834898,0.0317902054900485,8.70611633285555e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24788,-0.0598102003712925,0.00770760554527268,-0.0749171072400269,-0.044703293502558,8.82694234391062e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24235,0.0136750615628685,0.0017633938540537,0.0102188096089232,0.0171313135168137,9.18347284197669e-15
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELN,Elastin,24917,-0.0183606139288124,0.00237462876939993,-0.0230148863168363,-0.0137063415407885,1.09867629739666e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,24917,-0.0476388733795762,0.00617068068339809,-0.0597334075190364,-0.0355443392401159,1.20502499336981e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,29451,0.0333437288549483,0.00432030717294003,0.0248759267959859,0.0418115309139108,1.21990476406937e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,29492,0.0173457632961759,0.00225020487633591,0.0129353617385575,0.0217561648537943,1.31273867405159e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24933,-0.019393045327438,0.0025167523532372,-0.0243258799397829,-0.0144602107150931,1.3508793669941e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24252,-0.0146589398194368,0.00190319460686163,-0.0183892012488856,-0.010928678389988,1.38759625151837e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,29561,-0.0296340046927447,0.00384871335207722,-0.037177482862816,-0.0220905265226733,1.4061818043176e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,29429,-0.0475154528067895,0.0061832806030172,-0.0596346827887033,-0.0353962228248758,1.58360596053381e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLN,Promotilin,29429,-0.0461121477332868,0.00601117615331797,-0.05789405299379,-0.0343302424727835,1.75830500530574e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29815,0.0213037265243366,0.00278158099515879,0.0158518277738254,0.0267556252748479,1.93272550572756e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,29438,0.0124558396773589,0.00162670786825081,0.00926749225558728,0.0156441870991304,1.96024590463883e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29378,-0.0154330371942676,0.00201885831612191,-0.0193899994938665,-0.0114760748946687,2.16255915980053e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24840,-0.0410965648125021,0.00538021065953897,-0.0516417777051984,-0.0305513519198057,2.27741656601296e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24840,-0.0357267631841325,0.00467849005677234,-0.0448966036954063,-0.0265569226728587,2.3144078586707e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29576,-0.0149396361815491,0.00196258284092487,-0.0187862985497619,-0.0110929738133364,2.77420821712036e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29449,-0.0483723938730625,0.00635516295653264,-0.0608285132678665,-0.0359162744782586,2.79005241964082e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29390,-0.0426907099740748,0.00561045049042003,-0.053687192935298,-0.0316942270128515,2.84175305049593e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24933,0.0135933343625577,0.00178773350340527,0.0100893766958834,0.017097292029232,2.97994139748449e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,24235,0.0332195750733683,0.00437361107810322,0.024647297360286,0.0417918527864506,3.17784967553955e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29213,-0.0302159035582302,0.00398537198759057,-0.0380272326539077,-0.0224045744625527,3.51166131144239e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29781,-0.01988877859532,0.00262419403353177,-0.0250321989010423,-0.0147453582895977,3.58330469774375e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24788,-0.030496404595089,0.00402505199780835,-0.0383855065107934,-0.0226073026793847,3.66988118893216e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28792,-0.0301084080391389,0.00397597960273557,-0.0379013280605006,-0.0223154880177771,3.76855548971941e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29599,-0.0296012571490521,0.0039127051669562,-0.0372701592762863,-0.021932355021818,3.97832969197264e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29344,-0.0175936454890477,0.00232602358154158,-0.0221526517088692,-0.0130346392692262,4.0282057911025e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29421,-0.0312878493018736,0.00413765732994702,-0.0393976576685697,-0.0231780409351774,4.09332182411244e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29429,0.0238505704587764,0.00316647050274271,0.0176442882734007,0.0300568526441521,5.13133378137755e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29689,0.0139421836835678,0.00186624087831402,0.0102843515620723,0.0176000158050633,8.19447001370128e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24800,-0.02999629027682,0.00402346530932282,-0.0378822822830927,-0.0221102982705473,9.25739759335602e-14
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29429,0.0175769848537745,0.00236318776648234,0.0129451368314691,0.0222088328760799,1.05145754279837e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24800,-0.0255942318327148,0.00345211227507737,-0.0323603718918665,-0.0188280917735632,1.26396372345215e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29731,-0.0102547267684273,0.00138449703407773,-0.0129683409552196,-0.00754111258163489,1.32793813051153e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29213,-0.0266659068509645,0.00361069936667315,-0.0337428776096439,-0.0195889360922852,1.56235771039879e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,24946,-0.0115330632009691,0.00156259603913872,-0.014595751437681,-0.00847037496425726,1.62375604343251e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28911,-0.028561095392332,0.00387160494967348,-0.036149441093692,-0.020972749690972,1.66161903974625e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29540,0.0136156209970884,0.00184799377848793,0.0099935531912521,0.0172376888029248,1.78025905199382e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,24788,-0.0105929556970265,0.00143801495490073,-0.0134114650086319,-0.00777444638542106,1.80807989109596e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,29323,0.0213263407575981,0.00289539356546033,0.0156513693692958,0.0270013121459003,1.80981697854933e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29344,0.0194403302684436,0.00263996271779967,0.0142660033415562,0.024614657195331,1.83356545343788e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29429,-0.0284077655312582,0.00385852914709076,-0.0359704826595561,-0.0208450484029603,1.8546060360223e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24235,-0.0294829208294259,0.00400652114400898,-0.0373357022716835,-0.0216301393871683,1.91572165473862e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29164,-0.0443308060334472,0.0060341280042773,-0.0561576969218307,-0.0325039151450637,2.08516230538943e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29428,-0.0369271071039041,0.00503747900480864,-0.0468005659533291,-0.0270536482544792,2.35244727471256e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OCLN,Occludin,24863,-0.0217504168746784,0.00296776018317685,-0.027567226833705,-0.0159336069156517,2.39130006934607e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29815,0.0149009062722405,0.00203433613149406,0.0109136074545122,0.0188882050899689,2.45493619126656e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29344,-0.0333562892454393,0.00457406242988488,-0.0423214516080136,-0.0243911268828649,3.11981112955113e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,29346,-0.0157077399984928,0.00215825250216006,-0.0199379149027265,-0.0114775650942591,3.47331540758556e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,29689,0.0113765629283199,0.00156498770949321,0.00830918701771318,0.0144439388389265,3.69927176483403e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,29540,-0.0162033989267538,0.00223076976044731,-0.0205757076572305,-0.0118310901962771,3.86267695013267e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24376,-0.0406846595295043,0.00561191842695397,-0.0516840196463341,-0.0296852994126745,4.30184514615561e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29438,0.0392501121584213,0.00541911226431025,0.0286286521203732,0.0498715721964694,4.4995121947716e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29421,-0.0476468218604475,0.00658336987943658,-0.0605502268241432,-0.0347434168967518,4.68383147885396e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29668,0.0168973804977054,0.0023385735167696,0.012313776404837,0.0214809845905738,5.11270567311674e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29213,0.0247923467319811,0.00343210428593857,0.0180654223315415,0.0315192711324207,5.18456531504401e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29373,-0.0330932108567038,0.0045855105876788,-0.0420808116085543,-0.0241056101048534,5.44718524581914e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29473,-0.0375232303264868,0.00521163849892953,-0.0477380417843886,-0.0273084188685849,6.17027464697318e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29428,-0.0235176501017553,0.00326764863138368,-0.0299222414192673,-0.0171130587842433,6.29707013339657e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24224,-0.0386837014518947,0.00537987364634094,-0.049228253798723,-0.0281391491050665,6.64541996700528e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29344,-0.0135764317615475,0.00188888418711319,-0.0172786447682894,-0.00987421875480568,6.75437808588329e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,24224,-0.0220051733473493,0.00306252872797732,-0.0280077296541848,-0.0160026170405137,6.90037253802079e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,29473,0.0195314131592809,0.00271968232756671,0.0142008357972501,0.0248619905213116,7.05813622251733e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24840,-0.019709485479924,0.00274788958147888,-0.0250953490596226,-0.0143236219002254,7.5654583151538e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,29428,-0.0144391927511441,0.00201574255607622,-0.0183900481610535,-0.0104883373412347,8.06589078888383e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,29781,-0.0237468050261755,0.00332329397473219,-0.0302604612166506,-0.0172331488357004,9.16877074072875e-13
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24961,-0.0146338830738312,0.00205235164828177,-0.0186564923044634,-0.0106112738431989,1.02878633310176e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,24224,-0.0221318867337268,0.00310591134380111,-0.028219472967577,-0.0160443004998766,1.06430100786285e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29438,0.0193394771825648,0.00271835460508196,0.0140115021566042,0.0246674522085254,1.14964541280887e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28792,-0.0319756639178678,0.00450310868625983,-0.0408017569429371,-0.0231495708927986,1.26915569929258e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29395,-0.0404965407584814,0.0057045112013496,-0.0516773827131267,-0.0293156988038362,1.284788506158e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,24863,0.0222489846665748,0.00314179047008848,0.0160910753452014,0.0284068939879483,1.46264924284363e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,29317,-0.04023783510106,0.00569069079387474,-0.0513915890570544,-0.0290840811450655,1.57472943107087e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24235,-0.0355704285675141,0.00503160698314075,-0.04543237825447,-0.0257084788805583,1.59829347270419e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29531,-0.0411656885067341,0.00582504324477606,-0.0525827732664952,-0.029748603746973,1.61809258498636e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29429,-0.0335588635040649,0.00475318343971758,-0.0428751030459113,-0.0242426239622184,1.6983760137974e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24933,0.0126221949752117,0.00178859699598535,0.00911654486308037,0.0161278450873429,1.74542782129863e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24840,-0.0421285005889551,0.00597092317573049,-0.0538315100133869,-0.0304254911645233,1.76357818650773e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29589,-0.020052299210054,0.00284674354943954,-0.0256319165669554,-0.0144726818531525,1.90958482297902e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFI,Complement factor I,24961,-0.00947314221563572,0.00134623407436132,-0.0121117610013839,-0.00683452342988754,2.01830139883803e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,29781,0.0198517329560496,0.00282765716480062,0.0143095249130404,0.0253939409990588,2.25717817167891e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28911,-0.0260814870298929,0.00371555314036124,-0.0333639711850009,-0.0187990028747849,2.27505901848924e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29110,-0.0171202008789689,0.00244284568502904,-0.0219081784216258,-0.012332223336312,2.4647984590689e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24863,-0.0200182541858612,0.00285754579562905,-0.0256190439452941,-0.0144174644264283,2.5255859845431e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24376,0.0135033009694938,0.00193148741273539,0.00971758564053244,0.0172890162984552,2.7969461919475e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,29288,-0.0335042474766196,0.00480410774884599,-0.0429202986643577,-0.0240881962888814,3.14406289971838e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24440,-0.0530789391748634,0.00762751410758098,-0.0680288668257222,-0.0381290115240047,3.51659606499399e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,29473,0.032953230954891,0.00473918575971531,0.023664426865849,0.042242035043933,3.64139829196672e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29589,0.0161922678879517,0.00232875357724089,0.0116279108765596,0.0207566248993439,3.64528539922333e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29505,0.01071639294823,0.00154154065758704,0.00769497325935941,0.0137378126371006,3.68307986653507e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLC,Galectin-10,29421,0.0311356331991624,0.00448737552761952,0.0223403771650281,0.0399308892332966,4.04503794276764e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZN,Kazrin,24800,-0.0488155027101141,0.007035947662472,-0.0626059601285592,-0.035025045291669,4.07432702960555e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29815,-0.0191387670973854,0.00276004688780949,-0.024548458997492,-0.0137290751972788,4.16798069540776e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28911,-0.0176516625533883,0.00254843432945077,-0.0226465938391118,-0.0126567312676648,4.40491051432077e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,24324,0.0143391136945708,0.00207096470565968,0.0102800228714778,0.0183982045176638,4.50369498187848e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24235,0.0164132439330848,0.0023740119406163,0.0117601805294769,0.0210663073366928,4.83844158859192e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28792,-0.0279013529440633,0.00403686474181136,-0.0358136078380135,-0.019989098050113,4.89068298704598e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLU,Clusterin,24961,0.0148136247361111,0.00214704079092871,0.0106054247858908,0.0190218246863313,5.34130120169102e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29473,-0.016798070803585,0.00243999221693251,-0.0215804555487727,-0.0120156860583973,5.91623386516585e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24800,0.025503563341947,0.00370557297086822,0.0182406403190452,0.0327664863648487,6.02173999829281e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,28911,-0.026948534683668,0.00391676885795415,-0.0346254016452581,-0.0192716677220779,6.09450992563607e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,29473,-0.0164473525763574,0.00239242749684574,-0.021136510470175,-0.0117581946825397,6.33338894784985e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24235,-0.0392564057783201,0.00571115672614793,-0.05045027296157,-0.0280625385950701,6.41050172248754e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24800,0.0327359124421735,0.0047646488888901,0.0233972006199489,0.0420746242643981,6.54535201745101e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28792,-0.0510307930031015,0.00743621555424039,-0.0656057754894127,-0.0364558105167903,6.90518717913005e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24946,0.0131497029455067,0.00191642965823474,0.0093935008153666,0.0169059050756468,6.9705141456002e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,29438,-0.0257873684365655,0.0037589057642477,-0.033154823734491,-0.01841991313864,7.00564264549362e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,29720,-0.0199539092124061,0.002914224319606,-0.0256657888788339,-0.0142420295459784,7.68415664843824e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29281,-0.0212207751413449,0.00310361120424098,-0.0273038531016573,-0.0151376971810326,8.21998390736045e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29815,0.0115577843867614,0.00169151228327713,0.00824242031153826,0.0148731484619846,8.48671553211641e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,24933,0.0230429882071405,0.00337351743808459,0.0164308940284947,0.0296550823857863,8.65336172833675e-12
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28792,-0.0256302446010768,0.00376493627572405,-0.0330095197014959,-0.0182509695006577,1.01175890704402e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24133,-0.0230791518289673,0.00339002049752441,-0.0297235920041152,-0.0164347116538195,1.01308946290297e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28769,-0.0362017327253083,0.00534296003222386,-0.046673934388467,-0.0257295310621495,1.26283850550254e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24946,0.0119531853141876,0.0017641841186842,0.00849538444156656,0.0154109861868086,1.2675861995005e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24440,-0.0203208063837672,0.00300123460274423,-0.0262032262051459,-0.0144383865623885,1.30960829091708e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,29158,0.0222105850271285,0.00328148347923265,0.0157788774078325,0.0286422926464245,1.32626835524583e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,28769,-0.0159466183735533,0.00235908070598248,-0.020570416557279,-0.0113228201898277,1.40943334556865e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,29429,-0.0390192331295487,0.00577294210175798,-0.0503341996489944,-0.0277042666101031,1.41554123128017e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24946,0.0120928386272032,0.00178945039842406,0.00858551584629208,0.0156001614081144,1.43139577664026e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24235,0.0095875271664354,0.0014202168116887,0.00680390221552555,0.0123711521173452,1.50406859469763e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,24828,0.0215547947979968,0.00319881653248486,0.0152851143943265,0.0278244752016672,1.63684192451062e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,24560,-0.0498350556587564,0.00740435784351785,-0.0643475970320514,-0.0353225142854614,1.72801324697961e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,29473,-0.0119817858180224,0.00178047665449063,-0.015471520060824,-0.00849205157522074,1.73319254881285e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,24376,-0.0208249018670604,0.0030969472211142,-0.0268949184204443,-0.0147548853136766,1.80300558151911e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24917,0.0124929499049957,0.00186284933299604,0.00884176521232344,0.0161441345976679,2.0380084015301e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29360,-0.0301954675213352,0.00451294539610593,-0.0390408404977028,-0.0213500945449676,2.25856088123186e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,24106,-0.0346294885225439,0.00517792383085139,-0.0447782192310126,-0.0244807578140751,2.31335568297383e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,24106,-0.0358618533052032,0.00536893893406883,-0.0463849736159781,-0.0253387329944283,2.44972918868297e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28733,-0.0263240294581019,0.00394634670558114,-0.034058869001041,-0.0185891899151629,2.5959359746326e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,29589,0.0136255384459987,0.00204274212169454,0.00962176388747745,0.01762931300452,2.59920032763033e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24235,-0.0167626510183656,0.0025165681258855,-0.0216951245451012,-0.01183017749163,2.77955127571925e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28769,-0.0275792230366995,0.00414184486304828,-0.0356972389682741,-0.0194612071051249,2.81268672296867e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,24915,-0.0165760098467829,0.00249158694183653,-0.0214595202527825,-0.0116924994407833,2.93547487963185e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24946,-0.0284028012638771,0.00427182466610928,-0.0367755776094513,-0.0200300249183029,3.01456659750879e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28792,-0.0256931038873299,0.00386538907078765,-0.0332692664660736,-0.0181169413085861,3.04542239972181e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29283,0.0101084848823515,0.00152171510364532,0.00712592327920667,0.0130910464854963,3.13119458455228e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,24885,-0.0209520527353093,0.00315892482444895,-0.0271435453912293,-0.0147605600793894,3.36469243078032e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,29344,-0.0244294123201714,0.00369548904917853,-0.0316725708565613,-0.0171862537837815,3.89318764313532e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29441,-0.01937233114218,0.00293283198661125,-0.025120681835938,-0.0136239804484219,4.03381373950469e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28792,-0.0230924414059792,0.00349601512318179,-0.0299446310474155,-0.0162402517645429,4.03458463942428e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28926,-0.0308847612311098,0.00469218810731555,-0.0400814499214482,-0.0216880725407713,4.71571886195944e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29576,0.00936354329547786,0.00142288858263525,0.00657468167351277,0.012152404917443,4.76195335884373e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24735,-0.0484708589132438,0.00736621445969543,-0.0629086392542468,-0.0340330785722407,4.79346292915661e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28769,-0.0256999928036436,0.00391478738912108,-0.0333729760863209,-0.0180270095209663,5.29715182435302e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29344,-0.0239404625032829,0.00365738775212198,-0.031108942497442,-0.0167719825091238,6.01608983320936e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,29689,-0.0191577068332536,0.00293548738578372,-0.0249112621093896,-0.0134041515571175,6.85256595560549e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,24840,-0.0272015130686231,0.00417194763206694,-0.0353785304274743,-0.0190244957097719,7.16103695470307e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MENT,Protein MENT,24376,0.00999293389363381,0.00153452904532393,0.0069852569647989,0.0130006108224687,7.55748982200338e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,24840,-0.0167986022428269,0.00258008679005615,-0.021855572351337,-0.0117416321343169,7.6145366567669e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,28769,-0.0270555091693878,0.0041562102498789,-0.0352016812591505,-0.0189093370796252,7.656164327491e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,24440,-0.0239104288286368,0.00367628258727357,-0.031115942699693,-0.0167049149575806,7.97404226617432e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,24840,-0.031121504578599,0.00478901592136086,-0.0405079757844663,-0.0217350333727317,8.26530386679587e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24863,-0.0242511967060651,0.00373447693755201,-0.031570771503667,-0.0169316219084631,8.52406613057572e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24788,-0.0316453930021966,0.00487984828308358,-0.0412098956370404,-0.0220808903673528,9.0455630444231e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24863,-0.0427205975816574,0.00659313611064196,-0.0556431443585157,-0.0297980508047992,9.37150296914369e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,29692,-0.0116221357058705,0.00179574076233083,-0.0151417876000389,-0.00810248381170207,9.81846151755076e-11
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,24235,-0.0266982461598676,0.0041291355886803,-0.0347913519136809,-0.0186051404060542,1.02670710132296e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24224,-0.0228967383842593,0.00354439624361393,-0.0298437550217426,-0.015949721746776,1.06703840170551e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,29696,-0.0104216152765045,0.0016139742510033,-0.013585004808471,-0.00725822574453801,1.0836656237881e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29576,-0.017802413646187,0.00275766779308203,-0.0232074425206278,-0.0123973847717462,1.09457127903876e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,29720,-0.0174840948009406,0.00271091661815796,-0.0227974913725302,-0.012170698229351,1.13932580019239e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24800,0.0446646420668666,0.00694169696002628,0.0310589160252151,0.0582703681085181,1.26346706838581e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29689,-0.015028194292115,0.00234364183108323,-0.0196217322810381,-0.0104346563031918,1.45470074319702e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29344,-0.0137655075052232,0.00214863819410557,-0.0179768383656701,-0.0095541766447763,1.5103577214458e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29111,0.0127677882938179,0.00199303605657841,0.00886143762292417,0.0166741389647116,1.51469061977832e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24190,-0.0524587326575059,0.00819056638278421,-0.068512242767763,-0.0364052225472489,1.53360514608303e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,29269,0.012425924799538,0.00194292653103574,0.00861778879870793,0.016234060800368,1.62470988752329e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24800,-0.0130488306356936,0.00204113683404469,-0.0170494588304211,-0.00904820244096596,1.65641187412347e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,29213,-0.0156383410802325,0.00245039374753378,-0.0204411128253987,-0.0108355693350663,1.77444248474199e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28830,-0.0166837804076644,0.00261443998202269,-0.0218080827724289,-0.0115594780428999,1.78144221682083e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,28792,-0.0421552531277351,0.0066183837985627,-0.055127285372918,-0.0291832208825522,1.92610939882153e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24376,-0.0336095991254132,0.00527858712365656,-0.0439556298877801,-0.0232635683630464,1.95995398300362e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24190,-0.0311799918005024,0.00490043650271898,-0.0407848473458316,-0.0215751362551732,2.01793391442874e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29438,-0.0183906008047176,0.00289156391448856,-0.0240580660771151,-0.01272313553232,2.0459754227682e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,29344,-0.0224683281330182,0.00353336935501825,-0.029393732068854,-0.0155429241971824,2.06198716801466e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28792,-0.0218252872777163,0.00344371001803062,-0.0285749589130563,-0.0150756156423763,2.36633840404901e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,28529,-0.0327512847474638,0.00517597880310518,-0.0428962032015499,-0.0226063662933776,2.52775466446894e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29158,-0.0475537197183347,0.00753504919366578,-0.0623224161379196,-0.0327850232987498,2.81217180537798e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24840,0.0156389065262533,0.00248179245183557,0.0107745933206556,0.020503219731851,2.99813147899699e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24696,-0.0129325265586618,0.00205382577609656,-0.0169580250798111,-0.00890702803751254,3.08973535169614e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,28792,-0.0200268963086019,0.00318087690949946,-0.0262614150512208,-0.0137923775659829,3.09769348525118e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29627,-0.0308504290433519,0.00490646764829807,-0.0404671056340161,-0.0212337524526877,3.26681448738827e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,24235,-0.020092069399061,0.00319768323879427,-0.0263595285470977,-0.0138246102510242,3.3705690139558e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,29158,-0.0263205450358312,0.00419513504007414,-0.0345430097143766,-0.0180980803572859,3.5668457808967e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29513,0.0150869005558942,0.00240733364981281,0.0103685266022611,0.0198052745095274,3.73015037155624e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,28700,-0.0294746608325171,0.00470736709689238,-0.0387011003424262,-0.0202482213226081,3.86963319406514e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,24788,-0.0167326651938222,0.00267719191113239,-0.0219799613396417,-0.0114853690480027,4.16925146905399e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24788,-0.0336096932999612,0.00538003572482749,-0.0441545633206231,-0.0230648232792993,4.24907150362346e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24788,-0.018801565413809,0.00300984315639557,-0.0247008580003444,-0.0129022728272737,4.26050768872297e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,24235,-0.0216317374194152,0.00346347375632074,-0.0284201459818039,-0.0148433288570266,4.28983039266526e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29438,0.0212951314389641,0.00342850300529513,0.0145752655485857,0.0280149973293426,5.32832406844459e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28792,-0.0150273330011223,0.00241961783392127,-0.019769783955608,-0.0102848820466366,5.34964540662476e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24733,0.0114020323565325,0.00183581021386101,0.00780384433736487,0.0150002203757,5.35215055470954e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29531,-0.0319520367718025,0.00515816761844982,-0.0420620453039642,-0.0218420282396409,5.92584268371056e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,24840,0.0127610992877947,0.00206319804446133,0.00871723112065052,0.0168049674549389,6.30290405052939e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,29473,-0.0238322056163831,0.00385595613579409,-0.0313898796425395,-0.0162745315902267,6.46860773622546e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,28760,-0.0164796417767907,0.00267016717910816,-0.0217131694478427,-0.0112461141057387,6.84338167051458e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28769,-0.0354617382691041,0.00575106213749212,-0.0467338200585887,-0.0241896564796195,7.09167556607435e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23845,-0.0138228191782305,0.00224159134998429,-0.0182163382241997,-0.00942930013226131,7.09307772651396e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,29076,-0.0150570664461494,0.00244499037593467,-0.0198492475829814,-0.0102648853093174,7.44768065506377e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29213,-0.0161930374851259,0.00263071744171151,-0.0213492436708804,-0.0110368312993713,7.58768807700708e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29328,0.0262324434929843,0.00426179266836008,0.0178793298629985,0.03458555712297,7.59251629169564e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24961,-0.0071054094511813,0.00115552244478404,-0.00937023344295802,-0.00484058545940458,7.91122761452527e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24917,-0.0301455892088866,0.00490392150228826,-0.0397572753533716,-0.0205339030644016,8.00393094189332e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,24106,-0.0163762489352024,0.00266557109662541,-0.0216007682845882,-0.0111517295858166,8.19264494851796e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,24961,-0.0172590395508682,0.00280965911465886,-0.0227659714155996,-0.0117521076861369,8.23296309416859e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29438,-0.0124792070352245,0.00203274628145915,-0.0164633897468844,-0.00849502432356457,8.4056955274951e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOC,Myocilin,29438,0.0188851159362159,0.0030879253268264,0.0128327822956361,0.0249374495767956,9.72861681108182e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24543,0.00336207742932649,0.000549900840615073,0.00228427178172095,0.00443988307693204,9.86491240793965e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28926,-0.0247319790235208,0.00404601957559986,-0.0326621773916966,-0.0168017806553451,9.92306718161029e-10
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,24376,0.00883235526776724,0.00144709672907691,0.0059960456787765,0.011668664856758,1.05336802861811e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,29815,-0.0229774804582624,0.00376524727678489,-0.0303573651207608,-0.015597595795764,1.05697973738289e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,24917,-0.028241571009916,0.0046278790277603,-0.0373122139043262,-0.0191709281155058,1.05971595198791e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,24020,0.0258795695230222,0.00424270741615235,0.0175638629873636,0.0341952760586809,1.07839847286794e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29689,0.0119988648622982,0.00197272493912015,0.00813232398162269,0.0158654057429737,1.19856600821518e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24800,-0.0445254702622445,0.00732853473047349,-0.0588893983339725,-0.0301615421905164,1.25300897300576e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24204,-0.0327137145468874,0.00539412116606613,-0.043286192032377,-0.0221412370613978,1.34162176325117e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24224,-0.034997671549988,0.00577091962084823,-0.0463086740068506,-0.0236866690931255,1.34335656654388e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFP,Properdin,24961,0.00941651481160011,0.0015574738189328,0.00636386612649183,0.0124691634967084,1.50577936226068e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,24235,-0.021251441875076,0.00352083034175689,-0.0281522693449195,-0.0143506144052325,1.60359151600981e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,29344,0.0313463248419873,0.0051995179897174,0.0211552695821412,0.0415373801018335,1.67257969464449e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,28911,-0.0217932568082839,0.0036243523208277,-0.0288969873571062,-0.0146895262594616,1.84296378542992e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24863,0.037195109852408,0.00618786979538407,0.0250668850534553,0.0493233346513608,1.86984700226911e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29344,-0.0343166162741047,0.00571295456985958,-0.0455140072310295,-0.0231192253171799,1.9143830796667e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24391,-0.026457850222011,0.00440489717849656,-0.0350914486918643,-0.0178242517521578,1.92300731546581e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29344,-0.0420534869176436,0.00700548531779698,-0.0557842381405256,-0.0283227356947615,1.96053764769702e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28926,0.017256502140011,0.00287557657001911,0.0116203720627735,0.0228926322172484,1.98366758297895e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29449,0.0160733473262262,0.00267961496726518,0.0108213019903864,0.0213253926620659,2.01619751431584e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29720,0.0233145844625953,0.00389733326185996,0.0156758112693498,0.0309533576558408,2.22674740215436e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29438,0.0137079410130712,0.00229204401558834,0.00921553474251807,0.0182003472836244,2.2479415275229e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,29720,-0.0154143293927489,0.00257975881794556,-0.0204706566759222,-0.0103580021095756,2.32558160331343e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24917,-0.0331596235696948,0.00555432226082703,-0.0440460952009158,-0.0222731519384738,2.40380782804164e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,29164,-0.0206607142972117,0.00346587360427832,-0.0274538265615972,-0.0138676020328262,2.53292025740868e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,24224,0.0172794804401012,0.00290675887581041,0.0115822330435128,0.0229767278366896,2.80951166860182e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24235,-0.0289728638004591,0.0049015007952899,-0.0385798053592273,-0.0193659222416908,3.44550570260457e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,23493,-0.0493114545887234,0.0083440372118718,-0.0656657675239921,-0.0329571416534546,3.47286107897987e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29218,0.0161389190130823,0.00273618271531343,0.0107760008910679,0.0215018371350966,3.71230202651495e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,28926,0.011521899358985,0.00195418813673357,0.00769169061098724,0.0153521081069828,3.76544199102293e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29213,-0.0175515503517695,0.00297711974651574,-0.0233867050549404,-0.0117163956485987,3.7769645797691e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28926,-0.0172070011952041,0.00292104953583557,-0.0229322582854418,-0.0114817441049664,3.88835599293068e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29328,0.0103517993532053,0.00176404784380801,0.0068942655793416,0.013809333127069,4.45263337183132e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29344,-0.0304317334436019,0.00518590309072881,-0.0405961035014304,-0.0202673633857735,4.45376402291881e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29438,-0.0182461176741579,0.00310997647944498,-0.0243416715738701,-0.0121505637744458,4.48595303349857e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24933,-0.0185524728440875,0.00316209133317484,-0.0247501718571102,-0.0123547738310648,4.48945474076928e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24933,0.0143479048681556,0.00244993013861744,0.00954604179646537,0.0191497679398457,4.78786165902884e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28769,-0.025409287807923,0.00433976033390671,-0.0339152180623801,-0.0169033575534659,4.82194576061019e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,24863,-0.0261721350468457,0.00447840060378727,-0.0349498002302687,-0.0173944698634226,5.15730173434888e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,24235,0.0168108415217322,0.00288056668991929,0.0111649308094904,0.022456752233974,5.41663159134195e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,29689,-0.0233651310153883,0.00400592388066997,-0.0312167418215015,-0.0155135202092752,5.51209414149664e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24863,-0.0307298948101378,0.00526959045722073,-0.0410582921062904,-0.0204014975139851,5.55935590695509e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28792,-0.0385914375830884,0.0066360257602694,-0.0515980480732164,-0.0255848270929604,6.11119088574356e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24917,-0.0286315896621099,0.00493086064921329,-0.0382960765345679,-0.0189671027896518,6.45241787331316e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28911,0.0124929643578808,0.00215310569501317,0.00827287719565502,0.0167130515201067,6.60936202745346e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24376,-0.00895501058462453,0.00154562711465232,-0.0119844397293431,-0.00592558143990598,6.96700705813224e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,24909,0.0146736679467091,0.00253285305834421,0.0097092759523545,0.0196380599410638,6.98327433312926e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,29781,-0.036843115214643,0.0063685675714942,-0.0493255076547716,-0.0243607227745143,7.31727313941903e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,29213,-0.0238633908920948,0.00412760787999227,-0.0319535023368796,-0.0157732794473099,7.48311015964234e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29576,-0.0406743645650021,0.0070368368224367,-0.054466564736978,-0.0268821643930261,7.53584893057987e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29429,-0.0196767278150628,0.00340554164313233,-0.0263515894356022,-0.0130018661945235,7.64209989385355e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29448,-0.0300942811935557,0.00520903322245176,-0.0403039863095611,-0.0198845760775502,7.66612382786751e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29429,0.0129785197089542,0.00224765663965557,0.00857311269522927,0.0173839267226791,7.80759015195988e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,24235,-0.0287781224523976,0.00498503817230658,-0.0385487972701185,-0.0190074476346767,7.88701982131203e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24788,-0.0154078605535654,0.00267184927022889,-0.020644685123214,-0.0101710359839168,8.17798536817982e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29356,0.0132158440744054,0.00229334762174024,0.00872088273579447,0.0177108054130162,8.36129752885667e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,24800,-0.0275078684785659,0.00477575844522719,-0.0368683550312112,-0.0181473819259206,8.51611452903372e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29815,-0.0194362310331905,0.00337616968318292,-0.026053523612229,-0.012818938454152,8.65186786586377e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,24840,0.0153795386019366,0.00267309579168104,0.0101402708502417,0.0206188063536314,8.84647926404921e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24566,-0.021812107381145,0.0037914018808266,-0.0292432550675652,-0.0143809596947249,8.86911604656253e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24917,-0.0299490104143624,0.00520763510871355,-0.040155975227441,-0.0197420456012839,8.97647702353588e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24440,-0.0207351345150517,0.00360673799755868,-0.0278043409902667,-0.0136659280398367,9.08422129185982e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,24788,-0.0244263157892158,0.00425014204739837,-0.0327565942021166,-0.016096037376315,9.18101579534095e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29344,0.00817875271737144,0.00142481649763661,0.00538611238200368,0.0109713930527392,9.54879377802719e-09
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24235,0.035459856655028,0.00618769024161349,0.0233319837814655,0.0475877295285904,1.0119753585016e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24235,0.0299171728580931,0.00522225287376162,0.0196815572255203,0.0401527884906658,1.02349679686536e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29344,-0.0530983118943395,0.00928482023356273,-0.0712965595521225,-0.0349000642365566,1.08301036663314e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24190,-0.0187496186860147,0.00327882822565779,-0.025176122008304,-0.0123231153637254,1.08805276531212e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,29576,-0.0160472624203854,0.00280793315085988,-0.0215508113960708,-0.0105437134447001,1.10775331404976e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29429,-0.0165704241235481,0.00290036625337703,-0.022255141980167,-0.0108857062669291,1.1192858545003e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24800,-0.0328970073558628,0.00576263318727538,-0.0441917684029225,-0.021602246308803,1.15158056425442e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28769,-0.0258983808421289,0.00453756563407566,-0.0347920094849172,-0.0170047521993406,1.15740485396649e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELP,P-selectin,29589,-0.021893814235596,0.00383798715733015,-0.0294162690639631,-0.0143713594072289,1.17794479064488e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,24800,-0.0326079824480682,0.00571647211466074,-0.0438122677928032,-0.0214036971033331,1.182111760474e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,29727,-0.0265920163964842,0.0046630861039225,-0.0357316651601722,-0.0174523676327961,1.19066624919292e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29589,0.0165375707399262,0.00290384958551966,0.0108460255523077,0.0222291159275448,1.24503399498976e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29781,-0.0290887468276992,0.00511090572374073,-0.039106122046231,-0.0190713716091674,1.27106360935285e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28926,0.015204324962534,0.00267306783202626,0.00996511201176256,0.0204435379133055,1.29799364990047e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24224,-0.0135275301225342,0.00237877730679112,-0.0181899336438448,-0.00886512660122359,1.30964842107071e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24917,0.0135920772769841,0.00240025509374039,0.00888757729325291,0.0182965772607152,1.50594198102328e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29429,0.017946788501933,0.00317218543084455,0.0117293050574776,0.0241642719463883,1.54976761786347e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,24376,0.0169502660402283,0.00299663847009203,0.0110768546388479,0.0228236774416087,1.5628887446134e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBN,Nibrin,28926,-0.0200692033513284,0.00355000539696054,-0.0270272139293711,-0.0131111927732857,1.58889132585999e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,28599,0.0267180868894734,0.00472854927328543,0.0174501303138339,0.0359860434651128,1.61617752025391e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,24917,-0.0285346284963298,0.00505200997422962,-0.0384365680458198,-0.0186326889468397,1.63928989379456e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24800,-0.0316994085698099,0.00562285837434688,-0.0427202109835298,-0.02067860615609,1.74314257258461e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24235,0.0265108344110109,0.00472055025295117,0.0172585559152266,0.0357631129067951,1.97516452965404e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,29363,-0.0260203263549681,0.00463734846520223,-0.0351095293467645,-0.0169311233631717,2.02931113193934e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,24788,0.0424252655550496,0.00756243966940927,0.0276028838030074,0.0572476473070918,2.0448873749147e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29429,0.0156916364069808,0.00280019358295384,0.0102032569843913,0.0211800158295703,2.11616266528625e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29428,-0.0431906561305816,0.007717936342691,-0.058317811362256,-0.0280635008989072,2.21125543233232e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,29518,0.0209294310375773,0.00374058479359292,0.0135978848421352,0.0282609772330195,2.22282357658754e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,29752,0.011338455038824,0.00203021624408366,0.00735923120042001,0.015317678877228,2.35942302972881e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24863,-0.0352675885377327,0.00631496988929383,-0.0476449295207486,-0.0228902475547167,2.36469816332385e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,29429,-0.0316136879692389,0.00566192511595201,-0.0427110611965048,-0.0205163147419729,2.37724528904554e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,24190,-0.0258333197818228,0.00463100047724103,-0.0349100807172152,-0.0167565588464304,2.45414560768657e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24800,-0.0112924889756234,0.00202502336085695,-0.015261534762903,-0.00732344318834373,2.48000509052458e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28911,0.0126385364873479,0.00226786621467318,0.00819351870658849,0.0170835542681074,2.5280050783737e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29815,0.0102555489744297,0.00184221456930761,0.00664480841858683,0.0138662895302727,2.61440027432206e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,24417,0.0144498415554297,0.0025964469935612,0.00936080544804974,0.0195388776628096,2.64545916710397e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,24235,-0.0151275357071606,0.00272294957812047,-0.0204645168802767,-0.00979055453404452,2.79615547618385e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,29490,-0.017500680577095,0.00315097057485462,-0.0236765829038101,-0.01132477825038,2.81514579657106e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24946,0.0239653054063338,0.00431571976254302,0.0155064946717494,0.0324241161409181,2.83626333730329e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29689,-0.0243698960119143,0.00438990720312898,-0.0329741141300471,-0.0157656778937815,2.85899600472569e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29554,-0.00876185735611948,0.00158211643575077,-0.011862805570191,-0.00566090914204796,3.0843941086091e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28911,-0.0349561533574512,0.00631869906445672,-0.0473408035237864,-0.022571503191116,3.19021066320155e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,24917,-0.0240458328064524,0.0043561287397624,-0.0325838451363867,-0.0155078204765181,3.42377108856729e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29429,-0.0229399652393707,0.00415810746235237,-0.0310898558655813,-0.01479007461316,3.47885923354229e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28792,-0.0315974646667867,0.00573469787612196,-0.0428374725039857,-0.0203574568295876,3.6216293358727e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29429,-0.0140544080351377,0.00255571971812195,-0.0190636186826567,-0.00904519738761866,3.84693118263944e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28769,-0.019103033303058,0.00347513919632376,-0.0259143061278526,-0.0122917604782635,3.89462651064424e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,29438,0.00959276610123546,0.00174578250351321,0.00617103239434956,0.0130144998081213,3.94340675735107e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,29434,0.0219362374352073,0.00399351707498093,0.0141089439682447,0.02976353090217,3.98516892476879e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,29286,-0.0208442644043094,0.00379484830079975,-0.0282821670738769,-0.0134063617347419,3.98945523532879e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,29209,0.0125009835229392,0.00227728508014007,0.00803750476586468,0.0169644622800138,4.06598924947421e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,24933,0.0175963544293342,0.00320633817973112,0.0113119315970612,0.0238807772616072,4.10489330137846e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28792,-0.0207100811282278,0.00377585070500629,-0.0281107485100402,-0.0133094137464155,4.17233090860988e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24106,-0.0133195161102927,0.00242866664005682,-0.018079702724804,-0.00855932949578132,4.19299645627482e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29576,0.0105941160289608,0.00193269005971733,0.00680604351191487,0.0143821885460068,4.25084083514159e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29473,0.0105136147047056,0.00191945994904572,0.00675147320457599,0.0142757562048352,4.35191748928077e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,29339,-0.0324299709161516,0.00593038085562789,-0.0440535173931823,-0.020806424439121,4.57698894556988e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29213,-0.0213462942677674,0.00390691309059633,-0.0290038439253362,-0.0136887446101986,4.70054242725886e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24106,-0.0229884693352096,0.00421303115897102,-0.0312460104067928,-0.0147309282636264,4.90351464535398e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28911,-0.0353485961594882,0.00648034466625693,-0.0480500717053518,-0.0226471206136246,4.94464403521145e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,29689,0.00991134407682447,0.00182137405109037,0.00634145093668735,0.0134812372169616,5.31961499242918e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29367,0.0219188440112627,0.00402888177921213,0.0140222357240069,0.0298154522985185,5.35769538932908e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24800,-0.0100961784642543,0.00185982077541856,-0.0137414271840747,-0.00645092974443393,5.73384251006422e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29344,-0.0200842272664358,0.00370533108126649,-0.0273466761857181,-0.0128217783471535,5.99477874402391e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBIN,Erbin,29344,-0.0374921686462194,0.00692150369622796,-0.0510583158908262,-0.0239260214016126,6.11633746981652e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,29118,0.00943069152379266,0.00174145985586735,0.00601743020629266,0.0128439528412927,6.16376080127199e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,24933,-0.014936102924642,0.0027582323593742,-0.0203422383490154,-0.00952996750026858,6.1820739031638e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,29164,0.0117536813408105,0.00217477276959757,0.00749112671239924,0.0160162359692217,6.54782574571214e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,24840,-0.0203147837556851,0.0037639494388075,-0.0276921246557478,-0.0129374428556224,6.83092610478271e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28792,-0.0165197543261344,0.00306103185740355,-0.0225193767666453,-0.0105201318856234,6.83782693179077e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,24788,-0.0301538648947005,0.00560766214959359,-0.0411448827079039,-0.0191628470814971,7.63115213165813e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24863,-0.0290243095211472,0.00540742456349716,-0.0396228616656016,-0.0184257573766928,8.05539292645333e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,24933,-0.0102091936283027,0.00190334798282262,-0.013939755674635,-0.00647863158197038,8.22111482429577e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,29689,-0.0219716942154593,0.004096677507571,-0.0300011821302984,-0.0139422063006201,8.23274923188865e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24840,-0.0228101973432802,0.00426400360913332,-0.0311676444171815,-0.0144527502693788,8.89882556742353e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24961,0.0060836979783883,0.00113913645905003,0.00385099051865025,0.00831640543812636,9.34381755100398e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24800,0.0181897901842987,0.00340636925116912,0.0115133064520072,0.0248662739165902,9.37982083186586e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28911,-0.0192778884958848,0.00361056668643782,-0.0263545992013029,-0.0122011777904667,9.40112317734341e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,29599,-0.0215594296618641,0.00403860011765873,-0.0294750858924752,-0.013643773431253,9.44906404722801e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,24235,-0.0247663277962309,0.00463940586491389,-0.0338595632914621,-0.0156730923009997,9.46900172472675e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPARC,SPARC,29561,-0.0253528719130544,0.00475420255771768,-0.034671108926181,-0.0160346348999277,9.74579405375577e-08
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,29132,0.0225177221829024,0.00423502925365134,0.0142170648457458,0.030818379520059,1.06258939357304e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,29815,-0.0202758994327783,0.00381353509129227,-0.0277504282117111,-0.0128013706538454,1.06352939296494e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,29213,-0.0239982543865162,0.00451389431655194,-0.032845487246958,-0.0151510215260744,1.06541124221411e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29373,-0.0234797986045479,0.004418361042868,-0.0321397862485691,-0.0148198109605266,1.0794184646676e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,29421,-0.0166488196566674,0.00313305403988253,-0.0227896055748372,-0.0105080337384977,1.08068179993658e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,29438,-0.0322942755181386,0.00607797105493686,-0.0442070987858148,-0.0203814522504623,1.08421099472948e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,24224,-0.0196614852126827,0.00370153953705354,-0.0269165027053077,-0.0124064677200578,1.09563082046365e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24800,0.031403095672582,0.00592538879927873,0.0197893336259957,0.0430168577191683,1.16950573537169e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29815,-0.0257068750689108,0.00485209342215888,-0.0352169781763422,-0.0161967719614794,1.1784423353282e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,24224,-0.0150762760534031,0.00285008529747889,-0.0206624432364617,-0.00949010887034447,1.23538704608128e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29438,0.0187494425996117,0.00354489126914951,0.0118014557120786,0.0256974294871447,1.23767016083771e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24190,-0.022397402746779,0.00423816027819273,-0.0307041968920368,-0.0140906086015213,1.27002535617136e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24224,0.0155219609384801,0.00294055480844876,0.00975847351392053,0.0212854483630397,1.31308653037683e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29473,0.0141254034027677,0.00268013071657791,0.00887234719827499,0.0193784596072604,1.37072326285816e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29473,-0.00999946460991907,0.00189828361442713,-0.0137201004941962,-0.00627882872564189,1.39162695240776e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,28586,-0.0300344489958497,0.0057025138840786,-0.0412113762086438,-0.0188575217830556,1.39766512886094e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,29781,-0.0176616261992877,0.00335355994673628,-0.0242346036948909,-0.0110886487036846,1.39990922427585e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24863,0.016605796622256,0.00315444364837856,0.0104230870714341,0.022788506173078,1.4192768744597e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24224,-0.0127686101057424,0.00242873119296661,-0.017528923243957,-0.00800829696752786,1.47411798226032e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24190,0.0113616588362828,0.00216323813118543,0.00712171209915935,0.0156016055734062,1.51602931901697e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24863,0.0150148358107,0.0028590031810573,0.00941118957582768,0.0206184820455723,1.51881549039257e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29720,-0.0190395891142306,0.00364304431751417,-0.0261799559765584,-0.0118992222519028,1.74116897005523e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29473,-0.0258561464788827,0.00495179868392166,-0.0355616718993692,-0.0161506210583963,1.78619328258316e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,29669,0.0109166274908685,0.00209274877784572,0.00681483988629085,0.0150184150954461,1.83652582512463e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24224,-0.0342747763799555,0.00658100308960886,-0.0471735424355889,-0.0213760103243222,1.92304138811e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,28792,-0.0261329029881999,0.00501995994485265,-0.0359720244801111,-0.0162937814962887,1.94489314483635e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,29158,-0.0224024835809045,0.00431370245297608,-0.0308573403887377,-0.0139476267730714,2.07951683998881e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,28769,0.0157378870868519,0.00303278681272715,0.0097936249339067,0.0216821492397971,2.12576021712968e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29158,-0.00825845510004213,0.00159443385438344,-0.0113835454546337,-0.00513336474545058,2.23895975432555e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,29340,-0.0150870545817267,0.00291445883491042,-0.0207993938981511,-0.0093747152653023,2.27427015667088e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29448,-0.0174170178024946,0.0033747063571756,-0.0240314422625588,-0.0108025933424304,2.47166222400932e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,24224,-0.0197075890350915,0.00381905993482608,-0.0271929465073506,-0.0122222315628323,2.48466991545626e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24788,0.0146073801131428,0.00283759510950137,0.00904569369852013,0.0201690665277655,2.65568162947015e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,24376,-0.0176375575005543,0.00342907453269466,-0.0243585435846359,-0.0109165714164728,2.71706853237073e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGN,Biglycan,28745,0.0416065766216636,0.0080973516939491,0.0257357673015233,0.0574773859418038,2.79055308047904e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",29720,0.025449587234962,0.00495879767612145,0.015730343789764,0.0351688306801601,2.88162576687881e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,24863,-0.0362956459121318,0.00707640113115776,-0.050165392129201,-0.0224258996950626,2.93299429366025e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24863,-0.0228118479062493,0.0044488249000896,-0.0315315447104249,-0.0140921511020737,2.95640957022794e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24917,-0.0220785048290261,0.00430796066919968,-0.0305221077406575,-0.0136349019173948,2.99683621760241e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24840,-0.0110157754780375,0.00214987807947244,-0.0152295365138035,-0.00680201444227152,3.01508570690047e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,28792,0.0191725153188128,0.00374346137465927,0.0118353310244807,0.026509699613145,3.04904469794013e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,24224,-0.0121199518979321,0.00236758267511108,-0.0167604139411498,-0.00747948985471434,3.0930401891314e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,24224,-0.0198940008378119,0.00388654427051267,-0.0275116276080167,-0.0122763740676071,3.10023652427053e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,29689,-0.0200029427376556,0.00390882081326297,-0.027664231531651,-0.0123416539436601,3.11729557151674e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29561,0.00945829100342544,0.00185078756116079,0.0058307473835503,0.0130858346233006,3.23453441442335e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24946,0.0499052115225792,0.00977001708905426,0.0307559780280329,0.0690544450171256,3.27990577665132e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29669,-0.0197535109833834,0.0038820200283462,-0.027362270238942,-0.0121447517278249,3.63180186012997e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24424,-0.0151391565350648,0.00297518971457902,-0.0209705283756397,-0.00930778469448992,3.63643538593387e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,29344,0.00521917418333161,0.00102614733973193,0.00320792539745702,0.0072304229692062,3.67587942408655e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24224,-0.0168059326433375,0.00330636205716018,-0.0232864022753715,-0.0103254630113036,3.74466428752016e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,29158,-0.0275161498868922,0.00541501047885838,-0.0381295704254546,-0.0169027293483297,3.76859666957803e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28792,0.0173874981070706,0.00342434485333677,0.0106757821945305,0.0240992140196107,3.8458784783834e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,29576,0.0145684432573442,0.0028726606211994,0.00893802843979337,0.020198858074895,3.97260488022952e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,24235,-0.0209909558291184,0.00414212755295425,-0.0291095258329088,-0.0128723858253281,4.05664922872539e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25972,0.0107051557562641,0.002112550574543,0.00656455663015985,0.0148457548823684,4.06034378809749e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24917,0.011887681844499,0.00234628609304382,0.00728896110213316,0.0164864025868649,4.07887428634324e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,24800,-0.0231223405551266,0.00456395175641648,-0.0320676859977029,-0.0141769951125503,4.08537072691621e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29689,-0.0223752469751432,0.00442048604215386,-0.0310393996177648,-0.0137110943325216,4.17979110088473e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,24788,-0.0164885829093411,0.00325775495771052,-0.0228737826264537,-0.0101033831922284,4.1931287408107e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24376,0.00738596632916821,0.00145939447915537,0.00452555315002368,0.0102463795083127,4.20139897882587e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24235,-0.0149028197993072,0.0029461267226171,-0.0206772281756367,-0.00912841142297765,4.25774825867025e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24961,-0.0111928102108184,0.00221526274409515,-0.0155347251892449,-0.00685089523239194,4.38938214860736e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,29390,-0.0226790651147977,0.00449500983434702,-0.0314892843901179,-0.0138688458394776,4.5529948135092e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNLY,Granulysin,29438,0.0177945631951666,0.00352828048849426,0.0108791334377179,0.0247099929526154,4.6002429972798e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,24840,-0.0129022887820777,0.00255923749761589,-0.0179183942774048,-0.0078861832867505,4.65245387077811e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,28792,-0.0327945093040798,0.00651588687019801,-0.0455656475696679,-0.0200233710384917,4.8575141705014e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24235,-0.0260513015934781,0.00517770296616677,-0.036199599407165,-0.0159030037797912,4.90290333666934e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29364,-0.00662790896072049,0.00131784424318565,-0.00921088367736436,-0.00404493424407663,4.95025533277385e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24800,-0.0348129166004637,0.0069271623788977,-0.0483901548631032,-0.0212356783378242,5.05439205660102e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28792,-0.0311163563468069,0.00619593846627992,-0.0432603957407155,-0.0189723169528982,5.14262875593228e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,29438,0.0107382262424209,0.00213917203461608,0.00654544905457342,0.0149310034302685,5.20255583188936e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24727,-0.0168518433585826,0.00337102974152806,-0.0234590616519776,-0.0102446250651876,5.80163928980078e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29369,0.0110805763353044,0.00221892232948729,0.00673148856950931,0.0154296641010995,5.95804394156764e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29781,-0.0333300742360787,0.00668395776775985,-0.046430631460888,-0.0202295170112694,6.18034297519491e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29473,0.00867775546290225,0.00174183183543668,0.00526376506544637,0.0120917458603581,6.32958739203885e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,24106,-0.0224210906788464,0.0045012993672998,-0.031243637438754,-0.0135985439189388,6.36852227325629e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24376,-0.0136168354884205,0.00273596079086593,-0.0189793186385177,-0.00825435233832329,6.50225355190263e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,24811,-0.0284736861783364,0.00572125809149959,-0.0396873520376756,-0.0172600203189973,6.50692694407087e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24376,0.0144161489509368,0.00289894213727287,0.00873422236188196,0.0200980755399916,6.64068638681559e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29561,0.0124233410225279,0.00249843840282572,0.00752640175298949,0.0173202802920663,6.64846748829907e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28926,-0.0147352392850674,0.00296787698281699,-0.0205522781713887,-0.00891820039874608,6.91241561468128e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,24840,-0.0360375578398685,0.00726252238208301,-0.0502721017087512,-0.0218030139709858,7.01863665668189e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29213,0.038486867059805,0.0077602974434189,0.023276684070704,0.0536970500489061,7.10865962256372e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29438,0.0398055758899192,0.00803280377031429,0.0240612805001032,0.0555498712797352,7.25903521792168e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24376,-0.0194325475899788,0.00393017931900348,-0.0271356990552256,-0.011729396124732,7.6869308951698e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24840,-0.0209674331217739,0.00425729716465149,-0.0293117355644909,-0.012623130679057,8.48771998508962e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29576,-0.0284430460721812,0.00578502738209499,-0.0397816997410874,-0.017104392403275,8.85021359093581e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24946,0.0198974405174955,0.00405571867589592,0.0119482319127395,0.0278466491222515,9.35281707623678e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,29637,0.0135159264862103,0.00275646230206836,0.00811326037415629,0.0189185925982643,9.47094799028214e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23901,-0.0176996234900771,0.00361437462689037,-0.0247837977587823,-0.010615449221372,9.79419919476755e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,24800,-0.0187959139289077,0.00383856603712288,-0.0263195033616685,-0.0112723244961468,9.81235093850299e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,29473,0.0113409742472831,0.00231714122397301,0.006799377448296,0.0158825710462702,9.91359388117254e-07
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,29429,0.0199505143277832,0.00408442372675982,0.0119450438233339,0.0279559848322324,1.04216842327788e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,24106,-0.0219869451287427,0.00450508134277156,-0.030816904560575,-0.0131569856969105,1.06505908738954e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,28769,-0.023607339056388,0.00484137463935007,-0.0330964333495142,-0.0141182447632619,1.08745335453099e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,29438,-0.0214276186556824,0.00440055224687073,-0.030052701059549,-0.0128025362518157,1.12573571665544e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,29473,-0.0399911008980594,0.00822293920222646,-0.0561080617344232,-0.0238741400616955,1.16005297296954e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28769,-0.0147028740674387,0.00302394474277566,-0.020629805763279,-0.00877594237159844,1.16729822149114e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,28485,0.00866405955268043,0.00178227021201385,0.00517080993713328,0.0121573091682276,1.17268298057057e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,24817,-0.0319694403579758,0.00657650738117003,-0.044859394825069,-0.0190794858908825,1.17414460751623e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,28623,-0.0368105329992437,0.00757438271581467,-0.0516563231222405,-0.021964742876247,1.18083076280155e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29815,0.0203340874859746,0.00419063338854231,0.0121204460444317,0.0285477289275176,1.2267217906825e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29344,-0.00688538367864817,0.00141971172332336,-0.00966801865636195,-0.00410274870093438,1.24189859155842e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,28714,-0.0150934672526789,0.00311328679467127,-0.0211955093702346,-0.00899142513512325,1.2531283672214e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,24701,0.0236311903426324,0.00488026344014963,0.0140658739999391,0.0331965066853257,1.29189016531721e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,29720,-0.0181469916642562,0.00375233472725256,-0.0255015677296713,-0.0107924155988412,1.33015456445236e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24376,-0.0226405518776883,0.00468226710447226,-0.031817795402454,-0.0134633083529227,1.33700131814261e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,29473,0.0151254894952437,0.00313308273483404,0.00898464733496899,0.0212663316555184,1.38831687644977e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,24800,-0.0223919430051564,0.00464508056468793,-0.0314963009119447,-0.013287585098368,1.4399522286266e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29429,-0.0183224216217314,0.00380931889635826,-0.0257886866585936,-0.0108561565848692,1.51756889107764e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28926,-0.0276770747416759,0.00575719294397839,-0.0389611729118736,-0.0163929765714783,1.53681000147153e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24235,-0.00778036987644027,0.00162489500234834,-0.010965164081043,-0.00459557567183753,1.69252893921026e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",24961,-0.00537653035562839,0.00112395169079691,-0.00757947566959032,-0.00317358504166645,1.73170375571955e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,28792,-0.0131083435400432,0.00274248963424674,-0.0184836232231668,-0.00773306385691957,1.76402126607662e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24224,-0.0108683616221382,0.00228325945828062,-0.0153435501603682,-0.00639317308390816,1.94691214095517e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24235,0.0122472654466966,0.0025741068170126,0.00720201608535192,0.0172925148080413,1.9677380744504e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24920,0.00626613831403358,0.00131897859449043,0.00368094026883234,0.00885133635923483,2.03792025629167e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29438,-0.0163704396795588,0.00345593977683852,-0.0231440816421623,-0.00959679771695526,2.18024193221456e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24863,-0.0153884172999884,0.00325453096319782,-0.0217672979878561,-0.00900953661212068,2.27642477010111e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29213,-0.0302280072985624,0.00639562209728342,-0.0427634266092379,-0.0176925879878869,2.29645714595316e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29815,0.00725888930988058,0.00153888343782829,0.00424267777173714,0.010275100848024,2.40449834646849e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29781,-0.0108225795171405,0.00229712977931083,-0.0153249538845898,-0.00632020514969132,2.47193174501004e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,29374,-0.0328579711715689,0.00697895568366121,-0.0465367243115449,-0.019179218031593,2.51115681251837e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,28911,-0.016751131506664,0.00355960346320215,-0.0237279542945402,-0.00977430871878783,2.53920383940499e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29302,-0.0333400426011962,0.00708499611872991,-0.0472266349939068,-0.0194534502084856,2.54120383548965e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,29720,0.0199848461285177,0.004259014415679,0.0116371778737869,0.0283325143832485,2.71268390644666e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,24235,-0.0096429724334431,0.00205749654106653,-0.0136756656539335,-0.00561027921295269,2.79086679363294e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29781,-0.0213350372025348,0.00455281634420426,-0.0302585572371751,-0.0124115171678944,2.79665788037218e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29449,-0.00880871570920735,0.00188062908979564,-0.0124947487252068,-0.0051226826932079,2.82696114466587e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28911,-0.0154317547368453,0.00329479550220515,-0.0218895539211674,-0.00897395555252325,2.83055790213526e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,24096,-0.0126001566011765,0.00269137782369859,-0.0178752571356257,-0.00732505606672722,2.86089837054759e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24799,-0.0186096571790873,0.003976026582896,-0.0264026692815634,-0.0108166450766111,2.87736621666393e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24190,-0.0217733549055933,0.00467818984376052,-0.0309426069993639,-0.0126041028118226,3.26924009087429e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,28769,-0.0112996488586527,0.00243326622434076,-0.0160688506583606,-0.00653044705894482,3.43538173157438e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29429,-0.0241031996411608,0.00519284045898185,-0.0342811669407652,-0.0139252323415563,3.47176445881561e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,29473,0.0241252670813476,0.00520614809976717,0.013921216805804,0.0343293173568912,3.60209394937709e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24800,-0.0125340750360917,0.00270711473977698,-0.0178400199260546,-0.00722813014612885,3.67432088684949e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29561,0.00906801074628819,0.00195986869404916,0.00522666810595184,0.0129093533866245,3.72850747712401e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,29473,0.00897193240856073,0.00193912424123209,0.00517124889574583,0.0127726159213756,3.72945372507043e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,24961,0.00653907488129941,0.00141461623975923,0.00376642705137132,0.00931172271122749,3.81026160399967e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,29815,0.0127558874445319,0.00277116959616855,0.00732439503604155,0.0181873798530222,4.18024456498663e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,29589,-0.0312090327284506,0.00678476431077215,-0.044507170777564,-0.0179108946793372,4.24506329679514e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,24235,-0.00992762465934079,0.00216089472911729,-0.0141629783284107,-0.0056922709902709,4.36559655972996e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,24788,-0.0111896797637891,0.0024377970504886,-0.0159677619827468,-0.00641159754483145,4.45253446167302e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28792,-0.0160139701224476,0.0034916949114441,-0.022857692148878,-0.00917024809601717,4.53063356319687e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,24235,-0.0165347172101866,0.003609182140453,-0.0236087142054745,-0.00946072021489872,4.64414415261171e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,29531,-0.0178517005645477,0.00390118117001437,-0.0254980156577759,-0.0102053854713195,4.7593976282128e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,29213,0.0108485530846081,0.00237148447007276,0.00620044352326553,0.0154966626459508,4.79129214950577e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24800,-0.0432178067904845,0.00945042049673592,-0.0617406309640869,-0.0246949826168821,4.82862507697412e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,29274,-0.0186078426529089,0.00407442011466709,-0.0265937060776564,-0.0106219792281614,4.96789220903195e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29561,-0.0292418928914385,0.00642937801899714,-0.0418434738086729,-0.0166403119742041,5.43297356578663e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24863,-0.0191110696414229,0.00420341822196393,-0.0273497693564722,-0.0108723699263736,5.47884582288482e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29473,0.00875906204402565,0.00192820417277498,0.00497978186538669,0.0125383422226646,5.57846272150468e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29531,-0.019810311592412,0.00437902124773343,-0.0283931932379695,-0.0112274299468545,6.09430461125651e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,29689,0.00914284351896175,0.00202482870328626,0.00517417926052067,0.0131115077774028,6.34504271122059e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28792,-0.0102093082422295,0.00226353038902327,-0.0146458278047151,-0.00577278867974394,6.49771133484166e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29115,0.0131927069853102,0.00292953464287588,0.00745081908527343,0.0189345948853469,6.71515953841504e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,29531,0.0251697585565801,0.00560128779442367,0.0141912344795097,0.0361482826336505,7.03059610485292e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,29164,-0.0139382021193149,0.00310245144807776,-0.0200190069575473,-0.0078573972810825,7.0615246874346e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24440,-0.0103297602730856,0.00229950589989615,-0.0148367918368821,-0.00582272870928915,7.08257324688013e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29344,0.0101961062421834,0.00227002646633155,0.00574685436817354,0.0146453581161932,7.09514887117087e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24933,0.0101110290483255,0.00225510431861402,0.00569102458384207,0.014531033512809,7.37147479661699e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,29473,0.0116327790219702,0.00259726266543918,0.00654214419770937,0.016723413846231,7.53240718593688e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24376,-0.0203843011022275,0.00455124401014007,-0.029304739362102,-0.011463862842353,7.53900393633741e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,29688,0.00975287178235246,0.00217980200691982,0.0054804598487896,0.0140252837159153,7.69824164469472e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29576,-0.0377750531510931,0.00845447837279802,-0.0543458307617772,-0.0212042755404089,7.92275721476205e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24106,-0.0204236372003919,0.00457142028059356,-0.0293836209503553,-0.0114636534504285,7.94326371688484e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,29130,0.0103712622351559,0.00232299216761881,0.00581819758662308,0.0149243268836888,8.05144566885288e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28792,-0.0119398167721516,0.00267775023799532,-0.0171882072386224,-0.00669142630568079,8.26931721286696e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,23902,-0.0213752479554116,0.00480068097031939,-0.0307845826572376,-0.0119659132535856,8.52427518248002e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29406,-0.0181815866521873,0.00409126088888682,-0.0262004579944054,-0.0101627153099691,8.862178201288e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24224,-0.0131171668944824,0.00295274453686511,-0.018904546186738,-0.00732978760222675,8.93698545930879e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29755,-0.0157855219265004,0.00355859432419422,-0.0227603668019211,-0.00881067705107972,9.20226537366478e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29381,-0.019383782593752,0.00437397776883495,-0.0279567790206685,-0.0108107861668355,9.38684706895304e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COCH,Cochlin,24917,-0.0138700448434304,0.00312973816740003,-0.0200043316515345,-0.00773575803532637,9.38941158882796e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24376,0.0111035551542843,0.00250878114342922,0.00618634411316299,0.0160207661954055,9.64683409371154e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,24946,-0.0213110960329756,0.00481562505288642,-0.030749721136633,-0.0118724709293182,9.66690524085099e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,24190,-0.0242501761737664,0.0054819610027931,-0.0349948197392409,-0.0135055326082919,9.74790343425574e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29344,-0.017880073279489,0.00404540840362861,-0.0258090737506011,-0.00995107280837694,9.9126329855281e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,24190,0.00937468466375956,0.00212100047258458,0.00521752373749379,0.0135318455900253,9.91600219971428e-06
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29422,-0.0220107597435747,0.00498540321238587,-0.031782150039851,-0.0122393694472984,1.01350390610553e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29720,0.0180167143770225,0.00408275516414582,0.0100145142552967,0.0260189144987483,1.0236271912581e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,29461,0.0119259164117774,0.00270607565607694,0.00662200812586655,0.0172298246976882,1.05139074295297e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,24224,-0.0132216861142514,0.00300027500912894,-0.0191022251321441,-0.00734114709635863,1.05347557229999e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29486,-0.0192131838385072,0.00436863560088438,-0.0277757096162406,-0.0106506580607738,1.09644135094883e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29213,0.0124225362272428,0.00282627297419497,0.0068830411978207,0.017962031256665,1.10970295615784e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,29385,0.00836972944740576,0.00191076075377256,0.00462463837001154,0.0121148205248,1.1891905692564e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,24840,-0.0404139643306392,0.00923149205051598,-0.0585076887496505,-0.0223202399116279,1.20352657772464e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29321,0.00843676973815395,0.0019277619602457,0.00465835629607237,0.0122151831802355,1.21039996390781e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2,Complement C2,29540,0.00690814499194106,0.00157963265744948,0.00381206498334007,0.010004225000542,1.22823114762373e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24224,-0.0131821260203695,0.00302019044396292,-0.0191016992905368,-0.00726255275020217,1.27843584996153e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,24800,-0.0334054322003474,0.00766241137671609,-0.048423758498711,-0.0183871059019839,1.30795084074677e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,29492,0.00710275642095866,0.00163026292542446,0.00390744108712672,0.0102980717547906,1.32413345337785e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24235,-0.0237760245893969,0.00546043001093287,-0.0344784674108253,-0.0130735817679684,1.34076712583294e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24106,-0.00824994271549069,0.00189743574155651,-0.0119689167689414,-0.00453096866203993,1.37983631576673e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,28272,0.00678481598080501,0.00156088651482756,0.00372547841174299,0.00984415354986702,1.38638749288616e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,24751,0.0172705761319859,0.00397784376498377,0.00947400235261771,0.0250671499113541,1.41950504470986e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24863,-0.0195520872263515,0.00450705076933299,-0.0283859067342441,-0.0107182677184588,1.44278786723131e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28717,-0.0208799449855447,0.00481599472385022,-0.0303192946442912,-0.0114405953267983,1.45896558224449e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24863,-0.0259170009508693,0.00598095293195584,-0.0376396686975028,-0.0141943332042359,1.47496497411745e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,28867,0.0164883717256047,0.00381016917775453,0.00902044013720579,0.0239563033140036,1.51342686993017e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NADK,NAD kinase,29473,-0.0158204549069363,0.00365726809743695,-0.0229887003779127,-0.00865220943595985,1.52508260933067e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24190,-0.023474669576459,0.00543845027432544,-0.0341340321141368,-0.0128153070387811,1.59205753015079e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29627,-0.0173464042620946,0.00401937711100265,-0.0252243833996598,-0.00946842512452942,1.59617459621212e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,24917,-0.01309040111992,0.00303524782069443,-0.0190394868484811,-0.0071413153913589,1.61823549833372e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24788,-0.0199527175905692,0.00462883188694588,-0.0290252280889831,-0.0108802070921552,1.6349214990365e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,29531,0.00873137869081116,0.00202772844305943,0.00475703094241469,0.0127057264392076,1.66776396389327e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29561,-0.0161782630864805,0.00376092010817567,-0.0235496664985048,-0.00880685967445617,1.70054218746486e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29673,0.00790830229743832,0.00183922164258011,0.00430342787798132,0.0115131767168953,1.71490619407371e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,24917,-0.0160329494009673,0.0037303413297903,-0.0233444184073563,-0.00872148039457833,1.73012271020303e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,29720,0.0129713806811995,0.00302099534898595,0.00705022979718701,0.0188925315652119,1.76241726302569e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24224,-0.0261836234943897,0.0060987113977679,-0.0381370978340148,-0.0142301491547647,1.76717870392837e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,28717,-0.0179019014429309,0.00417219416592805,-0.0260794020081499,-0.00972440087771192,1.78641704488472e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24933,-0.0157815277552336,0.00368075893429836,-0.0229958152664584,-0.00856724024400879,1.81313525546772e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29404,0.00511797481506584,0.00119407781038137,0.00277758230671835,0.00745836732341333,1.82389567609073e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,24440,-0.0372920550541181,0.00871242223986353,-0.0543684026442506,-0.0202157074639856,1.87325962718498e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24863,-0.0309600267372075,0.00723805871832512,-0.0451466218251247,-0.0167734316492902,1.89800320068706e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,28769,-0.0195522438387309,0.00457268046799482,-0.0285146975560008,-0.0105897901214611,1.90995132984651e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,24788,-0.0093922591182388,0.00219681991414682,-0.0136980261499666,-0.00508649208651104,1.91517453725873e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24321,-0.0157125111136935,0.00367675494876573,-0.0229189508132743,-0.00850607141411264,1.93184174583229e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29429,0.0101917130944821,0.00238618833259971,0.00551478396258669,0.0148686422263776,1.95097690652351e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29699,-0.0236179104105469,0.00553022382262556,-0.034457149102893,-0.0127786717182009,1.95468333010366e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29678,-0.0181808133191939,0.00425710858861786,-0.0265247461528849,-0.00983688048550287,1.95470336783126e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29429,-0.0291357839011537,0.00682696161510654,-0.0425166286667625,-0.0157549391355449,1.98069438493136e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,29344,0.00818515889550443,0.00192222720272912,0.00441759357815535,0.0119527242128535,2.06753447360798e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28792,-0.00831349718443796,0.00195455377765334,-0.0121444225886385,-0.00448257178023742,2.11214235156897e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29689,-0.0134179772005441,0.00316123557189212,-0.0196139989214526,-0.00722195547963553,2.19711449568196e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,29314,-0.0226342005417878,0.00533807394724237,-0.0330968254783828,-0.0121715756051927,2.24060826207928e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,24800,0.0327265236742012,0.00772947030218227,0.0175767618819239,0.0478762854664784,2.30404712906087e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24764,0.0249803514731726,0.00591386394627488,0.0133891781384738,0.0365715248078713,2.40827422948398e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,24840,-0.0214280457807429,0.00509420779890665,-0.0314126930666,-0.0114433984948859,2.60432628587362e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,29429,-0.0191690715148875,0.00456219003108322,-0.0281109639758106,-0.0102271790539644,2.65668356645007e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,29576,-0.0134506956437228,0.00320467014012588,-0.0197318491183695,-0.00716954216907602,2.71004114527645e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,29461,0.0150632232458829,0.00359259343234932,0.00802174011847826,0.0221047063732876,2.76269832216749e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24106,0.0160284461504555,0.00382323227060751,0.00853491090006476,0.0235219814008462,2.77026855058953e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29213,0.0102634905389843,0.00245000105433238,0.00546148847249281,0.0150654926054757,2.80788342759779e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,24190,-0.0128789676322135,0.00307518310724097,-0.0189063265224058,-0.00685160874202115,2.82379420408361e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,24961,0.00640972159857448,0.00153148913046586,0.00340800290286139,0.00941144029428756,2.85780984826999e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29429,-0.012273409624064,0.00293280266990803,-0.0180217028570837,-0.00652511639104424,2.86152267533131e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24440,-0.018858998738906,0.00450804031387527,-0.0276947577541016,-0.0100232397237105,2.88166173728757e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29473,0.00899483047342126,0.00215088906435181,0.00477908790729171,0.0132105730395508,2.89902155472067e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29531,0.0231033393974141,0.00554116333214359,0.0122426592664127,0.0339640195284155,3.06270202902827e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24933,0.0111914278966325,0.00268478631316978,0.00592924672281976,0.0164536090704453,3.07697805015511e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24863,-0.0203629507434657,0.00489002873983484,-0.029947407073542,-0.0107784944133894,3.13529573704214e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29647,0.00791943164689953,0.00190244518552474,0.00419063908327104,0.011648224210528,3.15304908020162e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,29561,0.00900758735959104,0.00216414524900344,0.00476586267154429,0.0132493120476378,3.16099503387735e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28911,0.00965913989070888,0.00232201083866958,0.00510799864691651,0.0142102811345013,3.19422393295014e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRELP,Prolargin,29449,0.00654188329812034,0.0015745090526992,0.00345584555482991,0.00962792104141077,3.26388249665027e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24946,0.0112365393766403,0.0027128193491271,0.00591941345235115,0.0165536653009294,3.45400849666186e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24106,0.0139755414859089,0.00338297534382532,0.00734490981201126,0.0206061731598065,3.62187969760595e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29168,-0.00791865904532116,0.00192083024384374,-0.0116834863232549,-0.00415383176738744,3.75788094141052e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29213,-0.00649702577903257,0.00157653476619715,-0.00958703392077899,-0.00340701763728615,3.78140358867767e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,29213,-0.0268766906986122,0.00652323594218612,-0.039662233145297,-0.0140911482519274,3.79673948186309e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24376,-0.0149246543188449,0.00362607448234853,-0.022031760304248,-0.00781754833344179,3.8689662351911e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,28862,-0.0166292763402825,0.00404096948813459,-0.0245495765370263,-0.00870897614353866,3.8796811216509e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,24840,-0.0184873558897601,0.00449318737986507,-0.0272940031542956,-0.00968070862522454,3.89219333371706e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29344,0.0105886932893066,0.00257650367942075,0.00553874607764189,0.0156386405009712,3.97225504499448e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRNN,Cornulin,28575,0.0185588144406325,0.00452428619488925,0.00969121349864959,0.0274264153826155,4.10653260671198e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29525,-0.0136523097160058,0.00333014340345032,-0.0201793907867685,-0.0071252286452432,4.14942757560966e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24235,-0.0151380569051218,0.0036925112068581,-0.0223753788705637,-0.00790073493967994,4.15098236627169e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29365,-0.0056040042901131,0.001367644584048,-0.00828458767484719,-0.00292342090537901,4.18650551051616e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29429,-0.0288379440647843,0.00705357273815821,-0.0426629466315744,-0.0150129414979942,4.35480983471446e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,29344,-0.0152447542577847,0.00372905792801249,-0.0225537077966892,-0.00793580071888025,4.3608241485928e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24224,-0.01369034326889,0.00334935558037247,-0.02025508020642,-0.00712560633135992,4.3753573850468e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24235,0.00911986859543984,0.00223348187434015,0.00474224412173316,0.0134974930691465,4.45524499534086e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24840,-0.011510974887806,0.00282005492563492,-0.0170382825420505,-0.0059836672335616,4.48229119314027e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28792,-0.0174421733081838,0.00427501511933579,-0.0258212029420819,-0.00906314367428563,4.51519250679217e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,28447,-0.0166318906051718,0.0040778976261834,-0.0246245699524913,-0.00863921125785236,4.54417232469887e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,24747,-0.0119899949699702,0.00294086853482889,-0.0177540972982348,-0.00622589264170557,4.5758135879427e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29689,-0.0167412473841942,0.00410891574207842,-0.0247947222386679,-0.00868777252972051,4.62587423366764e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24800,-0.0137857457185087,0.00338479540275445,-0.0204199447079075,-0.00715154672911003,4.65866958719541e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,29781,-0.00954038593110656,0.00234380412906008,-0.0141342420240643,-0.0049465298381488,4.70393326537974e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24106,0.00900376672327751,0.00221358136970925,0.00466514723864738,0.0133423862079076,4.76690826014627e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29344,0.00665546691531376,0.00163644900234562,0.00344802687071635,0.00986290695991117,4.77429660536763e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,24788,-0.0186283277766836,0.00458173799298174,-0.0276085342429278,-0.00964812131043944,4.802039183537e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29689,-0.0135576088832748,0.00334302516264319,-0.0201099382020555,-0.00700527956449419,5.01567828788841e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24096,0.00793759097715656,0.00195815161208393,0.00409961381747206,0.0117755681368411,5.05907808372135e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFD,Complement factor D,24961,0.00536502217696748,0.00132376450368417,0.0027704437497465,0.00795960060418846,5.0750208525387e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29213,-0.0157497818208836,0.00388957824484155,-0.023373355180773,-0.00812620846099414,5.15198155052854e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24788,-0.00964746528424884,0.00238405497098576,-0.0143202130273809,-0.00497471754111675,5.21106949715178e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,24840,0.0206455685293773,0.00510621440590572,0.0106373882938021,0.0306537487649525,5.28802732162311e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24324,-0.0233820329550053,0.00580072036299464,-0.0347514448664748,-0.0120126210435358,5.57366166575696e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F3,Tissue factor,29536,0.00742866896342206,0.00184986212010245,0.00380293920802125,0.0110543987188229,5.93919358137035e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29815,0.00860042062130599,0.00214318856920014,0.00439977102567371,0.0128010702169383,6.01215187450847e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29576,-0.0286131522071172,0.00713183114917691,-0.042591541259504,-0.0146347631547305,6.03457967392916e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24840,0.0108882460481505,0.00271722548382682,0.00556248409984996,0.0162140079964511,6.16431170714361e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,24011,-0.00977042384157464,0.00244116446531535,-0.0145551061935927,-0.00498574148955655,6.29016064582273e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,24800,0.0185805301029123,0.00465053601320376,0.00946547951703293,0.0276955806887917,6.47846885028763e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29561,-0.018541168744323,0.00464372338091206,-0.0276428665709106,-0.00943947091773534,6.54726867425304e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCT,Secretin,24190,-0.0127099957778855,0.00318363007548543,-0.018949910725837,-0.00647008082993406,6.56296557703407e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,24652,0.0080340704773897,0.00202110619064499,0.00407270234372552,0.0119954386110539,7.05544294192844e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24933,-0.00754346957000853,0.00189887255874027,-0.0112652597851395,-0.0038216793548776,7.12909238510003e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTG,Protogenin,29720,-0.00668393553960741,0.00168699103077148,-0.00999043795991952,-0.0033774331192953,7.44837905432625e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,29781,-0.011067176471143,0.00279336712743371,-0.016542176040913,-0.00559217690137288,7.45137771173527e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,24946,0.00658275242460968,0.00166186545199437,0.00332549613870071,0.00984000871051865,7.48244737045345e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24106,0.00548794423137164,0.00138573743945312,0.00277189885004352,0.00820398961269976,7.50689441040509e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24224,-0.0154680922966069,0.00391229074247409,-0.0231361821518561,-0.00780000244135767,7.71649582523104e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29589,-0.011317779037383,0.00287387442525101,-0.016950572910875,-0.00568498516389106,8.22968065689418e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,29429,0.0103486173687703,0.00262841487009351,0.00519692422338703,0.0155003105141536,8.26247548579872e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,24190,-0.0129989399504435,0.00330746603761894,-0.0194815733841766,-0.00651630651671033,8.51181614112816e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24224,-0.00960898636704501,0.00244592793030293,-0.0144030051104388,-0.00481496762365126,8.56914123152253e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24235,-0.00817955996439084,0.00208737687722949,-0.0122708186437606,-0.00408830128502104,8.93156271760956e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C5,Complement C5,24961,0.0040181381937701,0.00102557276344563,0.00200801557741666,0.00602826081012355,8.9544889905634e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,29344,-0.00865064283612021,0.00221039857848732,-0.0129830240499554,-0.00431826162228507,9.11308365505449e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24235,-0.00854232470653818,0.00218648323638011,-0.0128278318498432,-0.00425681756323317,9.37499823148261e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24840,-0.0285073222054169,0.00729768334978994,-0.0428107815710052,-0.0142038628398286,9.39479982322685e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24840,-0.00979162333283445,0.00250989380966955,-0.0147110151997868,-0.00487223146588214,9.59651966386786e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24788,-0.015653660388864,0.00401595811604268,-0.0235249382963077,-0.00778238248142037,9.73001246309209e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,29514,0.00806266859082345,0.00207189669723767,0.00400175106423761,0.0121235861174093,9.98685212347305e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,24224,0.00447283219630734,0.00114936972796481,0.00222006752949631,0.00672559686311837,9.98716200304127e-05
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28728,0.00754090871129058,0.00194140486915727,0.00373575516774232,0.0113460622548388,0.00010287475748192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24104,-0.0108499875411442,0.00279505828341207,-0.0163283017766318,-0.00537167330565654,0.000103942527352411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28926,0.0126976929762506,0.00327893448148462,0.00627098139254075,0.0191244045599605,0.000107959082589678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCN,Decorin,28911,0.00600219306763362,0.00155042094251177,0.00296336802031055,0.00904101811495669,0.00010848056448799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,29486,-0.0277251094785693,0.00716668740356846,-0.0417718167895635,-0.0136784021675752,0.000109693461928311
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,24449,-0.00656692088245331,0.0016995812480249,-0.00989810012858212,-0.0032357416363245,0.000111903570308048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29576,-0.010107422574644,0.00261632899186087,-0.0152354273986913,-0.00497941775059667,0.000112146344003648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,28926,0.0089173601410981,0.00231266810628567,0.00438453065277819,0.013450189629418,0.000115565814457834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29429,-0.00978031792436345,0.00254154727591601,-0.0147617505851588,-0.00479888526356807,0.000119252461532329
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,28769,-0.0111476662621402,0.00290005610459387,-0.0168317762271441,-0.00546355629713616,0.000121330871806186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29429,-0.020271414344185,0.00528026191141012,-0.0306207276905488,-0.00992210099782112,0.000123748305466926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28782,-0.0203868903779987,0.00531451801343351,-0.0308033456843284,-0.00997043507166902,0.000125282913138656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29473,-0.017347788238636,0.00452579456884908,-0.0262183455935802,-0.00847723088369181,0.000126805335806851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24863,-0.0150000336822678,0.00391607840817274,-0.0226755473622864,-0.00732452000224928,0.000128264446549377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,28911,-0.0147071709183763,0.00384386780563263,-0.0222411518174162,-0.00717319001933635,0.000130442824953402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAT,Catalase,24582,-0.0138592207545116,0.00362519867676338,-0.0209646101609678,-0.00675383134805533,0.000132150239210082
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,24189,-0.00712801030904004,0.00186581678626121,-0.010785011210112,-0.00347100940796807,0.000133613861913349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24376,0.00834357671481743,0.00218913186012573,0.00405287826897099,0.0126342751606639,0.000138542364746807
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24800,0.0292976818672736,0.00768855944359782,0.0142281053578219,0.0443672583767253,0.00013898978958995
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29429,0.0157292313250333,0.00412867904410001,0.00763702039859729,0.0238214422514693,0.000139390709762136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24235,-0.0264502718018788,0.00694461070839468,-0.0400617087903323,-0.0128388348134252,0.000140016824518472
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24800,-0.0121558916669288,0.00319350307447461,-0.018415157692899,-0.00589662564095855,0.000141318105202101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29438,0.0104430389341455,0.00275004147646364,0.00505295764027676,0.0158331202280142,0.000146508571625406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28792,-0.011430412626406,0.00301052976910196,-0.0173310509738459,-0.00552977427896619,0.000146870153848681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,24190,-0.0175979789361977,0.00463745576044116,-0.0266873922266623,-0.008508565645733,0.000148153370694565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28792,0.00935434458797163,0.00246892623245199,0.00451524917236573,0.0141934400035775,0.000151665839266026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29084,-0.0298460528052912,0.00788400343277549,-0.0452986995335311,-0.0143934060770512,0.000153617215125623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28329,0.0122817547433387,0.0032447308946712,0.00592208218978312,0.0186414272968942,0.000153939860848264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29561,-0.00838507494430422,0.00221783519149852,-0.0127320319196413,-0.00403811796896713,0.000156665666602527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28979,0.00871349250242186,0.00230480406097284,0.00419607654291509,0.0132309084619286,0.00015677826536073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,24198,0.017831556048147,0.00472247315591178,0.00857550866255989,0.0270876034337341,0.000159816348701994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28911,-0.00902472022234058,0.00239111873248164,-0.0137113129380046,-0.00433812750667656,0.000160799525925305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,24551,-0.0157379473977154,0.00416977031762921,-0.0239106972202687,-0.00756519757516218,0.000160837769569423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29386,0.00735003920160649,0.00195108422265752,0.00352591412519774,0.0111741642780152,0.000165439901198674
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,24788,-0.0107208778067374,0.00285265900664921,-0.0163120894597699,-0.00512966615370495,0.00017152905577067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29344,0.00581647185726446,0.00155384440660644,0.00277093682031583,0.00886200689421309,0.000181981567556384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,28792,0.0220037424346483,0.00588200921511098,0.0104750043730308,0.0335324804962658,0.000183751273762417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,29720,0.0115972370471918,0.00310322181010122,0.00551492229939341,0.0176795517949902,0.000186458858033002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,28863,0.0096655275360156,0.00258762654603218,0.00459377950579252,0.0147372755662387,0.000187862167372595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24863,-0.0191437016450131,0.00513899291202757,-0.0292161277525871,-0.00907127553743903,0.00019560340353728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29370,0.00932931823071438,0.00250573213432738,0.00441808324743271,0.014240553213996,0.000197088485757263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24800,-0.0192618793608203,0.00517765849241902,-0.0294100900059616,-0.00911366871567902,0.000199511290641543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,29213,0.0107959081307726,0.00290283909090659,0.00510634351259571,0.0164854727489495,0.000200319035451204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24863,-0.0194475903636298,0.00523586085790477,-0.0297098776451232,-0.00918530308213649,0.000204207761820294
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29619,-0.0170472955448564,0.004595125557269,-0.0260537416371037,-0.00804084945260916,0.000207748832844976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24224,-0.0216719487881053,0.00584548716253522,-0.0331291036266743,-0.0102147939495363,0.000209809821558952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,24106,-0.0119859308862732,0.00323423236098842,-0.0183250263138105,-0.00564683545873594,0.000211064014810136
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,24338,-0.0144668359814192,0.00390623631827526,-0.0221230591652387,-0.00681061279759964,0.00021309597973209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,24808,-0.0186195876992477,0.00503894083658666,-0.0284959117389576,-0.00874326365953787,0.000220238972158346
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28926,0.00982752369832211,0.0026604284148098,0.0046130840052949,0.0150419633913493,0.000221192721212884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,29164,-0.00767909080802118,0.00207955932340928,-0.0117550270819034,-0.00360315453413898,0.000222331672852493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,27580,0.012238761178291,0.00331835076120363,0.00573479368633191,0.0187427286702502,0.000226274504438639
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24933,-0.0207050487446701,0.0056168787511793,-0.0317141310969815,-0.0096959663923587,0.000228092544226441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRN,Progranulin,29308,0.00612975405624594,0.00166752479480582,0.00286140545842653,0.00939810265406535,0.000237379766497698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,28926,-0.0197735500110878,0.00538115849981761,-0.0303206206707304,-0.00922647935144533,0.00023866206063788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,29260,-0.00571212989506011,0.00155594294913256,-0.00876177807535993,-0.00266248171476029,0.000241872897291891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,24106,0.0165721680961179,0.00451560793897112,0.00772157653573446,0.0254227596565013,0.000243097481722678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28911,-0.0121414391425056,0.0033119542981141,-0.0186328695668092,-0.00565000871820197,0.000246869111720991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,29438,0.0121511899940486,0.0033163823349347,0.00565108061757661,0.0186512993705206,0.000248752832260376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24235,0.0112476845309904,0.0030717563109281,0.00522704216157131,0.0172683269004095,0.000251133002484331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,29815,0.00786802106958605,0.00215086516818234,0.00365232533994867,0.0120837167992234,0.000254556733582683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,24106,0.017887150076545,0.00489464404372961,0.00829364775083496,0.027480652402255,0.000258297892153068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28926,0.00932127640834272,0.00255163955573918,0.00432006287909392,0.0143224899375915,0.000259597715524661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,29531,-0.0213690323102389,0.00586345048396614,-0.0328613952588126,-0.00987666936166529,0.000268427283309739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24840,-0.00985474900298427,0.00270667113670931,-0.0151598244309345,-0.00454967357503403,0.000272226914167929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29429,0.0121585107110764,0.00334421772341543,0.0056038439731822,0.0187131774489707,0.000277719461417778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24440,-0.0185939409142188,0.00511538627067584,-0.0286200980047434,-0.00856778382369413,0.000278654273064333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24190,-0.0106721299580922,0.0029376987540205,-0.0164300195159724,-0.00491424040021201,0.000280920946686173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24840,0.0066357200763437,0.00182881873759625,0.00305123535065504,0.0102202048020324,0.000285734505922427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28879,-0.0101297865811258,0.00279275310213421,-0.0156035826613089,-0.0046559905009428,0.000287039746903689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24863,-0.0154815758342057,0.00427228472726721,-0.0238552538996494,-0.00710789776876194,0.000290971861861585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24863,-0.0144001241064353,0.00397651674798215,-0.0221940969324804,-0.00660615128039032,0.000293719727507433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,24376,-0.016467163999083,0.00454778895108663,-0.0253808303432128,-0.00755349765495317,0.000294156667317062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24917,-0.0262796944251217,0.00725829119558213,-0.0405059451684627,-0.0120534436817807,0.000294452609223782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,29387,0.0192887496196304,0.00533667990313616,0.00882885700948357,0.0297486422297773,0.000301578804670916
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24224,-0.0221025454065526,0.0061233891954548,-0.034104388229644,-0.0101007025834612,0.00030737325771713
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29720,0.00631926163319624,0.00175243004069804,0.00288449875342809,0.00975402451296439,0.000311463103572391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPSE,Heparanase,24683,-0.0228836820704453,0.00634676957274923,-0.0353233504330337,-0.0104440137078568,0.000312090071156512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,24235,-0.0219233393521874,0.00611900247068804,-0.0339165841947359,-0.00993009450963881,0.000340559616783877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29561,0.0109682992884745,0.0030637314164471,0.0049633857122382,0.0169732128647108,0.00034408429081353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24106,0.00628228803376556,0.00175567026600789,0.0028411743123901,0.00972340175514103,0.00034653517345387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,24883,-0.0107528728166501,0.00300619715332783,-0.0166450192371727,-0.00486072639612757,0.00034835023250968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24946,-0.00589733947720281,0.00165108912725334,-0.00913347416661937,-0.00266120478778626,0.000355220685958774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24173,-0.00669244894353888,0.00187769082700939,-0.0103727229644773,-0.00301217492260047,0.000365683605439279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28911,-0.0212514960655533,0.00597120626825367,-0.0329550603513305,-0.00954793177977609,0.000372872643344054
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29618,-0.0197409097147422,0.00556295877025208,-0.0306443089044363,-0.00883751052504813,0.000387832839545831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,29213,-0.031608814020376,0.00891103795735987,-0.0490744484168013,-0.0141431796239507,0.000390028595440106
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,29781,-0.00834301106811917,0.00235422329508308,-0.012957288726482,-0.00372873340975633,0.000394935389007925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24096,0.0141820513003553,0.00400272651641336,0.00633670732818514,0.0220273952725255,0.000396204129964664
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,24863,-0.0131480230797624,0.00371214839963001,-0.0204238339430372,-0.00587221221648757,0.000397997709428533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24917,-0.0113964184793757,0.00321858500264216,-0.0177048450845543,-0.00508799187419707,0.000399618972134167
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,24771,-0.0225983271927652,0.00638753682553693,-0.0351178993708176,-0.0100787550147128,0.000404094181764418
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29429,0.0081301569591877,0.00229932008939889,0.00362348958396587,0.0126368243344095,0.000407018996625083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,29161,0.0167971050606478,0.00475380666786664,0.00747964399162917,0.0261145661296664,0.00041088432697001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24933,0.00544306806840492,0.00154104372475254,0.00242262236788995,0.00846351376891989,0.000413071508712229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,29213,-0.00790995454039673,0.00224329774709256,-0.0123068181246981,-0.00351309095609532,0.000422471670744891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24840,-0.0214916076945881,0.00610740625469507,-0.0334621239537905,-0.0095210914353858,0.000434046530639163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,24190,-0.0311939147460037,0.00886811393401394,-0.048575418056671,-0.0138124114353364,0.00043637119676804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,24096,0.0215393528281024,0.0061241537453764,0.00953601148716471,0.0335426941690402,0.000437067615250723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29589,-0.00708168376358482,0.00201444448577775,-0.0110299949557092,-0.00313337257146044,0.000439662005010195
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,28664,0.0213930181410073,0.00609163822714713,0.0094534072157989,0.0333326290662156,0.000445656444826328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24840,-0.00707193887862964,0.00201395392258656,-0.0110192885668993,-0.00312458919035998,0.00044642641789885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,29720,0.00673519542705953,0.00191980421383828,0.0029723791679365,0.0104980116861826,0.000451694107219839
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,29576,-0.00963575165479602,0.00274678957669494,-0.0150194592251181,-0.00425204408447395,0.000452150746474964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,29429,0.0080639888043509,0.00230019867447329,0.00355559940238325,0.0125723782063186,0.000455950263381888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28926,0.00834632987437167,0.00238266310662823,0.00367631018538033,0.013016349563363,0.000460844937816787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29576,-0.00609608721081571,0.00174590835688488,-0.00951806759031007,-0.00267410683132135,0.000480761280147534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,29493,-0.0153981865004957,0.00441164632975608,-0.0240450133068176,-0.00675135969417376,0.000483094409372236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,24917,-0.0126310834188166,0.00362206215259232,-0.0197303252378975,-0.0055318415997356,0.000488832395885586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,24235,-0.0068789105525673,0.0019753588495915,-0.0107506138977666,-0.00300720720736796,0.000497891421558437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29576,0.00787153561097432,0.00226082721422706,0.00344031427108929,0.0123027569508594,0.000498949605062912
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,29237,0.0116876847852734,0.00335871270363746,0.00510460788614401,0.0182707616844028,0.00050249915862842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24800,-0.0188713405624818,0.00542606109060349,-0.0295064203000646,-0.00823626082489893,0.00050621011048732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,28926,0.011539923956908,0.00331878326517767,0.00503510875715975,0.0180447391566562,0.000507508984112117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24863,-0.0142633906228982,0.00410310642857066,-0.0223054792228967,-0.00622130202289972,0.000509361510109403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24933,-0.0143879640084964,0.00414775788614609,-0.0225175694653427,-0.00625835855165002,0.000523567454967518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24862,0.00530761113001372,0.00153347865238484,0.00230199297133942,0.00831322928868801,0.000538761618700688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24917,-0.0163400020048071,0.00473004174661121,-0.0256108838281651,-0.00706912018144911,0.000552200239192242
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29531,-0.0119041333347346,0.00345168869369701,-0.0186694431743808,-0.00513882349508848,0.000563899923764088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24800,0.01086594362163,0.00315127340832074,0.00468944774132134,0.0170424395019386,0.000565457371954726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24235,0.0133718899707592,0.00387897515448392,0.00576909866797068,0.0209746812735476,0.000567235522690427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,24840,-0.016517478020944,0.004796085940606,-0.0259178064645317,-0.00711714957735621,0.000574228864988508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,24541,0.00797602640721871,0.00231755476922492,0.00343361905953787,0.0125184337548995,0.00057931305121213
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24863,-0.0275135059810441,0.00800478506938168,-0.0432028847170322,-0.011824127245056,0.000588870500069661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23400,-0.025745966957301,0.00749707679124596,-0.0404402374681431,-0.0110516964464589,0.000595480637923101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,28926,-0.0163610579640461,0.00477015081473886,-0.0257105535609343,-0.0070115623671579,0.000604684923514761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29344,-0.0140496397513115,0.00409647212996204,-0.0220787251260371,-0.00602055437658595,0.000605096810118391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_A,,24863,0.0075918832872667,0.00221356560809201,0.00325329469540636,0.011930471879127,0.000605212614589739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24317,0.0113187111440329,0.00330393491646481,0.00484299870776186,0.0177944235803039,0.000613942804838824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28792,-0.0151280010919732,0.00441671571633155,-0.0237847638959831,-0.00647123828796338,0.000615272534782663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,29308,0.0161044414907861,0.00470963749415046,0.00687355200225117,0.025335330979321,0.000628298166656867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29344,0.0079971949833271,0.00234088569229336,0.00340905902643212,0.0125853309402221,0.000635616169243822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,24224,0.00655612192723341,0.00192099397381621,0.00279097373855365,0.0103212701159132,0.000643854257270008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,28669,0.0103669650720818,0.00304019450329738,0.00440818384561888,0.0163257462985446,0.000650601055954115
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LXN,Latexin,29112,0.0155113547492703,0.00454938803627944,0.00659455419816256,0.024428155300378,0.000651590027367628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24096,0.0141825907864174,0.0041621988015481,0.0060246811353831,0.0223405004374517,0.00065674003844792
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29213,-0.0180314197144348,0.00529547401142813,-0.028410548776834,-0.0076522906520357,0.00066237904840477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29127,0.00941498458961548,0.00276701607665045,0.0039916330793806,0.0148383360998504,0.000668434164420226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,29438,0.00894657646913515,0.00263077095418725,0.00379026539892814,0.0141028875393422,0.000672922082762405
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29492,0.00781827591260595,0.00229959014474998,0.00331107922889599,0.0123254725963159,0.00067510613168467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29720,0.00883578223703321,0.00259909086921462,0.00374156413337256,0.0139300003406939,0.000675814701185679
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,24096,0.00648326435927557,0.00190737145373556,0.00274481630995388,0.0102217124085973,0.000677281862226647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29164,0.00773089931924259,0.00227475976394655,0.00327237018190736,0.0121894284565778,0.000678331282192825
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,29127,0.0156238868220321,0.00459965963559315,0.0066085539362695,0.0246392197077946,0.000682827843181387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24440,-0.0121724433809352,0.00358383262499912,-0.0191967553259335,-0.00514813143593696,0.000683653700947522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28792,0.0123463353868575,0.00363605738217804,0.00521966291778857,0.0194730078559265,0.000685888339001121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,29585,0.00941051640972019,0.00278378862452534,0.00395429070565051,0.0148667421137899,0.000724552979570332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24224,-0.0128044496895382,0.00379036137288587,-0.0202335579803945,-0.00537534139868186,0.000730873906649331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29344,0.0082825306979133,0.00245284495766982,0.00347495458088044,0.0130901068149462,0.000734552570999416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGRN,Agrin,29576,-0.00785302996539401,0.00232668239232515,-0.0124133274543513,-0.00329273247643672,0.000738555784188047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29531,-0.0161608008366934,0.00479144935951126,-0.0255520415813355,-0.00676956009205135,0.000744922357728474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29781,-0.00955199569156193,0.00283780272395297,-0.0151140890305097,-0.0039899023526141,0.000763678257546363
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,28911,0.0113858360334799,0.00338677960667249,0.00474774800440182,0.018023924062558,0.000775232706694266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,29158,0.00724636085116983,0.00215685326228091,0.00301892845709925,0.0114737932452404,0.000781296944920407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29689,0.0104309747635416,0.00310493161296363,0.00434530880213292,0.0165166407249504,0.000781858721645261
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24800,-0.0173062140757118,0.00516263879470027,-0.0274249861133243,-0.00718744203809922,0.00080291043349309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,24235,-0.0165440876193215,0.00494844536542443,-0.0262430405355534,-0.00684513470308962,0.000829167887281478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29344,-0.012245182281651,0.00366646062213961,-0.0194314451010447,-0.00505891946225737,0.000839484151108062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,28792,-0.00985629453466761,0.00295155239753061,-0.0156413372338276,-0.00407125183550762,0.00084078425966856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSPN,Persephin,29429,-0.0212023253762509,0.00635923140198556,-0.0336664189241426,-0.00873823182835922,0.00085680979295223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29781,0.0132699061173711,0.00398695351301384,0.00545547723186401,0.0210843350028783,0.000874735170289696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,24788,-0.00917991470989532,0.00275901899102995,-0.014587591932314,-0.00377223748747661,0.000878388412474097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29640,0.0110992056831862,0.00333719906921948,0.004558295507516,0.0176401158588564,0.000882391648302068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,29213,-0.0181374372882558,0.00546030901065161,-0.0288396429491329,-0.00743523162737863,0.000895847899687569
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28792,0.00686932091580964,0.00207025812035159,0.00281161499992053,0.0109270268316987,0.000907448039350905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28792,0.00845830423835804,0.00255442963947696,0.00345162214498321,0.0134649863317329,0.0009300109270372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29025,-0.00653874115480606,0.0019749738694942,-0.0104096899390147,-0.00266779237059742,0.000931435550713164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24376,-0.0232931682827657,0.00704923152810119,-0.037109662077844,-0.00947667448768738,0.000953322794350084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24376,-0.00720825879216773,0.00218162931373644,-0.0114842522470912,-0.00293226533724431,0.000954289978709874
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29164,0.00555782297014123,0.00168394677665488,0.00225728728789766,0.00885835865238479,0.000966374110944878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,24224,-0.0207519210274822,0.00629708391403807,-0.0330942054989968,-0.00840963655596761,0.000983945076752222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28769,-0.0150014125417937,0.00455479588936554,-0.0239288124849502,-0.00607401259863728,0.000990529166522729
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24106,-0.0156737008997267,0.00475968411416566,-0.0250026817634914,-0.00634472003596202,0.0009926269050833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24800,0.0047647105084332,0.00145086261210538,0.00192101978870664,0.00760840122815975,0.00102467272568522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,29438,-0.0162573996910481,0.00495462844146442,-0.0259684714363184,-0.00654632794577787,0.00103466486587452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29781,0.00994016354029461,0.00303025000337204,0.00400087353368542,0.0158794535469038,0.00103811710868078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,24096,0.0105614500328244,0.00322260807113183,0.00424513821340599,0.0168777618522428,0.00104953684699961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28792,-0.0130468019508689,0.00398707608399529,-0.0208614710754997,-0.00523213282623817,0.00106812096444415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24235,-0.00814854288385896,0.00249702727181339,-0.0130427163366132,-0.00325436943110472,0.00110276389530757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29815,-0.00770863806366659,0.00236787929190872,-0.0123496814758077,-0.0030675946515255,0.00113318016026037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,24190,-0.00741178510748292,0.0022772028555829,-0.0118751027044254,-0.00294846751054045,0.00113637821727862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29213,0.0153727036230192,0.00472490134372549,0.0061118969893172,0.0246335102567211,0.00114102102921097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,29576,-0.0203122101367876,0.00624821962248422,-0.0325587205968567,-0.00806569967671857,0.00115177275432488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,29473,-0.00935761451079457,0.0028809583394722,-0.0150042928561601,-0.00371093616542905,0.00116312200685149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,24800,-0.00980282197144698,0.00301851717992138,-0.0157191156440929,-0.00388652829880108,0.00116553030439404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,24011,-0.0123101661371083,0.00380079685468305,-0.0197597279722871,-0.00486060430192955,0.00120180825727097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29439,-0.0124207798376175,0.00383672381286287,-0.0199407585108287,-0.00490080116440624,0.00120783089270383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29561,-0.0133715283295369,0.0041377113908637,-0.0214814426556298,-0.00526161400344409,0.00123223623567595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,29560,0.00842531407477444,0.00261243424836034,0.00330494294798817,0.0135456852015607,0.00126073599625388
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,24863,0.00773385659619385,0.00240201729694085,0.00302590269418979,0.0124418104981979,0.00128474475188223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24096,0.00723478821324743,0.00224982311487524,0.00282513490809195,0.0116444415184029,0.00130292042818333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24840,-0.015230102863465,0.00474697883384135,-0.0245341813777941,-0.00592602434913597,0.00133655326244442
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,29448,0.00690393134346305,0.00215667143081019,0.00267685533907507,0.011131007347851,0.00137002965015712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29438,0.00733646150566126,0.0022934569924614,0.00284128580043692,0.0118316372108856,0.00138115443742543
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24604,-0.00688126649502517,0.00215600570767601,-0.0111070376820701,-0.0026554953079802,0.00141628896642889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_DRA,,29317,0.00778969368881014,0.0024449487425703,0.00299759415337235,0.0125817932242479,0.00144388015472684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29815,0.00749620033986826,0.00235324654130871,0.00288383711890318,0.0121085635608333,0.00144667045851232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29429,-0.0323364351512061,0.0101516233542861,-0.0522336169256068,-0.0124392533768054,0.00144731740434565
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,29815,0.0156013444540805,0.00490942547957241,0.00597887051411862,0.0252238183940425,0.00148530586804765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,24440,0.00896620921371439,0.00282389174269248,0.00343138139803713,0.0145010370293916,0.0014995792379013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24788,-0.0231646276421764,0.0072958976919953,-0.0374645871184872,-0.0088646681658656,0.00150009086901689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,24106,-0.0134432603018132,0.00424118064828102,-0.021755974372444,-0.00513054623118244,0.00152788513164961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29368,0.0188059033106388,0.00593448005930058,0.00717432239440969,0.0304374842268679,0.00153162475200044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,29213,-0.0145393595522363,0.00458876954638227,-0.0235333478631456,-0.00554537124132708,0.00153403680277609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,24863,-0.0147536867790536,0.00466298595756313,-0.0238931392558773,-0.00561423430222983,0.00155804360199913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29492,-0.00571154911268088,0.00180692877052907,-0.00925312950291785,-0.0021699687224439,0.0015743326686823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29781,0.00784892124303679,0.00248577350454101,0.00297680517413641,0.0127210373119372,0.00159266972037835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28769,-0.01366595203859,0.00432807935819261,-0.0221489875806476,-0.00518291649653254,0.00159287411446534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,29589,0.00993797727377362,0.00315229098456813,0.00375948694402009,0.0161164676035272,0.00161973625832155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29429,-0.0204420007773058,0.00649191990939473,-0.0331661637997195,-0.00771783775489216,0.00164085218950741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29335,0.00732250526239474,0.00232695218418782,0.00276167898138661,0.0118833315434029,0.0016522034963312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28911,-0.00772883661035921,0.00246312107831586,-0.0125565539238583,-0.00290111929686012,0.00170378959303926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERVV_1,,24106,0.00982252112516335,0.00313097315546346,0.00368581374045496,0.0159592285098717,0.00170769172227893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29657,0.00864558767630514,0.0027571288442113,0.003241615141651,0.0140495602109593,0.00171599520377282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24917,-0.00536446716787747,0.00171231496520572,-0.00872060449968068,-0.00200832983607425,0.00173304347244535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24917,-0.006386377580303,0.0020385668655338,-0.0103819686367493,-0.00239078652385675,0.00173361015875607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29429,-0.0129410521311899,0.00413247959745801,-0.0210407121422076,-0.00484139212017219,0.00174058605770599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29689,-0.0134291273190068,0.00428857594435636,-0.0218347361699452,-0.00502351846806831,0.00174160466335824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24847,-0.00848733500008857,0.00271085698931111,-0.0138006146991384,-0.00317405530103879,0.00174492695890885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24096,0.012497164954506,0.00399673408793558,0.00466356614215226,0.0203307637668597,0.00176903824300894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28911,-0.0154228819439016,0.00493313823366317,-0.0250918328818814,-0.00575393100592174,0.00177146047764696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,28926,0.0126834667738017,0.00406008973584691,0.00472569089154175,0.0206412426560617,0.00178624630625673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28792,-0.0164277951373862,0.00525941299163625,-0.0267362446009932,-0.00611934567377911,0.00178889005717001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,28792,0.0113064633603788,0.00362553927667478,0.00420040637809621,0.0184125203426613,0.0018191611411885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29344,0.0180418414562448,0.00578540940871552,0.0067024390151624,0.0293812438973272,0.00181945537587535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,28885,-0.0116969286963525,0.00375755418671691,-0.0190617349023177,-0.00433212249038737,0.0018543330550072
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28792,0.0121628898692247,0.00390813978319417,0.00450293589416414,0.0198228438442853,0.00185884102824794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24106,0.00794296650231702,0.00255381307481966,0.00293749287567049,0.0129484401289636,0.00187154747930815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29213,0.00601319585061277,0.00193353355662008,0.0022234700796374,0.00980292162158813,0.00187298037708081
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29627,-0.0149703329858816,0.00481761528509925,-0.0244128589446761,-0.00552780702708704,0.00188909391331824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29473,0.00370666156209266,0.00119324148770904,0.00136790824618294,0.00604541487800237,0.00189573002942734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29438,0.00789282059868792,0.00254461471534788,0.00290537575660608,0.0128802654407698,0.00192546469601489
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24715,0.00589912646605466,0.00190190015591065,0.0021714021604698,0.00962685077163953,0.00192628662324871
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24800,-0.0135425202053268,0.00436938553560921,-0.0221065158551209,-0.00497852455553279,0.00194123134303891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24106,0.0100493870659154,0.00324402135160616,0.00369110521676732,0.0164076689150635,0.0019517538739626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,29493,-0.0194809656370716,0.00629265999347184,-0.0318145792242764,-0.00714735204986677,0.0019645101915407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,24011,-0.0106854434790007,0.00345288802772759,-0.0174531040133468,-0.00391778294465462,0.00197278878697651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24224,-0.0161923555836159,0.00524576050804633,-0.0264740461793867,-0.00591066498784506,0.00202585642230416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29429,-0.00767820987961728,0.00249010028545019,-0.0125588064390997,-0.00279761332013491,0.00204774464192561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24863,0.0148831003181041,0.00482687216431576,0.00542243087604522,0.024343769760163,0.00204885149615383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,24863,-0.00619563032813326,0.00200966999369485,-0.0101345835157752,-0.00225667714049136,0.00205212104156535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,29473,0.0168093757901054,0.00546330914505247,0.00610128986580259,0.0275174617144083,0.0020944470866573
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24106,-0.0138744608296105,0.00451589718129665,-0.0227256193049519,-0.00502330235426903,0.00212610482211535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28581,0.00799213580964639,0.00260182403441545,0.00289256070219212,0.0130917109171007,0.00213012618891453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28769,-0.00797078783986501,0.00259540884896023,-0.0130577891838271,-0.00288378649590296,0.0021346308162223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24376,0.0051971039991761,0.00169818807463641,0.00186865537288873,0.00852555262546346,0.00221295319563819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24235,-0.0108462047066584,0.00354445483648688,-0.0177933361861727,-0.00389907322714411,0.0022154289203304
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29428,0.00663766264363148,0.0021712418977562,0.00238202852402933,0.0108932967632336,0.00223704262926742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29531,-0.0107432475907352,0.00351583095238551,-0.0176342762574108,-0.00385221892405964,0.00224752599250189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,24106,0.0114813956631228,0.0037612113118346,0.00410942149192699,0.0188533698343186,0.00227130961007454
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24235,0.00948079821836231,0.00310633642956128,0.0033923788164222,0.0155692176203024,0.00227504962664597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,29635,-0.0149400814787652,0.00489916141857097,-0.0245424378591643,-0.00533772509836612,0.00229411142137456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,29344,0.00611237868869735,0.00200572490026959,0.00218115788416895,0.0100435994932258,0.00230984768600823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29634,0.0052456210979226,0.00172248451196872,0.0018695514544639,0.0086216907413813,0.00232590072281001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24440,-0.0217820159798907,0.00716733010047386,-0.0358299829768195,-0.00773404898296194,0.00237560793781092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALLD,Palladin,24224,0.00820272977499089,0.00270583243327553,0.00289929820577084,0.0135061613442109,0.00243599484976027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24946,-0.00969046805437287,0.00319838979609148,-0.0159593120547122,-0.00342162405403357,0.00244969753296661
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24961,-0.0052191271814613,0.0017258273582281,-0.00860174880358838,-0.00183650555933422,0.00249602329190759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,29430,-0.00808297968550195,0.00267979670059537,-0.0133353812186689,-0.00283057815233503,0.0025612718523715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,29720,-0.00784354549692098,0.0026010949256754,-0.0129416915512448,-0.00274539944259719,0.00256790991341563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENG,Endoglin,29815,0.00351119163127008,0.00116526760178626,0.00122726713176902,0.00579511613077115,0.00258720248937159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24788,0.00857144549681384,0.00284740006194658,0.00299054137539854,0.0141523496182291,0.00261277544468584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,29647,-0.00757153247877704,0.00251914373138303,-0.0125090541922878,-0.0026340107652663,0.0026528127396772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,29731,0.00562348570280392,0.001871337566086,0.00195566407327536,0.00929130733233247,0.0026574800153614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24961,0.0037446611566688,0.00125324328513922,0.00128830431779594,0.00620101799554166,0.00281104613030917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29429,-0.0226704267047008,0.00758744670101362,-0.0375418222386875,-0.00779903117071415,0.00281145959731717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29492,-0.00616180046947295,0.00206594323974925,-0.0102110492193815,-0.00211255171956441,0.0028608204930366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGRN,Neugrin,24840,-0.00446124341756801,0.00149909877636221,-0.00739947701923795,-0.00152300981589807,0.00292363603652911
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24096,0.0155324574797252,0.00522059362174909,0.005300093981097,0.0257648209783534,0.00293061155616526
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29109,0.00668332574203142,0.00225104657107494,0.00227127446272455,0.0110953770213383,0.00299027726754993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,24840,0.00749257000194022,0.00252729426371447,0.00253907324505986,0.0124460667588206,0.00303304831678189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24863,-0.00790102031668386,0.00266522224878462,-0.0131248559243017,-0.00267718470906601,0.00303474458580446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,24235,-0.00855657112300638,0.00288878115121403,-0.0142185821793859,-0.00289456006662688,0.00305944007788042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,29278,0.00768657897034331,0.00259920004538893,0.00259214688138099,0.0127810110593056,0.00310607581178315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,24096,0.010756845784243,0.00364228452606444,0.00361796811315673,0.0178957234553293,0.0031467561887374
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,24011,-0.00730072453436006,0.00247355545388763,-0.0121488932239798,-0.00245255584474032,0.00316529787313735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29381,-0.01352916633448,0.00459500759015562,-0.022535381211185,-0.00452295145777502,0.00323920143191267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24106,0.00822711568448997,0.00280089051984048,0.00273737026560262,0.0137168611033773,0.00331374179738265
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,24096,-0.0127216863379373,0.00433340129574372,-0.021215152877595,-0.00422821979827959,0.00333080767616151
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29429,0.00919597489733498,0.00313305646649057,0.00305518422301347,0.0153367655716565,0.00333649672020678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,29781,0.00930048075983218,0.00317431047394639,0.00307883223089726,0.0155221292887671,0.00339304929662393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29781,-0.0107910532098852,0.00368357092779787,-0.018010852228369,-0.00357125419140135,0.0033975585491063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,24190,-0.00970084148794367,0.00333075505695247,-0.0162291213995705,-0.00317256157631684,0.00358870154872909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,24376,0.00589759171272173,0.00203089184753056,0.00191704369156185,0.00987813973388162,0.00368827581286124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28792,-0.0117387617659133,0.00405199306160066,-0.0196806681666506,-0.00379685536517601,0.00376992804647008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24863,-0.0103167102836681,0.0035632412556206,-0.0173006631446845,-0.00333275742265174,0.00379106625488427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24946,0.0142116784404974,0.00491287983699456,0.00458243395998808,0.0238409229210068,0.00382229111060209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24946,0.00512802348069282,0.00177322358551295,0.00165250525308744,0.0086035417082982,0.00383224519288518
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24510,0.00266233671655675,0.000921046631910422,0.000857085318012317,0.00446758811510117,0.00384898954511951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,24064,-0.0192011927014438,0.00665236820083336,-0.0322398343750772,-0.00616255102781045,0.00390061112583989
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29390,0.00570781381896608,0.00197857180358459,0.00182981308394029,0.00958581455399187,0.00391928358879804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29635,0.00565965116140328,0.00196209714554246,0.00181394075614006,0.00950536156666649,0.00392329788478501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24235,-0.0143039388319707,0.00496629577775769,-0.0240378785563757,-0.00456999910756561,0.00397767924390925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24788,-0.00850131362967021,0.00295304919179726,-0.0142892900455929,-0.00271333721374758,0.00399500549161053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29344,-0.0174681586946771,0.00607119164771767,-0.0293676943242037,-0.00556862306515042,0.00401484179857552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,24946,0.00438382677543742,0.00152432991222133,0.00139614014748361,0.00737151340339124,0.00403213270371811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28911,-0.0120160761035077,0.00418493459300954,-0.0202185479058064,-0.00381360430120898,0.00409123552654178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28926,-0.0106208735132282,0.00370082708114782,-0.0178744945922779,-0.00336725243417848,0.00410944991776124
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,24601,0.00601740646872693,0.00209884399005885,0.00190367224821158,0.0101311406892423,0.00414722049492855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,24106,0.00662778806209329,0.00231443136898351,0.00209150257888562,0.011164073545301,0.00419113880534452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24917,-0.00533389186755393,0.00186379404069736,-0.00898692818732076,-0.00168085554778711,0.00421532180300768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24011,-0.00819451347678005,0.00286579740088615,-0.0138114763825169,-0.00257755057104319,0.00424784604568018
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,28840,-0.00853528783166205,0.00298614757662675,-0.0143881370818505,-0.00268243858147363,0.00426230700927102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24863,0.0149760833096617,0.00524581610152173,0.00469428375067907,0.0252578828686442,0.00430911092625559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24376,-0.00556860413301026,0.00195100217363674,-0.00939256839333826,-0.00174463987268226,0.00431780104611739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,29429,-0.0116748295231065,0.00409075264589076,-0.0196927047090524,-0.00365695433716065,0.0043208616221326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29344,-0.0162802364322647,0.00570470245631904,-0.02746145324665,-0.00509901961787933,0.0043226235223211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24235,-0.00989098469384195,0.00346635114770041,-0.0166850329433347,-0.00309693644434916,0.00432869351771161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24440,-0.00956359560434831,0.00335554518653201,-0.016140464169951,-0.00298672703874558,0.00437438550275146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29576,0.00821250331811275,0.00288191536126719,0.00256394921002906,0.0138610574261964,0.00437950683211105
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29683,-0.0180180845691718,0.00632533286192357,-0.030415736978542,-0.00562043215980158,0.00439478935389316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29473,-0.013002729270493,0.00457035854027549,-0.0219606320094329,-0.004044826531553,0.00444402337874798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29755,0.00732634218092248,0.00257685275853711,0.00227571077418975,0.0123769735876552,0.00447024735344937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24224,0.00569233158957128,0.00200226850818092,0.00176788531353667,0.00961677786560589,0.00447367206385853
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29082,0.0114201986255132,0.00402186668228753,0.00353733992822965,0.0193030573227968,0.00452118340804424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,24823,-0.00590824485419138,0.00208105558739796,-0.00998711380549137,-0.00182937590289139,0.00452831943478218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24096,0.0120734776714599,0.00425962975819993,0.00372460334538802,0.0204223519975317,0.00459505974568172
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,24321,-0.0217983440353773,0.00769332184304519,-0.0368772548477458,-0.00671943322300869,0.00460920237709163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24917,0.00646727988742003,0.00228461236620282,0.00198943964966249,0.0109451201251776,0.00464689848885806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,24096,0.00944147671895558,0.00333978936091565,0.0028954895715609,0.0159874638663503,0.00470297948833088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29438,0.00672107553777005,0.00237915201060113,0.00205793759699184,0.0113842134785483,0.00473142216589744
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29373,0.00778864032941585,0.00275731963692463,0.00238429384104357,0.0131929868177881,0.00473546846603248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,29077,-0.00897964152010638,0.00318173092210917,-0.0152158341274404,-0.0027434489127724,0.00477202913996192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29512,0.00513913140574289,0.00182110176595926,0.00156977194446274,0.00870849086702304,0.0047758539332157
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24106,0.00526294741908969,0.00187019762374536,0.00159736007654878,0.0089285347616306,0.00489516726146898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28769,-0.0117946280678245,0.00419214094908284,-0.0200112243280268,-0.00357803180762209,0.0049037196250095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,29473,0.00677639932872685,0.00241226899258441,0.00204835210326141,0.0115044465541923,0.00497068788046052
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28926,0.0136897390240298,0.00487535295855994,0.00413404722525233,0.0232454308228073,0.00498916341970648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,24796,-0.00610503155878758,0.00217590604306953,-0.0103698074032039,-0.0018402557143713,0.00502399547476307
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24946,0.00492718986957401,0.00175698286125985,0.0014835034615047,0.00837087627764331,0.00504575783840816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29678,-0.00652302810448953,0.00232610256548903,-0.011082189132848,-0.00196386707613103,0.00504628589845943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28769,-0.00782030562794093,0.00279147956137557,-0.0132916055682371,-0.00234900568764481,0.00509009982984463
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28926,-0.0125158607325661,0.0044700732715628,-0.0212772043448292,-0.00375451712030304,0.00511486987301546
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,28769,0.00724760269737129,0.00259036776300267,0.00217048188188606,0.0123247235128565,0.00514694542882053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,29378,-0.00894307510603892,0.0032015856121512,-0.0152181829058553,-0.00266796730622257,0.0052202717777035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,29429,-0.0125816982846735,0.00450436504199063,-0.0214102537669751,-0.00375314280237182,0.00522193401313586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24190,0.0119548521963568,0.00428104120297594,0.00356401143852396,0.0203456929541897,0.00523418612299003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,24106,0.00597856573509035,0.00214148324377996,0.00178125857728163,0.0101758728928991,0.00524590755759233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,29391,-0.00489231656552689,0.00175498403343635,-0.00833208527106214,-0.00145254785999165,0.00531226713835885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,24235,-0.0144359158882124,0.00519974498868594,-0.0246274160660369,-0.00424441571038797,0.00550280891127362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,24376,-0.0104903649043334,0.00377930083721266,-0.0178977945452702,-0.00308293526339657,0.00551178631144139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,24961,0.0100090145373258,0.0036086806524347,0.00293600045855376,0.0170820286160978,0.00554820210599396
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,28926,-0.0154366231155724,0.00556996179127,-0.0263537482264615,-0.00451949800468316,0.0055850527531593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,24961,-0.0136234505110158,0.00491873852626692,-0.0232641780224989,-0.00398272299953262,0.00561486933140973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,24721,0.00649657039735925,0.00234759650289107,0.00189528125169276,0.0110978595430257,0.00565598383162407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,24376,-0.0101294867647133,0.003660471162294,-0.0173040102428096,-0.00295496328661711,0.00565717564228536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29429,0.0153868106360075,0.00557756775944678,0.00445477782749185,0.0263188434445232,0.00580684483792408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24224,-0.0149032737139241,0.0054182769304734,-0.0255230964976519,-0.0042834509301962,0.00595384223670824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24106,-0.00852218872715172,0.00309858513560145,-0.0145954155929306,-0.00244896186137287,0.00595763474596008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIM,Vimentin,28911,-0.0216739902819805,0.00789593616155865,-0.0371500251586355,-0.00619795540532557,0.00605565579300682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,24011,0.00764118050123999,0.00278702931584497,0.00217860304218384,0.0131037579602961,0.00611685960639909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24800,0.00634707086938681,0.00231575981067483,0.00180818164046414,0.0108859600983095,0.00613307687738366
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24096,0.0106391435741339,0.00388661977033448,0.0030213688242783,0.0182569183239895,0.00619767243020619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24172,-0.0108270964091107,0.00395853904010357,-0.0185858329277137,-0.00306835989050773,0.00624022033146801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29429,-0.0154334216390306,0.0056597409189508,-0.0265265138401742,-0.00434032943788702,0.00639746071305024
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,29438,0.00622087896324171,0.00228261122749966,0.00174696095734237,0.0106947969691411,0.00642743611202275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24800,-0.0088250970801524,0.00324010807582745,-0.0151757089087742,-0.0024744852515306,0.00645994369168701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,28792,-0.0106886350873007,0.00392723419972401,-0.0183860141187597,-0.00299125605584159,0.00649920604406868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,29438,0.00362037821891431,0.00133060867776146,0.00101238521050185,0.00622837122732678,0.00651538122266226
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29344,0.00598858161190504,0.00220467403059775,0.00166742051193346,0.0103097427118766,0.00660524456728247
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,29492,0.00603347253024043,0.00222296320813452,0.00167646464229677,0.0103904804181841,0.00664831784517459
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,24440,0.00623624221191684,0.00230422474400124,0.00171996171367441,0.0107525227101593,0.00680564484486584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,24224,0.00483658813830511,0.0017876816440381,0.00133273211599043,0.00834044416061979,0.006824760945494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24788,-0.00822884563271901,0.00304771134999304,-0.0142023598787054,-0.00225533138673265,0.00693848497311123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24376,0.00686633653253335,0.00255043001092739,0.00186749371111567,0.011865179353951,0.00710251239903692
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,29331,-0.00836114668437209,0.00310852620812817,-0.0144538580523033,-0.00226843531644088,0.00715468441169208
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,24106,0.00731084624703098,0.00272074106166543,0.00197819376616673,0.0126434987278952,0.00721293685501622
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24106,-0.00817283762156438,0.00304258160342301,-0.0141362975642735,-0.00220937767885529,0.00723296782752166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29158,-0.0132805628765228,0.00494439630803025,-0.0229715796402621,-0.00358954611278351,0.00723578055893343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFH,Complement factor H,23688,-0.00425294859571943,0.00158540106076419,-0.00736033467481723,-0.00114556251662163,0.00731096839242773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,28792,0.00716268731377728,0.00267021750744477,0.00192906099918554,0.012396313628369,0.00731298911858838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29033,0.0311650495492798,0.0116231187593305,0.008383736780992,0.0539463623175675,0.0073378558025437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,29429,0.0161593249268347,0.00602938468171873,0.00434173095066595,0.0279769189030034,0.00736422149191578
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,29781,-0.011064072601547,0.00413380935743107,-0.0191663389421119,-0.00296180626098214,0.00744399723889571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29531,0.0161354599526184,0.0060290850893137,0.0043184531775635,0.0279524667276732,0.00744877354744884
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24788,-0.00524238342005353,0.00196389433791207,-0.00909161632236119,-0.00139315051774588,0.00760405931927557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24840,-0.00507783955799323,0.00190289875090617,-0.00880752110976933,-0.00134815800621713,0.00762457368148619
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29379,-0.0204829865202539,0.00769012186053167,-0.035555625366896,-0.00541034767361187,0.00773642322109764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24376,-0.0138269701823059,0.00519196853438313,-0.0240032285096969,-0.00365071185491501,0.00774647079641632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,24863,-0.00460563224121588,0.00172942281895684,-0.00799530096637128,-0.00121596351606048,0.00774734529520533
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24840,0.0108061867151899,0.0040586100223058,0.00285131107147049,0.0187610623589092,0.00776047469801909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28792,-0.00946208024481935,0.00355454259928997,-0.0164289837394277,-0.00249517675021102,0.00777283211225939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24440,0.00509408248642348,0.00191663675461513,0.00133747444737783,0.00885069052546913,0.00786982312425819
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24863,0.00633121308685756,0.00238668881862169,0.00165330300235904,0.0110091231713561,0.00798972211339686
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DMD,Dystrophin,24235,-0.00926325539298829,0.0034962306608129,-0.0161158674881816,-0.00241064329779501,0.00806638292222901
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24917,-0.00908136104619001,0.00343061639897544,-0.0158053691881819,-0.00235735290419815,0.00812240872309121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24863,-0.0120738452639584,0.00456637698181831,-0.0210239441483223,-0.00312374637959457,0.00819658476310962
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,28746,-0.0155317499438809,0.00587429978539099,-0.0270453775232472,-0.00401812236451454,0.0081972983853885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24235,-0.0164583880463419,0.00622542385023263,-0.0286602187927979,-0.004256557299886,0.00820489733139647
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24840,-0.0146950442813791,0.00556286792063598,-0.0255982654058256,-0.00379182315693259,0.00825595979762435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29344,0.00559286970448622,0.00211898769501424,0.0014396538222583,0.00974608558671414,0.00830952691160725
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,24933,0.00775493621690727,0.00294130131041837,0.00198998564848728,0.0135198867853273,0.00838017343295715
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28926,-0.0106211164809422,0.00403008879636195,-0.0185200905218117,-0.0027221424400728,0.00840694737542813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29438,-0.0043086804057182,0.00163612637919364,-0.00751548810893774,-0.00110187270249865,0.00845629150585087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,29525,-0.00503710803345675,0.00191752331529826,-0.00879545373144133,-0.00127876233547216,0.00862156634615795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24106,-0.0210454565809997,0.00802319739439657,-0.036770923474017,-0.00531998968798243,0.00871947014165056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,23598,0.0124414339671311,0.00474588151726024,0.00313950619330108,0.0217433617409612,0.00875942399396091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29492,0.00600998157802089,0.00229318349534271,0.00151534192714917,0.0105046212288926,0.00877680102585073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,24800,-0.0104770506333115,0.0039985801614629,-0.0183142677497788,-0.00263983351684425,0.00879336649692252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,24224,0.0077960232691357,0.00297616558065472,0.00196273873105245,0.0136293078072189,0.00881173699295149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,24909,0.00261675572644634,0.00100032714066734,0.00065611453073836,0.00457739692215432,0.00890463303563186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,28769,-0.0092218426044342,0.00352786815385299,-0.0161364641859861,-0.00230722102288235,0.00895360210014634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29349,-0.0157259694608194,0.00602554073684269,-0.0275360293050311,-0.00391590961660771,0.00906186217240379
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28911,0.00553138559651835,0.00212193581882054,0.00137239139163009,0.00969037980140661,0.00914493009733632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24224,0.00623402723753942,0.00239542484831905,0.00153899453483409,0.0109290599402448,0.00926106335758341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,28792,-0.0107591929657035,0.00414267126778301,-0.0188788286505582,-0.00263955728084878,0.00940451067393539
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,24011,0.011148952824028,0.00429300816994016,0.00273465681094532,0.0195632488371108,0.00940986205720534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24863,-0.00676573429264295,0.00260535850914312,-0.0118722369705635,-0.00165923161472244,0.00941374669485965
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,29429,-0.0119037828795229,0.00458911650263978,-0.0208984512246969,-0.00290911453434894,0.00949366847690591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29561,-0.00473163760748903,0.00182490879276691,-0.00830845884131218,-0.00115481637366588,0.00952428731054168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,24224,0.0102306881291384,0.00394681422567243,0.00249493224682047,0.0179664440114564,0.00954387278181657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,24224,0.00468680854907495,0.00181224149495277,0.00113481521896751,0.00823880187918238,0.00971000398928801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29473,-0.0139626609307571,0.00540001010923256,-0.0245466807448529,-0.00337864111666126,0.00972366085868737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,24106,0.00627702484597623,0.00243090522411835,0.00151245060670427,0.0110415990852482,0.00982379933229384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24440,0.00637843908526408,0.00247144041203957,0.00153441587766654,0.0112224622928616,0.00986126171344056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24800,-0.0111907487081832,0.00434163993069193,-0.0197003629723394,-0.00268113444402704,0.00995637116407776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28911,-0.0131961261503709,0.00512059460812545,-0.0232324915822968,-0.00315976071844503,0.00996911449693021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,28911,0.00568745416607576,0.00222069637266172,0.00133488927565878,0.0100400190564927,0.0104387747195917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24917,0.00924898991146163,0.00361357116795991,0.0021663904222602,0.0163315894006631,0.0104876824880944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24440,-0.0100973285138938,0.0039504245355253,-0.0178401606035233,-0.00235449642426417,0.0105939748634666
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,24788,-0.013695703372308,0.00537036465275123,-0.0242216180917004,-0.00316978865291563,0.0107709307648059
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,28792,0.0140804905263957,0.00552414759646449,0.00325316123732528,0.0249078198154661,0.0108115243954564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29449,0.004338425744956,0.00170604770735588,0.000994572238538465,0.00768227925137353,0.0109965841343968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPART,Spartin,24376,-0.0133082180046748,0.00523883105376238,-0.0235763268700491,-0.00304010913930054,0.0110818023963232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24863,-0.00825233246876955,0.00325071091297473,-0.0146237258582,-0.00188093907933907,0.0111349866081475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28769,0.00687564422370711,0.00271097091104247,0.00156214123806388,0.0121891472093503,0.0112105742447833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,24840,-0.011648127185329,0.00459565695654139,-0.0206556148201502,-0.00264063955050792,0.0112638429646655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29344,0.00973202806529356,0.0038481757810679,0.00218960353440048,0.0172744525961866,0.0114440710138237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,24917,-0.00535448546350641,0.00211846525712883,-0.00950667736747892,-0.0012022935595339,0.0114929192915591
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29213,-0.0160867695787264,0.00636478144836758,-0.0285617412175269,-0.00361179793992596,0.0114941216249316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,24917,0.0167321723286451,0.00662446094231042,0.00374822888171669,0.0297161157755735,0.0115491261737521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,24106,0.00799618022270501,0.00316775888157512,0.00178737281481777,0.0142049876305922,0.0116012799554621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,24440,0.00667058124862725,0.00264786728634505,0.00148076136739096,0.0118604011298635,0.0117675775376632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29403,-0.00603261564933772,0.00239659817802037,-0.0107299480782577,-0.00133528322041779,0.0118358603260327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29561,-0.0121370169266954,0.00482795560553235,-0.0215998099135388,-0.00267422393985199,0.0119455645651536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,29152,0.00477992337176405,0.00190622061419952,0.00104373096793299,0.00851611577559511,0.0121628955497651
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29438,-0.00968617151911667,0.00387217489999129,-0.0172756343230996,-0.00209670871513374,0.0123728994845457
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24440,0.00624629866554888,0.00250134109380839,0.00134367012168443,0.0111489272094133,0.0125250733426231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24840,-0.00647639243424083,0.00259637314181446,-0.0115652837921972,-0.0013875010762845,0.0126234870082633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,29781,-0.0106696226490486,0.00428168849957559,-0.0190617321082167,-0.00227751318988042,0.0127108842918104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24840,-0.00785968336385253,0.00315540266236122,-0.0140442725820805,-0.00167509414562454,0.0127497197908667
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28769,0.00565534254438116,0.00227341542113019,0.00119944831896598,0.0101112367697963,0.0128665407427321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,29594,0.0188994993835778,0.00759853351242613,0.00400637369922263,0.0337926250679331,0.0128787338440676
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,24909,0.00380054914164633,0.0015290016771807,0.000803705854372151,0.00679739242892051,0.0129383485153755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29340,-0.0311966686620923,0.0125530104178995,-0.0558005690811753,-0.0065927682430094,0.0129536085049914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,24096,0.0123354271998094,0.00496664151375413,0.00260080983285132,0.0220700445667675,0.0130108988569982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24863,0.00598719292377899,0.00241767260867314,0.00124855461077963,0.0107258312367783,0.0132770336286165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24235,0.00886241090033768,0.00358155164276037,0.00184256968052734,0.015882252120148,0.0133505245452276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWC2,Brorin,29109,0.00667116577639631,0.0026961246838726,0.00138676139600602,0.0119555701567866,0.01335341070037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,28439,-0.00602156859115913,0.00243492942136778,-0.01079403025704,-0.00124910692527828,0.0134043999606284
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28792,-0.00968560046491498,0.00391672737147929,-0.0173623861130144,-0.00200881481681557,0.0134086112620422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,29429,0.00979429114168835,0.00396545536401031,0.00202199862822815,0.0175665836551485,0.0135205908483535
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24863,-0.0112075851083414,0.00453788483159575,-0.0201018393782691,-0.00231333083841374,0.0135262184116055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,29344,-0.00990311632125431,0.00401426664192651,-0.0177710789394303,-0.00203515370307836,0.0136314595691204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29438,0.00608667106575761,0.00247155803982005,0.0012424173077103,0.0109309248238049,0.0137957529107185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29344,-0.0193579063767969,0.0078666350766403,-0.0347765111270119,-0.0039393016265819,0.0138699993461199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28792,0.00535293162538152,0.00217644474816897,0.00108709991897033,0.0096187633317927,0.0139195177847898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,28666,0.0079068897729628,0.003215423904992,0.00160465891917848,0.0142091206267471,0.0139363694473735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28792,0.0131616861234934,0.00536614122470357,0.0026440493230744,0.0236793229239124,0.0141836322792714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,29561,0.00362422754876446,0.00147887988805947,0.000725622968167903,0.00652283212936102,0.0142653253369205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,24235,-0.0149248121236672,0.00610184144198985,-0.0268844213499673,-0.00296520289736711,0.0144540821148323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24840,-0.00926293478970971,0.00378933775927654,-0.0166900367978917,-0.00183583278152769,0.0145132896020501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,29689,0.00571627975099345,0.00233938422377584,0.0011310866723928,0.0103014728295941,0.0145514509226295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28926,0.0101960161175795,0.00417296994023901,0.00201699503471105,0.018375037200448,0.0145576525103876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24917,-0.0066231273304216,0.0027112073300883,-0.0119370936973947,-0.00130916096344853,0.0145778799505606
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,28740,0.00931802178049272,0.00381493600984741,0.00184074720119181,0.0167952963597936,0.014591483638233
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29438,-0.00630888393353961,0.00258700615702453,-0.0113794160013077,-0.00123835186577153,0.0147468276788433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,24106,-0.0099296879646362,0.00407846594660241,-0.0179234812199769,-0.00193589470929547,0.0149128961840905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29213,-0.0130233160022802,0.00535993385800968,-0.0235287863639792,-0.0025178456405812,0.0151150978238114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24376,-0.00691537850290573,0.00285333806938855,-0.0125079211189073,-0.00132283588690416,0.0153743350174775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,24106,0.00565061675659102,0.00233304699745777,0.00107784464157379,0.0102233888716083,0.0154431009951475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,24106,0.00887255453079725,0.00366719723717393,0.00168484794593636,0.0160602611156581,0.0155518863836963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24190,0.0070721860987872,0.00292815203420613,0.00133300811174319,0.0128113640858312,0.015732270186217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24440,-0.00918522262101048,0.00380794753926804,-0.0166487997979758,-0.00172164544404512,0.0158674272386949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24800,-0.00799394568263818,0.00331479626445069,-0.0144909463609615,-0.00149694500431484,0.0158901407260904
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24096,0.00535885426416289,0.00222249748118399,0.00100275920104226,0.00971494932728352,0.0159081846433828
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29561,-0.00413128947869189,0.00171618976776992,-0.00749502142352093,-0.000767557533862856,0.0160794686581007
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,24224,-0.0125024303355059,0.00520323025534866,-0.0227007616359893,-0.00230409903502253,0.0162766312181843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24096,0.00813838451513114,0.0033904007793551,0.00149319898759515,0.0147835700426671,0.0163838275351048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29429,-0.0117387204545005,0.00489179322646145,-0.021326635178365,-0.00215080573063606,0.0164157528672958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24096,-0.0124004336869679,0.00516904910907936,-0.0225317699407634,-0.00226909743317233,0.0164484686565137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24096,0.00768620963217671,0.00320633740602108,0.0014017883163754,0.013970630947978,0.0165287894958099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,24292,-0.0106430808265372,0.00444298075873214,-0.0193513231136522,-0.00193483853942218,0.0166060515273595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24800,0.0190897129372165,0.00797023964178822,0.00346804323931157,0.0347113826351214,0.0166221167895711
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28717,0.00871086974910874,0.00363809626275871,0.00158020107410167,0.0158415384241158,0.0166563026362743
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,24961,0.00314318122817744,0.00131303491466312,0.00056963279543773,0.00571672966091716,0.0166808541378627
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLG,Plasminogen,24416,-0.00358186939909595,0.0014993655228645,-0.00652062582391036,-0.000643112974281532,0.0169053749173367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24376,0.0102606050483035,0.004298090362396,0.00183634793800734,0.0186848621585996,0.016982642239209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,24190,-0.00678300055675772,0.00284602287680238,-0.0123612053952904,-0.00120479571822506,0.0171646638406672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,24788,-0.00645418116151606,0.00271187733820615,-0.0117694607444001,-0.001138901578632,0.0173216644356764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24440,0.00571920034543435,0.00240548131227925,0.00100445697336702,0.0104339437175017,0.0174347828198978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24106,0.00604999750757527,0.00254533913957579,0.00106113279400671,0.0110388622211438,0.0174669388747338
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29438,-0.0123626304999782,0.00521118974349269,-0.0225765623972239,-0.00214869860273256,0.0176829748434196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLGN,Calmegin,24190,-0.00723358357011113,0.00305032878812873,-0.0132122279948434,-0.00125493914537881,0.0177280976496516
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,24946,-0.0146496486839129,0.00617905500902733,-0.0267605965016065,-0.00253870086621938,0.0177545092713791
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,29473,0.00390252450638149,0.001647295196749,0.000673825920753453,0.00713122309200953,0.0178402582762223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24011,-0.00981949810833633,0.00415941498115012,-0.0179719514713906,-0.00166704474528209,0.0182440888110085
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28792,-0.00529973289498098,0.00224502754057664,-0.00969998687451121,-0.000899478915450759,0.0182493800622804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,29288,0.00894912926143926,0.00379216814150906,0.00151647970408149,0.016381778818797,0.0182864940755385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23965,-0.0140401034948772,0.00594951557654393,-0.0257011540249033,-0.00237905296485105,0.0182891472110697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28792,-0.00697736858456171,0.00296294063564656,-0.012784732230429,-0.00117000493869445,0.0185353828385646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,29540,-0.00411754054837324,0.00174875608746022,-0.00754510247979527,-0.000689978616951207,0.0185514618953563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,24788,0.00923052237000599,0.00392158466033539,0.00154421643574862,0.0169168283042634,0.0185916933740123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24440,-0.0118190378009327,0.00502507713718941,-0.0216681889898239,-0.00196988661204145,0.0186801056636996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24224,0.00919458971707206,0.00391558086740253,0.00152005121696311,0.016869128217181,0.0188720958396968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,29348,-0.00780678907198587,0.00333304342725722,-0.01433955418941,-0.00127402395456172,0.0191750127622327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23618,0.0171423945319802,0.00732571087961286,0.00278400120793895,0.0315007878560214,0.0192903982018867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,24376,0.00572626171286591,0.0024495328815616,0.000925177265005167,0.0105273461607267,0.0194111071168123
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29344,-0.003213749683962,0.00137514618093907,-0.00590903619860258,-0.00051846316932142,0.0194446269511883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29781,0.0115908308198932,0.00496285857891044,0.00186362800522878,0.0213180336345577,0.0195231378782314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,24096,0.00677942457428006,0.0029048088717493,0.00108599918565143,0.0124728499629087,0.0196111034929879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,24106,0.00800800204053268,0.00343239127879229,0.00128051513409979,0.0147354889469656,0.0196527662519279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,29781,-0.00888685249450142,0.00380957055695167,-0.0163536107861267,-0.00142009420287615,0.0196668397823907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,24788,0.00551703690069324,0.00236551731725183,0.000880622958879653,0.0101534508425068,0.0196941972259088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24440,-0.0110076347687922,0.00472081517099434,-0.0202604325039411,-0.00175483703364328,0.0197233389865176
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24788,-0.00809764687035081,0.00347299395291737,-0.0149047150180689,-0.00129057872263278,0.0197295036858165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,29429,0.00968481443281235,0.00415538213335087,0.00154026545144465,0.01782936341418,0.0197776186176186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28821,-0.00759866710712667,0.00326309928882205,-0.0139943417132179,-0.00120299250103546,0.0198836690467974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,29025,-0.00669114778916818,0.00287667009683046,-0.0123294211789559,-0.00105287439938048,0.0200251617866959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24106,0.00768116768337543,0.00330472451677179,0.00120390763050273,0.0141584277362481,0.0201177487387879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24106,0.00800953572499506,0.00344640197506451,0.00125458785386862,0.0147644835961215,0.0201322509249101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,29116,0.00900021297906928,0.00387278973015834,0.00140954510795893,0.0165908808501796,0.0201344246625133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24788,-0.00808632332087231,0.0034839136434706,-0.0149147940620747,-0.00125785257966992,0.0202924430232824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29438,0.00498247038098684,0.00214746058473254,0.000773447634911065,0.00919149312706261,0.0203385692702371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24011,0.00475320207810428,0.00205140713359717,0.00073244409625384,0.00877396005995473,0.0205096696413156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24376,-0.00400665313292607,0.00172985235522099,-0.00739716374915922,-0.000616142516692921,0.0205565826948601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,24011,0.00550462402230555,0.00237842267244917,0.000842915584305182,0.0101663324603059,0.0206541309583421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29473,-0.0200070878300189,0.00864574093924433,-0.0369527400709378,-0.00306143558910002,0.0206692170367218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28714,-0.0103849344831151,0.00449014776761967,-0.0191856241076497,-0.0015842448585806,0.0207391948665926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24011,-0.0120112293328895,0.00519486764481641,-0.0221931699167297,-0.00182928874904935,0.0207787299152196
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29438,0.00429880819231139,0.00186314613921477,0.000647041759450436,0.00795057462517234,0.021045872148534
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23970,0.00403622099467453,0.00175085650763742,0.000604542239705182,0.00746789974964388,0.0211591915710013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24788,0.00865067958451126,0.00375639184770413,0.00128815156301116,0.0160132076060114,0.0212914437611699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24840,-0.00828891312127933,0.00360136039542979,-0.0153475794963217,-0.00123024674623694,0.0213656338215699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24096,0.00766553164333308,0.00333059387200976,0.00113756765419395,0.0141934956324722,0.0213690005067747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24788,-0.00807304155803368,0.00351684279805873,-0.0149660534422288,-0.00118002967383856,0.0217107014183032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,24235,-0.018221875646431,0.00794321460585575,-0.0337905762739083,-0.00265317501895373,0.0217979942927693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24676,-0.00935617954230326,0.00409095083284284,-0.0173744431746752,-0.00133791590993129,0.0222017574642764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29522,0.0088619481973653,0.00387840576520552,0.00126027289756248,0.0164636234971681,0.0223230501425646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29213,-0.00459906129468073,0.00201332487395944,-0.00854517804764123,-0.00065294454172023,0.0223603692149031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24440,0.0106535300355803,0.00466866575006013,0.00150294516546246,0.0198041149056982,0.0225025200044936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24190,0.0120297359009656,0.00528136737773359,0.00167825584060779,0.0223812159613234,0.022749022147032
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,28911,0.00821089618534522,0.00360948464743462,0.00113630627637337,0.0152854860943171,0.0229245500477954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24800,0.0147072585034965,0.00647669449333096,0.00201293729656784,0.0274015797104252,0.0231678094869283
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,24106,0.00794209523364856,0.00351303655568074,0.00105654358451431,0.0148276468827828,0.0237836634124838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,24096,0.0146408500952102,0.00647921702878363,0.00194158471879431,0.0273401154716261,0.0238510415956759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24190,0.00566644444392674,0.00250810054705184,0.000750567371705138,0.0105823215161483,0.023876251348223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24788,0.00796141439845461,0.00352845949326888,0.00104563379164761,0.0148771950052616,0.0240578463348632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24106,0.00567630006337998,0.00251900063005201,0.000739058828478033,0.0106135412982819,0.0242432919296631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,29344,-0.0136885930258427,0.00607489012871517,-0.0255953776781245,-0.00178180837356099,0.0242471477412437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29784,0.00877217601865431,0.00389603777975369,0.00113594197033707,0.0164084100669715,0.024357136762287
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,29781,-0.0118332871441353,0.00525576813399572,-0.022134592686767,-0.00153198160150372,0.0243620485199894
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24440,-0.0103256416747329,0.00458729566208621,-0.0193167411724218,-0.00133454217704389,0.0243993744328042
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24440,-0.00699244285237144,0.00310657502949443,-0.0130813299101805,-0.000903555794562368,0.0244037220659475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29213,0.00622597513705396,0.00276751403748037,0.000801647623592428,0.0116503026505155,0.0244777350165347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28926,-0.00481965010874525,0.00214259987987349,-0.00901914587329729,-0.000620154344193206,0.0244920012856822
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEXN,Nexilin,24946,-0.0104760714575954,0.00466231332092351,-0.0196142055666055,-0.00133793734858537,0.0246507473579056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,24096,-0.00828553278674336,0.00369992002094233,-0.0155373760277903,-0.00103368954569639,0.0251401889103944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24106,-0.0150912202276195,0.00673953897833619,-0.0283007166251585,-0.00188172383008061,0.0251515647109613
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24863,-0.00486203440213009,0.00217736247502205,-0.00912966485317331,-0.000594403951086874,0.0255582982612802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24106,0.0130620362498892,0.00585542018997621,0.00158541267753584,0.0245386598222426,0.0257062100327917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,24376,-0.00466569963193341,0.00209265447746613,-0.00876730240776703,-0.000564096856099787,0.0257857175093695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28769,-0.0110659146985003,0.00496410865085912,-0.0207955676541842,-0.00133626174281642,0.0258093175254854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,29815,-0.013256549002222,0.00594845638052703,-0.024915523508055,-0.00159757449638901,0.0258499855215074
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24096,0.00847285074798785,0.00380517831420459,0.00101470125214685,0.0159310002438288,0.0259789994388957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24106,-0.00550801457860212,0.00247492886555148,-0.010358875155083,-0.000657154002121212,0.026055273734816
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29336,0.00525252281140358,0.00236045849925959,0.000626024152854784,0.00987902146995237,0.0260745229793395
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24946,0.00649843660790632,0.00292293844542453,0.00076947725487425,0.0122273959609384,0.0262075598352279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,29492,0.00447515240909486,0.00201296456559259,0.000529741860533377,0.00842056295765633,0.0262122271716482
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24788,-0.0129997945529458,0.00584788483333749,-0.0244616488262873,-0.00153794027960429,0.0262254043865881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29589,0.00464549568680205,0.00208995798955884,0.000549178027266725,0.00874181334633738,0.0262388513767797
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,29213,-0.0150936409304134,0.00679308420660845,-0.0284080859753659,-0.0017791958854608,0.0262968319379005
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,24096,0.00724270616360743,0.0032627067652666,0.000847800903684896,0.01363761142353,0.0264385078240258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24933,0.0207004537483833,0.0093293546886718,0.00241491855858654,0.03898598893818,0.0265057948246978
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23716,-0.0074310432336401,0.00335372942002345,-0.0140043528968861,-0.00085773357039414,0.0267177400202302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24224,0.00725462202741316,0.00327624909907972,0.000833173793216902,0.0136760702616094,0.0268169318618159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24800,-0.0131026194837655,0.00592638367451366,-0.0247183314858123,-0.00148690748171876,0.0270521169779616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24840,-0.00468944874443421,0.00212478726871854,-0.00885403179112255,-0.000524865697745869,0.0273217533714376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,24276,-0.00639107551183779,0.00289803671373161,-0.0120712274707517,-0.000710923552923843,0.0274415430732058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,24840,-0.0124541334226831,0.00567977588039239,-0.0235864941482521,-0.00132177269711399,0.0283371190100821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29720,0.00891138118717798,0.00407309177397342,0.000928121310190088,0.0168946410641659,0.0286870893899187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,29429,0.00592523135583471,0.00271292407670322,0.000607900165496408,0.011242562546173,0.0289645608333239
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,29164,0.00762122497747371,0.00349345229205519,0.000774058485045541,0.0144683914699019,0.0291489417849561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,29438,-0.00394759938766613,0.00181022552958299,-0.00749564142564879,-0.000399557349683468,0.0292118468348806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,24190,0.00616333787071758,0.00282839952842251,0.000619674795009456,0.0117070009464257,0.0293345846882413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,24224,0.00518433758333985,0.00238090597525996,0.000517761871830331,0.00985091329484937,0.0294555709745365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRN1,Neuritin,24863,-0.00526547942976561,0.00241992425109546,-0.0100085309619127,-0.000522427897618498,0.029573171287942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,24840,-0.00564943144758234,0.00259668094396997,-0.0107389260977635,-0.000559936797401188,0.0295919211581277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29520,-0.0175588736371328,0.00807909759611323,-0.0333939049255148,-0.00172384234875089,0.0297603580348091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24800,-0.0062927258311719,0.00289738708311883,-0.0119716045140848,-0.000613847148259,0.0298754988709314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,21651,-0.0155036826559515,0.00713889127645383,-0.029495909557801,-0.00151145575410198,0.0298875128519452
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24096,0.00505138917022072,0.00232656630078804,0.000491319220676148,0.00961145911976528,0.0299274647089879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29344,0.0107019879092783,0.00493240920986258,0.00103446585794762,0.0203695099606089,0.0300354356200537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,28649,-0.0103691242905775,0.0047790301600003,-0.0197360234041781,-0.00100222517697693,0.0300367838911929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28769,0.00962770026987502,0.00443910939262974,0.000927045860320731,0.0183283546794293,0.0301033054569969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29781,-0.00815062067231226,0.00375814042927243,-0.0155165759136862,-0.000784665430938294,0.0301064555062915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28792,-0.011165077515466,0.00515480517105858,-0.0212684956507408,-0.0010616593801912,0.0303227881745403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,29613,-0.00606043206469335,0.00280452626468553,-0.011557303543477,-0.000563560585909701,0.0307074438027219
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29781,0.00395294906259243,0.00183027499056038,0.000365610081094079,0.00754028804409078,0.0307994513794299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,24235,-0.00333427211353526,0.00154617311994491,-0.00636477142862729,-0.000303772798443232,0.0310569882857527
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24376,0.0129798625641179,0.00602388219515299,0.00117305346161808,0.0247866716666178,0.0311924412351011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29731,-0.00474297879942084,0.00220701594000142,-0.00906873004182363,-0.00041722755701805,0.0316388043612634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29689,0.00761727006833833,0.0035506528865747,0.00065799041065192,0.0145765497260247,0.0319357340763112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,24096,0.0132383527909458,0.0061730713259057,0.00113913299217063,0.0253375725897209,0.0320002116745086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,24750,-0.012788561663179,0.00596640069605158,-0.0244827070274401,-0.00109441629891792,0.0320883167283189
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,24933,-0.0121232502117958,0.00566619591235139,-0.0232289942000045,-0.00101750622358706,0.0323988267709168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,28109,-0.00407048240267027,0.0019042898851691,-0.00780289057760171,-0.000338074227738838,0.0325632735494663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,24788,0.00498533511191655,0.00233302518662703,0.000412605746127584,0.00955806447770553,0.0326196023670782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29669,-0.00408417748931407,0.00191361868091409,-0.00783487010390568,-0.000333484874722464,0.0328289248908416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,24096,-0.00632632755295242,0.00296711893232068,-0.012141880660301,-0.000510774445603888,0.0330050238373834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,24946,-0.00377871833491419,0.00177420495657939,-0.0072561600498098,-0.00030127662001858,0.0331971202940559
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24011,0.00951558826385726,0.00447026311090304,0.000753872566487297,0.0182773039612272,0.0332940757283552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24917,-0.0143871751272163,0.00675906473919685,-0.0276349420160421,-0.00113940823839048,0.0332992395308104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28792,0.0180136560131032,0.00846309532540521,0.00142598917530896,0.0346013228508974,0.0333045347970929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,28792,0.0131531614110617,0.00618305760807086,0.00103436849924283,0.0252719543228806,0.0334044098550924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29815,-0.0045615537859946,0.00215455070384267,-0.00878447316552623,-0.000338634406462963,0.0342535391296321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,29344,-0.0111194731170348,0.00525493210029232,-0.0214191400336077,-0.000819806200461843,0.0343526145133974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,28926,0.00718784844133022,0.00339751759566476,0.0005287139538273,0.0138469829288331,0.0343858600199426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,24224,0.00993479464333801,0.00469729977412174,0.0007280870860594,0.0191415022006166,0.03444003367991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24235,-0.00579324622497359,0.00275263718456542,-0.0111884151067218,-0.000398077343225361,0.0353349608270041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24106,-0.0098505633346239,0.004690851633728,-0.0190446325367308,-0.000656494132517022,0.0357434339043603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,24440,0.00749868785850204,0.00357859428959366,0.000484643050898461,0.0145127326661056,0.0361432019346147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29213,-0.00823511962554013,0.00393845818626524,-0.01595449767062,-0.00051574158046025,0.0365411576964765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29438,0.00813375370986342,0.00389021540285755,0.000508931520262625,0.0157585758994642,0.0365524477232996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,24224,0.00805982260927045,0.00385758100422118,0.000498963840996946,0.015620681377544,0.0366869742514873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,29429,-0.0066001103247883,0.00316125225516569,-0.0127961647449131,-0.000404055904663546,0.0368230945366049
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24376,-0.0101249908565894,0.00485120699105058,-0.0196333565590485,-0.000616625154130251,0.0368887789169655
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24235,-0.010878455745483,0.00521879798334991,-0.0211072997928489,-0.000649611698117215,0.037127400726499
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24011,-0.00414225918118349,0.00198899137483107,-0.00804068227585238,-0.000243836086514604,0.0372989174614513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,24011,0.0131675131094507,0.00633049268034177,0.000759747455980796,0.0255752787629205,0.0375348397464027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,24224,0.00766709924701392,0.0036889434109651,0.000436770161522314,0.0148974283325055,0.0376830585735703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,24224,0.00469165583353576,0.00226136945022116,0.000259371711102277,0.00912393995596924,0.0380251885343567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24224,0.00836981533014807,0.00403568502046269,0.000459872690041194,0.0162797579702549,0.0380943533114403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29576,0.00378798897353603,0.00182745545274832,0.000206176286149322,0.00736980166092273,0.0381975378423922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24863,0.00725649221723814,0.00350385460995984,0.000388937181716857,0.0141240472527594,0.0383688462513293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24800,-0.0205053405146035,0.00991383723086965,-0.039936461487108,-0.00107421954209894,0.038616946235058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,29438,-0.00729306102608948,0.00352717648060844,-0.014206326928082,-0.000379795124096948,0.0386791443076987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28769,-0.00950998479338874,0.00461849819997504,-0.0185622412653398,-0.000457728321437666,0.0394929154005102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,24800,-0.0142964156950608,0.00695287883875851,-0.0279240582190275,-0.000668773171094112,0.0397749889041536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2,Prothrombin,24961,0.00205919899762868,0.00100202726808951,9.52255521732364e-05,0.00402317244308413,0.0398862166425813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28792,0.00680696711184817,0.00331444938458425,0.000310646318063038,0.0133032879056333,0.0400113438624521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,29213,0.00779827035101167,0.00380075443400855,0.000348791660354918,0.0152477490416684,0.0402010103428602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29815,-0.00321112110532216,0.00156677600564107,-0.00628200207637866,-0.000140240134265665,0.0404211291228447
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29720,0.00867533072092625,0.00423748240653209,0.000369865204123342,0.0169807962377291,0.0406389669311536
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7,Complement component C7,24369,0.00449744121690136,0.00219779147708705,0.000189769921810746,0.00880511251199197,0.0407330804079704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24106,-0.00551517172693804,0.00269948699173887,-0.0108061662307462,-0.000224177223129852,0.0410589029538445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,24224,0.0140793048937653,0.00690076630457559,0.000553802936797135,0.0276048068507335,0.0413360228307764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,28769,-0.0113479571485696,0.00556745482311312,-0.0222601686018713,-0.000435745695267909,0.0415324095626641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,29213,-0.00526482501682872,0.00258310486542109,-0.0103277105530541,-0.000201939480603383,0.0415412232296117
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29429,-0.00334989803270239,0.0016451918711315,-0.00657447410012012,-0.000125321965284654,0.041741757215083
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,24106,0.00590472835038932,0.00290712632560555,0.000206760752202429,0.0116026959485762,0.042253572347424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,28621,0.00923489554939719,0.00455148806391846,0.000313978944117008,0.0181558121546774,0.0424691818849776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,29576,-0.00882505541998485,0.00436446345836445,-0.0173794037983792,-0.000270707041590523,0.0431827299324477
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23965,0.00715984183619062,0.00355336806048379,0.0001952404376424,0.0141244432347388,0.0439215458767994
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24106,0.00717095484687186,0.00356203239969061,0.000189371343478262,0.0141525383502655,0.0441084964626969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIT,Vitrin,24917,-0.0051041918830079,0.00254941048818656,-0.0101010364398536,-0.000107347326162238,0.0452840788683322
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,29194,0.0172666795089124,0.00863462142348792,0.000342821518876105,0.0341905374989488,0.0455415831731403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24863,-0.00659148641807334,0.00329721161134218,-0.013054021176304,-0.000128951659842669,0.0456073991817537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29561,-0.011298883403617,0.0056555637858456,-0.0223837884238744,-0.000213978383359622,0.0457436994447872
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24106,-0.00901325592539741,0.00451217373060699,-0.0178571164373871,-0.000169395413407703,0.045777576058365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24106,0.00987436168851106,0.00494398443969818,0.000184152186702638,0.0195645711903195,0.045809505585623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24190,-0.0083707954472745,0.00420334807797498,-0.0166093576801055,-0.000132233214443538,0.046441678924879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24440,-0.00591883800852974,0.00297859758734907,-0.0117568892797339,-8.07867373255654e-05,0.0469199845280484
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,24376,-0.00991435157686241,0.00500375111307448,-0.0197217037584884,-0.000106999395236423,0.0475594686347435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,24106,0.00812447966162735,0.00411663150224206,5.58819172329136e-05,0.0161930774060218,0.0484415348237201
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,28769,0.00438300885885074,0.00222105226329107,2.97464228002304e-05,0.00873627129490124,0.0484603708713959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29322,0.00587364254018144,0.00298758246589003,1.79809070369793e-05,0.0117293041733259,0.0493058928499698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24800,0.00738724233343459,0.00375805562842812,2.14533017154853e-05,0.0147530313651537,0.0493434252384183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24800,-0.010923644765858,0.00556065858277625,-0.0218225355880994,-2.47539436164998e-05,0.0494888969686625
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28857,0.00696150032183809,0.00355192671413842,-2.76037873209352e-07,0.0139232766815494,0.0500144887934161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,24788,-0.00683185018296683,0.00348792344308788,-0.0136681801314191,4.47976548541198e-06,0.0501573004238769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24190,-0.00901861594953056,0.00461943060132344,-0.0180726999281245,3.54680290633857e-05,0.0509115139109636
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24800,-0.00523416639350284,0.002684954877455,-0.0104966779533146,2.83451663089613e-05,0.0512538103424604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24788,-0.0109103506075082,0.00562204854523855,-0.0219295657561757,0.000108864541159392,0.0523137561310609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29344,-0.0112398699720257,0.00581808493400728,-0.0226433164426799,0.000163576498628608,0.0533833438438834
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,24106,0.005278472803238,0.00273387976152318,-7.99315293474202e-05,0.0106368771358234,0.0535241367512979
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28792,-0.00685974123643645,0.00355733543193749,-0.0138321186830339,0.000112636210161026,0.0538230582991144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24706,-0.00630060024204363,0.00327468335924109,-0.0127189796261562,0.000117779142068904,0.0543618742292053
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,24840,0.0123296907392476,0.006412902930476,-0.000239599004485364,0.0248989804829806,0.0545369584236494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29213,-0.00616339436321905,0.00320716122009103,-0.0124494303545975,0.000122641628159371,0.0546456763406082
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,24096,0.0122657488331677,0.00638797765402789,-0.000254687368726988,0.0247861850350623,0.0548532530651243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24863,-0.00616654088983673,0.00321370163803533,-0.012465396100386,0.000132314320712518,0.0550175395137155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28769,-0.00499767414461141,0.00260508862035106,-0.0101036478404995,0.000108299551276662,0.0550666932003697
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24783,-0.00559819847070995,0.00291926875524088,-0.0113199652309821,0.000123568289562177,0.0551641657482781
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,24788,0.00352060417929555,0.00183934711630134,-8.45161686550784e-05,0.00712572452724617,0.0556251487791727
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24106,-0.00594477906383939,0.00310756013648641,-0.0120355969313528,0.000146038803673982,0.0557592132772275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29356,0.00349113470315893,0.00182651790962491,-8.88403997058823e-05,0.00707110980602375,0.0559679645409875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARTN,Artemin,28926,0.00579415510929791,0.00303323571973267,-0.00015098690137812,0.0117392971199739,0.0561144547106359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24440,0.00966513707662165,0.00506108781606129,-0.000254595042858479,0.0195848691961018,0.0561841207787759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,28926,0.00652480693841789,0.00341753615712869,-0.000173563929554347,0.0132231778063901,0.0562444149549277
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24863,-0.00878946798992965,0.00460436962695565,-0.0178140324587627,0.000235096478903418,0.0562812655753614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29344,-0.00429202433044005,0.00225164350940093,-0.00870524560886588,0.000121196947985775,0.0566373976972831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,29449,0.00463551850238632,0.00243405427171935,-0.000135227870183608,0.00940626487495624,0.056862205128793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24096,0.00997208547995044,0.00523922878664447,-0.000296802941872719,0.0202409739017736,0.0570068171835653
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24096,0.00905022228014184,0.00475686126059954,-0.00027322579063326,0.0183736703509169,0.0571096703581703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,29326,0.0036843745665933,0.001938354174538,-0.000114799615501187,0.00748354874868778,0.0573413293826118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,24224,0.00380244809101828,0.00200311049721807,-0.000123648483529142,0.0077285446655657,0.0576721729479383
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24946,-0.00345315375751119,0.00182012537524605,-0.00702059949299344,0.000114291977971064,0.0578122283000568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,24106,0.00539703016557414,0.00284501622087918,-0.000179201627349057,0.0109732619584973,0.0578382899736781
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,29561,-0.00803716945394452,0.00423762172165428,-0.0163429080283869,0.000268569120497868,0.057887499189372
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28769,0.00644050829685106,0.00339707584163601,-0.000217760352755516,0.0130987769464576,0.0579835883446813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,24946,0.00770108230494195,0.00406533013020338,-0.000266964750256664,0.0156691293601406,0.0581926043106056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,29627,0.00788131255164593,0.00416475042478684,-0.000281598280936275,0.0160442233842281,0.058449405276099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24788,-0.00365914392673101,0.00193875851568117,-0.00745911061746611,0.000140822764004091,0.0591230002826932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24863,-0.0107388439658868,0.00569077656029629,-0.0218927660240675,0.000415078092293901,0.0591637325625793
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28926,-0.00805288531597216,0.00427322085660553,-0.016428398194919,0.000322627562974685,0.0595073779887255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,29429,-0.00615719201300438,0.00326873999053756,-0.012563922394458,0.000249538368449233,0.0596209499783397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24863,0.00457346474861347,0.00242833401257888,-0.000186069916041131,0.00933299941326807,0.0596611683964632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,24096,0.00944292804617093,0.00502444610656002,-0.000404986322686715,0.0192908424150286,0.0602023947028493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,24096,0.00447709220729486,0.00238247692915522,-0.000192562573849361,0.00914674698843908,0.06023260381303
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24224,0.00530150508030472,0.00282286613036719,-0.000231312535214976,0.0108343226958244,0.060385300442384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28792,-0.00451353226006698,0.0024040502277116,-0.00922547070638171,0.000198406186247745,0.0604638069068848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29815,-0.00537660462300262,0.0028660294780651,-0.0109940224000102,0.000240813154004974,0.0606682412381088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24235,-0.00535737318753999,0.00285675750686396,-0.0109566179009933,0.00024187152591336,0.0607588716693282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29344,0.00276036837492812,0.00147317426131825,-0.00012705317725565,0.00564778992711189,0.0609740671745063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24168,0.00488883764416307,0.0026091923544753,-0.000225179370608523,0.0100028546589347,0.0609841708737302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29781,0.00859362173498981,0.00459051603791733,-0.000403789699328151,0.0175910331693078,0.061211105593409
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24440,0.00520970513240872,0.00278707348244264,-0.000252958893178847,0.0106723691579963,0.0616015929555987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28926,0.00685297063624289,0.00366687046745531,-0.000334095479969507,0.0140400367524553,0.0616484853930964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29449,0.00373757512071713,0.00200037182494082,-0.00018315365616687,0.00765830389760113,0.0617106649149057
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,24440,0.00448899334150705,0.00240396050677597,-0.000222769251773839,0.00920075593478794,0.0618671516728738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,29456,0.0236952941112395,0.0126959111816357,-0.00118869180476645,0.0485792800272455,0.0619992609278119
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,24190,0.00476107578686932,0.00255988288252982,-0.000256294662889139,0.00977844623662777,0.0629145971217275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,28792,-0.00480702177491641,0.00258684892343828,-0.00987724566485545,0.00026320211502262,0.0631431886099445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24863,0.00475679459513173,0.00256163082125129,-0.000264001814520795,0.00977759100478426,0.0633315233549789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,24096,0.00580212528482182,0.00312844586478738,-0.000329628610161448,0.0119338791798051,0.0636605772800384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,24235,-0.00372313194626338,0.00201365395180594,-0.00766989369180302,0.000223629799276264,0.0644781806207246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,24440,0.00358405509747001,0.0019404402813138,-0.000219207853905039,0.00738731804884506,0.0647546034960479
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29473,0.0130183891009194,0.00706621778316347,-0.000831397754080983,0.0268681759559198,0.0654351975926084
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24106,-0.00853043750433999,0.00463092807587517,-0.0176070565330553,0.000546181524375342,0.0654789676590889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29473,0.00560418154618947,0.00304558322390189,-0.000365161572658228,0.0115735246650372,0.0657634249682118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24788,0.0050671221129342,0.00276666253721299,-0.000355536460003259,0.0104897806858717,0.0670390443856134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29561,0.00982202864346786,0.00536847901021662,-0.00070019021655671,0.0203442475034924,0.0673237627487446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,24324,-0.0127237349636392,0.00696823839391315,-0.026381482215709,0.000934012288430531,0.0678683228131859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,29473,-0.014434607142474,0.00790823603834362,-0.0299347497776275,0.0010655354926795,0.0679715377088956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23489,0.00618912802778709,0.00339450796185814,-0.000464107577454862,0.012842363633029,0.068274170782335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24224,0.0037931866486271,0.00208657884052503,-0.000296507878801965,0.00788288117605617,0.0690921399361364
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24106,0.00722726979592555,0.003977883118208,-0.000569381115762134,0.0150239207076132,0.0692504687973775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24011,-0.00981233282929565,0.00541041566648885,-0.0204167475356138,0.000792081877022496,0.0697517312684462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29448,0.0115123497995737,0.00636214426601064,-0.000957452961807182,0.0239821525609545,0.0703823428983707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24840,-0.00583564384499628,0.00322953214874723,-0.0121655268565409,0.000494239166548287,0.0707802106579845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,29720,0.00360085856310042,0.00199408233151181,-0.000307542806662727,0.00750925993286356,0.0709640383140799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,24224,0.00340630495190799,0.00189326249665473,-0.000304489541535287,0.00711709944535127,0.0720039188313112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24011,0.00570266066336848,0.00317586875854428,-0.000522042103378321,0.0119273634301153,0.0725671881563309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29473,0.00595562503388858,0.00331702166065386,-0.000545737420992986,0.0124569874887701,0.0725885102017343
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24224,-0.0110017855674709,0.00613685584798045,-0.0230300230295126,0.00102645189457077,0.0730270229880194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28911,-0.00501211178694674,0.00279781446058373,-0.0104958281296909,0.000471604555797376,0.0732334591326821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24863,-0.00914284579974738,0.00511292417015669,-0.0191641771732545,0.000878485573759729,0.0737586135538966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,28911,0.00737301325912571,0.00412612101120674,-0.000714183922839506,0.0154602104410909,0.0739622652141897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24054,0.00416782489822539,0.00233253738094843,-0.000403948368433534,0.00873959816488431,0.0739791502123714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24190,0.00653354057858874,0.00366141469340648,-0.000642832220487958,0.0137099133776654,0.0743662516665045
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24863,-0.00951611366090885,0.00535490151796255,-0.0200117206361154,0.000979493314297745,0.0755665314722146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24165,-0.010194490995926,0.00574014322988266,-0.021445171726496,0.00105618973464401,0.0757456021106765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24800,-0.00700045569059162,0.0039488126289097,-0.0147401284432546,0.000739217062071387,0.076274104993056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28911,0.00648470240982402,0.00366251648009759,-0.000693829891167251,0.0136632347108153,0.0766445651444419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24440,0.00755427801810392,0.00427629742503976,-0.000827264934974011,0.0159358209711818,0.0773167040694571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24863,0.00536652421000659,0.00303849128988968,-0.000588918718177184,0.0113219671381904,0.0773778399273354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28757,-0.00378848986268169,0.00214873477730224,-0.00800001002619407,0.000423030300830693,0.077889888062077
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,29429,0.00664884857971688,0.00377709138617019,-0.000754250537176688,0.0140519476966105,0.0783657926625959
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24011,-0.00668092378981476,0.00379699427656908,-0.0141230325718902,0.000761184992260625,0.0785003394316485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24235,-0.00393452918425339,0.00224458688688475,-0.0083339194825475,0.00046486111404072,0.0796323724239513
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,29336,0.00851754104629187,0.00487440796147505,-0.00103629855819924,0.018071380650783,0.0805784249824071
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,28926,0.00391519863599435,0.00224292190450943,-0.000480928296844133,0.00831132556883284,0.0808946585850487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,24863,-0.00735433984779787,0.0042171852497089,-0.0156200229372273,0.000911343241631576,0.0811892875483362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,24224,0.00547690999808952,0.00314076069202794,-0.00067898095828525,0.0116328009544643,0.0812038024520762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,24917,0.00767400978543595,0.00442107425434032,-0.00099129575307107,0.016339315323943,0.0826152101458282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28792,-0.00854154530090707,0.00492238170906265,-0.0181894134506699,0.00110632284885572,0.0827078705272722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,29322,-0.00694210784677704,0.00401114588396001,-0.0148039537793387,0.000919738085784584,0.0835150248169955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24788,0.0072336477937958,0.00418231342533944,-0.000963686519869503,0.0154309821074611,0.08371770619309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24917,-0.0105646918788611,0.00612838933522239,-0.0225763349758969,0.00144695121817483,0.0847394425385416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,24828,-0.00301325809565729,0.00174875150247241,-0.00644081104050321,0.000414294849188623,0.0848845159126384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24096,0.0106620890431439,0.00618980744371689,-0.00146993354654123,0.022794111632829,0.084987560855173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24235,0.0101364450995428,0.00588943606624625,-0.00140684959029988,0.0216797397893854,0.0852412387716704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29449,-0.00604619047554815,0.00351906373536137,-0.0129435553968564,0.000851174445760129,0.0857843811763799
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,24106,0.00419965561700416,0.00244567872823856,-0.000593874690343411,0.00899318592435174,0.0859602596696646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,24440,0.0195621688012527,0.0114305967429599,-0.00284180081494877,0.0419661384174542,0.0870224855978753
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24840,-0.00257991536204537,0.00150898008519916,-0.00553751632903573,0.000377685604944992,0.0873323742238721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,29338,0.0125664293378739,0.00735394273120282,-0.00184729841528364,0.0269801570910314,0.0874982823138408
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24788,-0.00393211056114344,0.00230718394829954,-0.00845419109981053,0.000589969977523655,0.0883394592546093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24106,0.00363607237903968,0.00213837708935234,-0.000555146716090915,0.00782729147417027,0.0890707301393411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24800,-0.00541646255302124,0.00318724365919459,-0.0116634601250426,0.000830535019000159,0.0892528054193601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,24190,0.00681832133647763,0.004023176362193,-0.00106710433342065,0.0147037470063759,0.0901336971470603
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RETN,Resistin,29357,0.00483705710555238,0.00285463886330301,-0.000758035066521528,0.0104321492776263,0.0901894667036855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28911,-0.00397704486797166,0.00234826021085139,-0.00857963488124038,0.000625545145297052,0.0903495549117305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,29576,-0.00882231263994071,0.00520960012475506,-0.0190331288844606,0.0013885036045792,0.0903761700073315
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29127,0.00344330949925293,0.00203377662587009,-0.000542892687452442,0.0074295116859583,0.0904544047611158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24376,-0.00946101251393093,0.00559156686778346,-0.0204204835747865,0.00149845854692466,0.0906559871526973
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24106,0.00497442522445001,0.00294136746940923,-0.000790655015592084,0.0107395054644921,0.090812547193734
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29678,0.00342216217779912,0.00202859372643971,-0.000553881526022708,0.00739820588162095,0.0916210171043104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,24011,0.00691979474483771,0.00410744241173039,-0.00113079238215385,0.0149703818718293,0.0920601039238977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28926,-0.00678197196946645,0.00403162990211125,-0.0146839665776045,0.00112002263867159,0.0925425866842079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,24096,0.0110191497185851,0.00655572985973314,-0.00183008080649184,0.0238683802436621,0.0928064688563492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29344,0.0078647593236125,0.00469388288518295,-0.00133525113134608,0.0170647697785711,0.0938402087677397
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,24096,0.00394043610551727,0.00235347244980052,-0.000672369896091755,0.0085532421071263,0.0940832056777566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28792,-0.0059832276003406,0.0035755122085176,-0.0129912315290351,0.00102477632835389,0.0942613460627344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,24800,-0.00348640838042085,0.00208387115313476,-0.00757079584056497,0.000597979079723271,0.0943312303758555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24800,-0.00861902001080021,0.00515877187715667,-0.0187302128900273,0.00149217286842685,0.0947836208329705
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24106,0.00435241992424457,0.00260820270906004,-0.000759657385513115,0.00946449723400226,0.0951813239738648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29689,-0.00639949724727581,0.00383529268851682,-0.0139166709167688,0.00111767642221717,0.0952109582685212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24235,-0.00541327641132328,0.0032478898216331,-0.0117791404617242,0.000952587639077589,0.0955858725823474
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24106,-0.00628659032054107,0.00377642210202336,-0.0136883776405069,0.00111519699942472,0.0959866599973899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,28792,0.0186230035827094,0.0111997212066596,-0.00332844998234339,0.0405744571477622,0.0963614505610562
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,24011,0.00531888824584179,0.0032036856056841,-0.000960335541299038,0.0115981120329826,0.0968791671833748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29689,0.00798373829689441,0.00481553589851628,-0.00145471206419749,0.0174221886579863,0.0973456507710382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24840,-0.0109394361968818,0.00659939596421536,-0.0238742522867439,0.00199537989298033,0.0974023733728095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,29211,-0.00580046616668842,0.00350114465772546,-0.0126627096958303,0.00106177736245348,0.0975839659609991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28769,-0.0125420784688827,0.00757935056593968,-0.0273976055781244,0.00231344864035911,0.0979821679617702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29438,-0.00333662139792675,0.00201914764871423,-0.00729415078940665,0.000620907993553143,0.0984453613436628
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24106,0.00791893834168473,0.00479639359539012,-0.0014819931052799,0.0173198697886494,0.098747670165878
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29561,-0.00806982618425673,0.00489284532220931,-0.017659803015787,0.00152015064727351,0.0990944599253952
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,28926,0.015886515579506,0.00963291727323068,-0.0029940022760261,0.0347670334350382,0.0991194792041312
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,24840,0.00312053776891757,0.00189405545860062,-0.000591810929939643,0.00683288646777477,0.0994591454484783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,29296,0.00741176023356329,0.00450253220236125,-0.00141320288306476,0.0162367233501913,0.0997474135343594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28769,-0.00530128317237584,0.0032262360418342,-0.0116247058143709,0.00102213946961918,0.100356845761964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24440,0.00796636751215241,0.00485435105763611,-0.00154816056081435,0.0174808955851192,0.100794151625144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24840,-0.00409977693614645,0.0025029551021754,-0.00900556893641022,0.000806015064117326,0.101439660935678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24011,-0.00740419910448167,0.00452382736144466,-0.0162709007329132,0.00146250252394985,0.101703931668509
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24440,-0.00815124316246414,0.00498879092452639,-0.0179292733745359,0.00162678704960759,0.102290309607245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28792,-0.00934098578524571,0.00573220758883153,-0.0205761126593555,0.00189414108886409,0.103205115157847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28926,-0.00469158370772576,0.00288480605506246,-0.0103458035756482,0.000962636160196671,0.103895009124731
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24096,-0.00483147134596047,0.00297357159414572,-0.0106596716704861,0.000996728978565139,0.104217391554158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28769,-0.004056186368095,0.00251054992921435,-0.00897686422935513,0.000864491493165135,0.106179566704276
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28792,-0.00735763753020825,0.00456272965070544,-0.0163005876455909,0.00158531258517442,0.106852900861153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,29344,0.00804822235157068,0.00499418834958546,-0.00174038681361682,0.0178368315167582,0.107077717389941
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24784,0.0062167765192819,0.00385931934689152,-0.00134748940062548,0.0137810424391893,0.107225616524445
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,28769,0.00495052995564522,0.00307412191926946,-0.00107474900612293,0.0109758089174134,0.107324090632345
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29449,-0.0321178095962938,0.019989022542361,-0.0712962937793215,0.00706067458673381,0.10811503246378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28769,0.00424651555583735,0.00265846045134439,-0.000964066928797643,0.00945709804047235,0.11019670869944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,24096,0.00369154103375286,0.00231418516871364,-0.000844261896925867,0.0082273439644316,0.110685195542634
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24863,0.00452761596179008,0.00283881289546331,-0.00103645731331802,0.0100916892368982,0.110747846971898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,28926,0.00827682567435838,0.00519049466008864,-0.00189654385941536,0.0184501952081321,0.110809931980767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24961,0.00209699508901344,0.00131618173793592,-0.000482721117340969,0.00467671129536784,0.111118740804414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24096,-0.00491691496779549,0.00309030381340098,-0.0109739104420614,0.00114008050647043,0.111605108152897
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24096,0.00665950886363331,0.00418649096263525,-0.00154601342313178,0.0148650311503984,0.111687130384885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,24190,0.00512630255387239,0.00322400324155683,-0.00119274379957899,0.0114453489073238,0.111838274515611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29657,-0.00685906598478809,0.00431480738614248,-0.0153160884616274,0.00159795649205117,0.111922689495062
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,29635,-0.00747842151883628,0.00471104396579994,-0.0167120676918042,0.00175522465413159,0.11242745233769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29429,-0.0107248896336163,0.00675792762535852,-0.023970427779319,0.00252064851208637,0.112521432924363
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24440,0.00790654700543556,0.00498807348329245,-0.00187007702181764,0.0176831710326888,0.112958759374775
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,29213,0.0065251516752049,0.00412314368330736,-0.00155620994407753,0.0146065132944873,0.113530990394747
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,24106,0.00896565552810929,0.00567591335559214,-0.00215913464885131,0.0200904457050699,0.114212322184868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29473,-0.00671765410016979,0.00425495347664394,-0.0150573629143919,0.00162205471405233,0.114396258621455
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,28911,-0.00477380195539092,0.00302468944810576,-0.0107021932736782,0.00115458936289637,0.114512616842142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29449,-0.00414801126263683,0.00263532401053121,-0.00931324632327799,0.00101722379800434,0.115497208214958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24840,-0.0105951864216238,0.00673658207172998,-0.0237988872822146,0.00260851443896695,0.115781656283683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24917,-0.00343861222574817,0.00218833945397265,-0.00772775755553456,0.000850533104038223,0.116117787966392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,24788,0.00412243646320224,0.00262492431503559,-0.00102241519426752,0.00926728812067201,0.116312240528251
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24376,-0.00906631651055727,0.00577611774071318,-0.0203875072823551,0.00225487426124056,0.116516264615441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24224,-0.00596117976877639,0.00380124729907874,-0.0134116244749707,0.00148926493741794,0.116843620636833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,29671,0.00460408788650186,0.00293652971523448,-0.00115151035535772,0.0103596861283614,0.116922855289382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,24224,0.0042308087777561,0.00270004535466856,-0.00106128011739427,0.00952289767290648,0.117141811444368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24190,0.00336485280810554,0.00215522041701819,-0.000859379209250105,0.00758908482546119,0.118476230934514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29014,0.00236363087247446,0.0015139958608435,-0.0006038010147788,0.00533106275972773,0.118490513515044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29344,-0.0059344376851159,0.00381704550182783,-0.0134158468686984,0.00154697149846665,0.120023514939659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24106,0.00511641016551061,0.00329797447689595,-0.00134761980920544,0.0115804401402267,0.120823887953153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24106,0.00728092280818924,0.00470650556684485,-0.00194382810282667,0.0165056737192052,0.121878496724097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24235,-0.0106882811611701,0.00691464890868089,-0.0242409930221846,0.00286443069984447,0.1221793278355
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,24224,0.00348625665655166,0.0022584225025707,-0.00094025144848691,0.00791276476159024,0.122681626231003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29473,0.0033468884437119,0.00216848367075242,-0.000903339550962842,0.00759711643838664,0.122738820696321
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,29160,0.00500019063319552,0.00325286126776683,-0.00137541745162747,0.0113757987180185,0.124263301739604
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,24144,-0.0070742683968182,0.00460562302974255,-0.0161012895351136,0.0019527527414772,0.124549818267939
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,29324,-0.00809728951125925,0.00529687214193848,-0.0184791589094587,0.00228457988694017,0.126351446556258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24106,0.00532586102570429,0.0034860453541926,-0.00150678786851319,0.0121585099199218,0.126583813263875
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,24822,0.00246315902066668,0.00161392010254118,-0.000700124380314027,0.00562644242164739,0.126973712564969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,24840,0.00530920135578703,0.00348805420749231,-0.0015273848908979,0.012145787602472,0.127994317060429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,24840,-0.00711140045066415,0.00468230918374271,-0.0162887264507999,0.00206592554947155,0.128830459396399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,24011,-0.0080781737163464,0.00532260078936811,-0.0185104712635079,0.00235412383081511,0.129100255784218
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24190,-0.00391907968097892,0.00258407189857947,-0.00898386060219467,0.00114570124023683,0.129373326791384
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28792,0.00486133289286821,0.00320608469340272,-0.00142259310620112,0.0111452588919376,0.129458699374009
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,29473,0.00382002932453894,0.00252451473477554,-0.00112801955562111,0.00876807820469899,0.130246268190326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24863,-0.0030323858858471,0.00200813077570176,-0.00696832220622255,0.000903550434528336,0.131042363888869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSPN,Claspin,28714,0.00355059297683031,0.00235440896385654,-0.00106404859232851,0.00816523454598912,0.131549853216164
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24106,0.00381426151923972,0.00252979372750606,-0.00114413418667216,0.00877265722515159,0.131635175203864
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24011,0.00568701702488534,0.00377845560721121,-0.00171875596524862,0.0130927900150193,0.132307211083798
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24759,-0.00417244021519695,0.00277229345706276,-0.00960613539103996,0.00126125496064606,0.132323990759021
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,24106,0.00453333966334481,0.00302234531284126,-0.00139045714982407,0.0104571364765137,0.133642788944168
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29815,0.00308198293653974,0.00205504917026957,-0.000945913437188624,0.0071098793102681,0.133699483465159
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29344,-0.00394350901789821,0.00263407470686419,-0.00910629544335202,0.0012192774075556,0.134374467199566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24106,0.00635152431618371,0.00424646899916393,-0.00197155492217759,0.014674603554545,0.134739998466637
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29189,0.00987485194212157,0.00663204232122325,-0.003123951007476,0.0228736548917191,0.136508464692838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29473,-0.00837473870784688,0.00563050127479011,-0.0194105212064355,0.00266104379074175,0.13692312933557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,28926,0.00485369834170623,0.00326469928480727,-0.00154511225651601,0.0112525089399285,0.137099308777885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,24106,-0.003988530490041,0.00268669425998031,-0.0092544512396024,0.00127739025952041,0.137676297216618
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,29790,-0.0033991504501558,0.00229130829155853,-0.00789011470161051,0.00109181380129892,0.1379528264611
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24917,0.00343248870863604,0.00231566075818435,-0.0011062063774053,0.00797118379467737,0.138274891499264
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,24863,-0.00498893887482851,0.00336784358675759,-0.0115899123048734,0.00161203455521637,0.138527293673263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,28911,-0.0134210653443612,0.00907298285679759,-0.0312041117436845,0.00436198105496207,0.139088667759876
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24800,0.00434544429868837,0.00294853460332136,-0.00143368352382149,0.0101245721211982,0.140557830389378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,28769,-0.0067627989566416,0.00460467424725429,-0.01578796048126,0.00226236256797681,0.141930191022034
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,24096,0.00767251132594315,0.00523488191251969,-0.00258785722259544,0.0179328798744817,0.142756371808144
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,24440,0.00562281768818841,0.00385430593510522,-0.00193162194461782,0.0131772573209946,0.144621864778881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24096,0.00407968097092501,0.00279697546279148,-0.00140239093614629,0.00956175287799631,0.144687038591742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24917,-0.00873108448745979,0.00599056963379131,-0.0204726009696908,0.00301043199477118,0.144998883414512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24863,-0.00270685493577346,0.00185786386797361,-0.00634826811700174,0.000934558245454826,0.145136849275585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24106,-0.00653004270878128,0.00448812417491623,-0.0153267660916171,0.00226668067405453,0.145693267958174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24096,0.00296440535068282,0.00204016787199952,-0.00103432367843625,0.00696313437980189,0.146231145220641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,29018,-0.00736715009531863,0.00508106072662659,-0.0173260291195067,0.00259172892886949,0.147090625369718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24235,-0.00554041377199931,0.00382134473705434,-0.0130302494566258,0.00194942191262721,0.147110592599401
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28701,0.00743154622147005,0.00512659035914551,-0.00261657088245516,0.0174796633253953,0.147178805171373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,24235,-0.00292435655934043,0.00202006358346547,-0.00688368118293275,0.00103496806425189,0.147726308271996
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29473,0.00277313349947045,0.0019183430623851,-0.000986818902804352,0.00653308590174526,0.148303462968785
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24400,0.00517572327983241,0.00358986877133306,-0.00186041951198039,0.0122118660716452,0.149383397519162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24106,-0.00836078122658161,0.0058023409715608,-0.0197333695308408,0.00301180707767755,0.149616771618038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,28926,0.00464971953740855,0.00322759806058689,-0.00167637266134176,0.0109758117361589,0.149704890959706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,24096,0.00429862891925567,0.00298454236949599,-0.00155107412495648,0.0101483319634678,0.149796247808141
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,24344,0.00357964919578629,0.00248941868938298,-0.00129961143540436,0.00845890982697694,0.150462289443263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28926,0.00441331087799916,0.00306989065151805,-0.00160367479897623,0.0104302965549745,0.150555067165028
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,29689,-0.00352001617377977,0.0024501721479849,-0.00832235358383019,0.00128232123627064,0.150830754301236
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24106,0.00593320536021151,0.0041382338238108,-0.00217773293445766,0.0140441436548807,0.151655725680222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,24190,-0.004941749079593,0.00344701023274039,-0.0116978891357642,0.00181439097657816,0.151689832753001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PI3,Elafin,29009,-0.0053383905122603,0.00373158704090797,-0.0126523011124399,0.00197552008791931,0.152557040059359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,24224,-0.00615233906529328,0.00432536995579789,-0.0146300641786571,0.00232538604807059,0.154927551652215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,29513,0.00365100205172011,0.00256685690134645,-0.00138003747491893,0.00868204157835916,0.154931498153737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,24840,-0.00443600364227828,0.0031258535970102,-0.0105626766924183,0.00169066940786172,0.155872645514421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24788,0.00357875822384866,0.00252256971193179,-0.00136547841153766,0.00852299485923497,0.156000398160969
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24391,0.00484945858386857,0.00342422802690798,-0.00186202834887108,0.0115609455166082,0.156724018859291
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24190,0.00397758885880833,0.0028165291550187,-0.00154280828502834,0.00949798600264499,0.15789492379286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28769,-0.00704837763696426,0.00500420632899528,-0.016856622041795,0.00275986676786649,0.158996656807877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29393,-0.00232501632236182,0.00165303825842653,-0.00556497130887782,0.000914938664154187,0.159583048522491
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29344,-0.00838850846350547,0.00597344106636345,-0.0200964529535778,0.00331943602656689,0.160239865468348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24096,0.0030399651915873,0.00216675455110782,-0.00120687372858402,0.00728680411175862,0.160628553681629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28769,0.00522168201784488,0.00373145434372506,-0.00209196849585625,0.012535332531546,0.161713106153104
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,29390,-0.00381221633157254,0.00272565958059715,-0.00915450910954296,0.00153007644639788,0.161931542286013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29429,-0.00642890794890225,0.00459810645041712,-0.0154411965917198,0.0025833806939153,0.162074298285594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24917,0.0100291701410155,0.00717354000087233,-0.00403096826069431,0.0240893085427252,0.162102026419681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24011,0.00538596154717109,0.0038536224634132,-0.00216713848111877,0.012939061575461,0.162235317127698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24011,0.00385813222123414,0.00276670011419751,-0.00156460000259297,0.00928086444506126,0.163182969400443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28769,0.00804602944014359,0.00577582836206527,-0.00327459414950435,0.0193666530297915,0.163614825633983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,24224,0.00543434741217005,0.00390374510206874,-0.00221699298788469,0.0130856878122248,0.16390926004757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24106,-0.0036198178300952,0.00260404652436183,-0.00872374901784439,0.00148411335765398,0.16451919637317
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,24011,0.003486987539251,0.00250928561187338,-0.00143121226002082,0.00840518733852283,0.164653066373137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,29720,-0.00199128833238205,0.00143411355276938,-0.00480215089581003,0.000819574231045935,0.164990659080178
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,24190,0.00544865285551416,0.00392494796480445,-0.00224424515550257,0.0131415508665309,0.165085834237886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,29574,0.0143165924237714,0.0103171218151302,-0.00590496633388381,0.0345381511814266,0.165252976146158
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,24917,0.00277126648571599,0.00200610651808228,-0.00116070228972528,0.00670323526115725,0.167163660021132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,24224,0.00622164918054409,0.00450505069684532,-0.00260825018527274,0.0150515485463609,0.167279821085514
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,29109,0.00973756298041015,0.00706405811420642,-0.00410799092343443,0.0235831168842547,0.168070098753889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,28769,-0.0067895556494156,0.00493177219162366,-0.016455829144998,0.00287671784616676,0.168616685996496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24788,-0.00345787299977802,0.00251199746263921,-0.00838138802655088,0.00146564202699483,0.168665965800285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,24224,0.00317558928365053,0.0023078316518605,-0.00134776075399605,0.00769893932129711,0.168832626704508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28926,-0.00525962325854128,0.00382311899000692,-0.0127529364789548,0.00223368996187228,0.168912351793886
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24106,0.0037449962440395,0.002722965740387,-0.00159201660711901,0.00908200909519801,0.169039697516422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,24811,0.00600727009133314,0.00436891832937996,-0.00255580983425158,0.0145703500169179,0.169143343431722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24224,0.00393468706182473,0.00286228124979894,-0.0016753841877812,0.00954475831143066,0.169247052018413
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24096,0.00605554327339828,0.00440846301736811,-0.00258504424064322,0.0146961307874398,0.169573154250802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRTN,Neurturin,28926,-0.00459697226589564,0.00335012976799769,-0.0111632266111711,0.00196928207937984,0.170018873025545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,24190,0.00254151731463756,0.00185547295310602,-0.00109520967345024,0.00617824430272537,0.170780497458985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,24096,0.00533664664191789,0.00390618675535376,-0.00231947939857547,0.0129927726824113,0.171887805932031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,28769,-0.0047615939768812,0.00348548171340758,-0.0115931381351601,0.00206995018139766,0.171911292144453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24376,0.00778425989843853,0.00569812765392159,-0.00338407030324778,0.0189525901001248,0.171917560508268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29429,0.00517954379674675,0.00379976421199815,-0.00226799405876963,0.0126270816522631,0.172854364964327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,24011,0.00730932677514947,0.00538675183206035,-0.00324870681568882,0.0178673603659878,0.17482320069624
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,24011,0.00403539281199168,0.00297425546631321,-0.00179414790198221,0.00986493352596557,0.174865758985748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,24106,-0.0112972216866919,0.00832949687331772,-0.0276230355583946,0.00502859218501081,0.175019306506393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24190,-0.00561909715743155,0.00414729994209104,-0.01374780504393,0.0025096107290669,0.175468190602181
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,24096,-0.00777590936204439,0.00574111536983419,-0.0190284954869194,0.00347667676283063,0.175613579343673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,29781,0.00362800955081061,0.00267988553999912,-0.00162456610758766,0.00888058520920888,0.175812793348954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,24106,0.00448025341034314,0.00331724644791915,-0.0020215496275784,0.0109820564482647,0.176838184165943
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29429,0.00511861163678165,0.00379092375850677,-0.00231159892989163,0.0125488222034549,0.176953228333339
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24235,0.00367621800782624,0.00272559611449858,-0.00166595037659099,0.00901838639224346,0.177421608466498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29576,0.00257588869529523,0.00191010759889784,-0.00116792219854453,0.00631969958913499,0.177489677865963
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24224,0.0040494696378721,0.00300664949909704,-0.0018435633803581,0.00994250265610229,0.178045037529033
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24440,-0.006843709854959,0.00508597191711242,-0.0168122148124994,0.00312479510258135,0.178442389595892
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,24800,-0.00314830329396294,0.0023549768430308,-0.00776405790630332,0.00146745131837743,0.181276595898185
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,24224,0.00372855123359086,0.00279117162811559,-0.00174214515751569,0.00919924762469741,0.181615008048483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28769,0.00462500655295166,0.00346343274828946,-0.00216332163369567,0.011413334739599,0.181761847574532
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,24224,-0.0108476630256295,0.00812479141899837,-0.0267722542068663,0.00507692815560732,0.181845942727765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24106,0.00463754202515899,0.00348027637356523,-0.00218379966702886,0.0114588837173468,0.182701584888393
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29344,0.00235487296766745,0.00176760025594099,-0.00110962353397689,0.00581936946931179,0.182790720381044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,29473,0.00687289301488148,0.0051616954081631,-0.0032440299851182,0.0169898160148812,0.183028759115882
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24376,-0.00578758291969492,0.00434780518593018,-0.0143092810841181,0.00273411524472823,0.183151961435222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24917,-0.00267426943994284,0.00201339959611344,-0.00662053264832517,0.0012719937684395,0.184112390762367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28792,-0.00357791161347331,0.00269582958761198,-0.0088617376051928,0.00170591437824617,0.184452253815523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29404,0.00414738677895822,0.00312507604661114,-0.0019777622723996,0.010272535830316,0.184475505267132
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29457,-0.00521319711024479,0.00393189541634113,-0.0129197121262734,0.00249331790578383,0.184891789268984
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24224,-0.0039429482875695,0.00297854365735347,-0.00978089385598231,0.00189499728084331,0.185587307225566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,24106,-0.00451653616985884,0.00341561670351684,-0.0112111449087519,0.00217807256903417,0.186074374320814
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOST,Sclerostin,29428,-0.0034542650583757,0.00261671159543508,-0.00858301978542845,0.00167448966867706,0.18681903944966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24224,-0.00250950418428366,0.00190311272821131,-0.00623960513157782,0.0012205967630105,0.187304847402548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24224,0.00260667683162983,0.00198941065898924,-0.00129256805998908,0.00650592172324873,0.190114949845879
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29781,0.00244070413110049,0.0018633458872055,-0.00121145380782229,0.00609286207002326,0.190256598496415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FN1,Fibronectin,24961,-0.00236811777427667,0.00181034494342127,-0.00591639386338236,0.00118015831482903,0.190850405707649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24106,0.00312411397141312,0.00239548228491075,-0.00157103130701195,0.00781925924983819,0.19218839304654
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29815,0.00616815007492254,0.00474015580548959,-0.00312255530383705,0.0154588554536821,0.193181343568709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29815,0.00195461264463264,0.00150651316014666,-0.000998153149254806,0.00490737843852009,0.194489375818414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24946,0.00463398968312646,0.0035732801465396,-0.00236963940409115,0.0116376187703441,0.194696603102487
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24096,0.00494571172922206,0.00381681814612487,-0.00253525183718268,0.0124266752956268,0.195067762501341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,28911,0.00937319143812728,0.0072694042842825,-0.00487484095906641,0.023621223835321,0.197268351430561
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28714,0.00409909563264335,0.00318168869612407,-0.00213701421175983,0.0103352054770465,0.197638150195926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24933,0.00258260365954206,0.00201626627033426,-0.00136927823031308,0.0065344855493972,0.200246255107709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24011,-0.00750447931232728,0.00586528983398831,-0.0190004473869444,0.00399148876228982,0.200742952154301
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29473,-0.00570554970625506,0.00446109093367097,-0.0144492879362502,0.00303818852374004,0.200921781265888
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,24224,-0.00464236172098602,0.00363268020796927,-0.0117624149286058,0.00247769148663375,0.201281440121206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,24440,-0.00378594333257257,0.00296702844940544,-0.00960131909340724,0.00202943242826211,0.201965861460466
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,28926,0.00407553056109181,0.00319493176896961,-0.00218653570608862,0.0103375968282722,0.202098834473308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24096,0.00488469151503708,0.00383062040138815,-0.0026233244716837,0.0123927075017579,0.202261443720494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CGN,Cingulin,24190,-0.00345378501963842,0.00271172337478781,-0.00876876283422253,0.00186119279494569,0.202799919036183
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28388,-0.00550965212958358,0.0043286596358629,-0.0139938250158749,0.00297452075670771,0.20308845080076
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29576,0.00227798661367779,0.00178984717901951,-0.00123011385720045,0.00578608708455603,0.203124985597406
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,24224,0.00258647937125805,0.00204606143234317,-0.00142380103613456,0.00659675977865067,0.206196990930166
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24096,0.00638239036014746,0.00505708659737757,-0.00352949937071257,0.0162942800910075,0.206936314152641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,24106,0.00505717851826246,0.00401789207103176,-0.00281788994095979,0.0129322469774847,0.208163699161344
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24800,0.012530116447645,0.0099680632281965,-0.00700728747962009,0.0320675203749102,0.208756000556642
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,24190,0.00294978970352784,0.00234971897559545,-0.00165565948863924,0.00755523889569492,0.209353057566614
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28769,-0.00460899726241958,0.0036724565529327,-0.0118070121061677,0.00258901758132851,0.209482604713508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,29689,-0.0104086006905967,0.00831371804161125,-0.0267034880521548,0.00588628667096134,0.210587371142957
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24096,0.00621910392783446,0.00497124557338287,-0.00352453739599597,0.0159627452516649,0.210941074032362
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28926,0.00253609224146781,0.00203036094063714,-0.00144341520218098,0.00651559968511661,0.211644306974097
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,24224,0.00244486437324535,0.00195897503532729,-0.00139472669599614,0.00628445544248683,0.212031251368067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24190,-0.00251865345126094,0.00201918262378918,-0.00647625139388773,0.00143894449136586,0.212276553926483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24096,-0.00838164844232111,0.00672107874707433,-0.0215549627865868,0.00479166590194457,0.212384354372094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,24190,-0.0026485623557167,0.00212568661961626,-0.00681490813016456,0.00151778341873117,0.21278392546237
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,24863,0.00314661126841599,0.00253037193613831,-0.0018129177264151,0.00810614026324709,0.213681726151067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24011,0.00735390979737964,0.00592036882267416,-0.00425001309506172,0.018957832689821,0.21419811887938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,24011,0.00431056943992008,0.00347539097129966,-0.00250119686382724,0.0111223357436674,0.214872109192043
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24788,-0.00398433133249518,0.00321397461839289,-0.0102837215845453,0.00231505891955488,0.215101919187583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24011,0.00481681189894291,0.00388712209108636,-0.00280194739958635,0.0124355711974722,0.215294018087347
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24376,-0.00577921159304997,0.00466975154703196,-0.0149319246252326,0.00337350143913268,0.215882135048702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,29213,0.00101581398427101,0.000823289999189763,-0.000597834414140922,0.00262946238268295,0.217269813032207
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,24863,0.00573904485588311,0.00465819349766742,-0.00339101439954503,0.0148691041113112,0.217948675991295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29576,-0.0091447611074785,0.00743304207541291,-0.0237135235752878,0.00542400136033081,0.218600141859547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,24011,0.0025953522441532,0.00211019480098394,-0.00154062956577532,0.00673133405408172,0.218742412807993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24863,0.00496208122426788,0.00403714755206708,-0.00295072797778359,0.0128748904263194,0.219043802563389
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,28769,0.00387940211173554,0.00316209969450695,-0.00231831328949808,0.0100771175129692,0.219891384671161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,24800,-0.00495211937786844,0.00407287306841239,-0.0129349505919567,0.00303071183621984,0.224042734854404
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,24224,0.00247398506358763,0.00203499388462373,-0.00151460295027488,0.00646257307745015,0.224103026605776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,24863,0.00248198745348026,0.00205409442813488,-0.00154403762566411,0.00650801253262463,0.226938678118067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,29618,-0.00483123933785057,0.0040004252150452,-0.0126720727593392,0.00300959408363801,0.227179462690905
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,29344,0.00611786235014399,0.00506904610396012,-0.00381746801361785,0.0160531927139058,0.227478065698161
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24440,0.00426704778274291,0.00354872316218266,-0.00268844961513511,0.0112225451806209,0.229213364613923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24235,-0.00212809556390839,0.00177013180553132,-0.00559755390274977,0.001341362774933,0.229288369761685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28769,0.0055302886852082,0.00461043859637174,-0.00350617096368041,0.0145667483340968,0.230337771388335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,28911,0.00312739514530675,0.00261104428703507,-0.00199025165728198,0.00824504194789549,0.231021668799652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,28926,-0.009211441912528,0.00770448466580057,-0.0243122318574971,0.00588934803244112,0.231864522072589
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24106,-0.0035712318387314,0.00298830549288038,-0.00942831060477694,0.00228584692731413,0.232071760455903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28792,-0.00423298410221593,0.00354676701206261,-0.0111846474458586,0.00271867924142678,0.232692535996974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,24011,0.00649210101755153,0.00544274214205702,-0.00417567358088024,0.0171598756159833,0.232959633970577
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29755,0.00413114033817193,0.00347467869563332,-0.00267922990526938,0.0109415105816132,0.234477771294093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24440,-0.0056673302154139,0.00478725346657041,-0.0150503470098919,0.0037156865790641,0.236488911766621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28769,0.00339659829484014,0.00287573851849168,-0.00223984920140355,0.00903304579108383,0.237563993712126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29385,-0.00183814993134827,0.00155683222537301,-0.00488954109307938,0.00121324123038283,0.237731961949838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24440,-0.00279620805663164,0.00237166197004514,-0.00744466551792012,0.00185224940465684,0.238406538174709
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24841,0.00158956338638047,0.0013538389333019,-0.00106396092289125,0.0042430876956522,0.240359995471243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29473,0.00279736739834527,0.00238372476099584,-0.00187473313320657,0.00746946792989712,0.240593682306262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24917,0.00391001593100458,0.00333467384787944,-0.00262594481083913,0.0104459766728483,0.240994250902891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,24190,0.00550978305896868,0.0047134647464328,-0.0037286078440396,0.014748173961977,0.242437145132382
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24796,-0.00294731988571295,0.00252542784474327,-0.00789715846140977,0.00200251868998386,0.24319831831987
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29561,-0.00776203202797457,0.00665967674440257,-0.0208149984470036,0.00529093439105447,0.243815208775873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23965,0.00630822699038889,0.00541291150040162,-0.00430107955039828,0.0169175335311761,0.243867233727658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,24190,0.00540044114284312,0.00464769529658429,-0.00370904163846209,0.0145099239241483,0.245262736973944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24106,0.00256479807380265,0.00220811036398395,-0.0017630982396059,0.00689269438721119,0.245435794924331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,24224,-0.0039047950213665,0.00336230327084046,-0.0104949094322138,0.00268531938948079,0.245512963758567
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29286,-0.00238678490444089,0.00206384861850423,-0.00643192819670918,0.00165835838782739,0.247497234436616
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,24728,-0.00363985477112481,0.00314963424710587,-0.00981313789545231,0.00253342835320269,0.247838124076188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ESPL1,Separin,24011,0.00434477602104804,0.0037620118897464,-0.0030287672828549,0.011718319324951,0.248139777906812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29512,0.0038291856500173,0.00332516054725271,-0.00268812902259801,0.0103465003226326,0.249503375225641
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28769,0.00370909603666993,0.00322203029945442,-0.00260608335026072,0.0100242754236006,0.24967297217698
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29315,0.00326627865088482,0.00283855537123911,-0.00229728987674383,0.00882984717851348,0.24987188324891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSC1,Hamartin,24224,0.0058505318140533,0.00508632355044666,-0.00411866234482215,0.0158197259729288,0.250053238659506
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24224,0.00826473379903971,0.00718660491619926,-0.00582101183671084,0.0223504794347903,0.250147313682779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29689,0.00221944798120305,0.00193260013545592,-0.00156844828429054,0.00600734424669665,0.250802058506649
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24190,0.00282345877372021,0.00246404925209624,-0.00200607776038841,0.00765299530782883,0.251863872267334
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,24054,0.00659537149004884,0.00578259072657521,-0.00473850633403857,0.0179292493141362,0.254065886874974
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24788,-0.00516113953463702,0.00452819147613868,-0.0140363948278688,0.0037141157585948,0.254389221857248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24788,0.00343286068973356,0.00302365339910529,-0.00249349997251281,0.00935922135197993,0.256245806065222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24106,0.00311426558133478,0.00274444876740599,-0.00226485400278096,0.00849338516545051,0.256491013170863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28769,0.0021183738424084,0.00187419030601656,-0.00155503915738407,0.00579178684220087,0.258364535047373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,29187,-0.0036495679569234,0.0032297857522559,-0.00997994803134497,0.00268081211749817,0.258497249385041
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,24933,0.00676807057061485,0.00599078189284872,-0.00497386193936864,0.0185100030805983,0.25859353119446
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24788,0.0037705997071964,0.00334466237555517,-0.00278493854889175,0.0103261379632845,0.259606133747956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,24106,0.00848041790042615,0.00753139594141146,-0.00628111814474032,0.0232419539455926,0.260173022317787
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27981,0.00222354816355629,0.00197697797845431,-0.00165132867421416,0.00609842500132674,0.260717036827308
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28911,-0.00838782638763426,0.00751485805157282,-0.023116948168717,0.00634129539344846,0.264360518033098
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,24863,-0.00341554642132536,0.00306050099300828,-0.00941412836762159,0.00258303552497086,0.264429106278913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,24788,-0.00286737085371817,0.0025713784433749,-0.00790727260273299,0.00217253089529664,0.264813930700685
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28926,0.00492191457958958,0.00442479048157532,-0.00375067476429805,0.0135945039234772,0.265997050559121
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24011,-0.00477217614639352,0.00429989829221843,-0.0131999767991416,0.0036556245063546,0.26708140320421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,24840,-0.00723833980454938,0.00654628668905228,-0.0200690617150919,0.00559238210599308,0.268859789082328
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,29720,-0.0082499929033665,0.00747011262121693,-0.0228914136409517,0.00639142783421867,0.269428575727602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28714,-0.00316805575354829,0.00287201129598492,-0.00879719789367872,0.00246108638658215,0.270002047471298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24863,-0.00224729817289558,0.0020377979032708,-0.00624138206330635,0.0017467857175152,0.270121586710778
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28792,-0.0056672555617023,0.00515687407892247,-0.0157747287563903,0.00444021763298575,0.271789867019548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24518,0.00413608900126893,0.00377613861260293,-0.0032651426794328,0.0115373206819707,0.273386206775548
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,24224,-0.00466390236753003,0.0042635921100814,-0.0130205429032896,0.00369273816822952,0.274013944539712
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28926,0.00279748984797109,0.00256143427549843,-0.00222292133200584,0.00781790102794802,0.274772946785951
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24190,-0.00575028257357829,0.00527476578737561,-0.0160888235168345,0.00458825836967791,0.275658219303877
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,24096,0.0081524122136168,0.00751663981370566,-0.00658020182124631,0.0228850262484799,0.278117690109126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24788,0.00318599207432549,0.00293769125148139,-0.00257188277857803,0.00894386692722901,0.278143778208947
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,24224,0.00192492830763024,0.00177501704790118,-0.00155410510625608,0.00540396172151657,0.278173359969202
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,24828,-0.00229863826219653,0.00212466363134328,-0.00646297897962937,0.00186570245523631,0.279314866101412
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24788,-0.00292645613069197,0.00270834597965296,-0.00823481425081177,0.00238190198942784,0.279915595186358
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29568,-0.00814476218916306,0.00755817420201579,-0.022958783625114,0.00666925924678789,0.281216746191438
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24190,-0.00382389699512771,0.00354986526029923,-0.0107816329053142,0.00313383891505877,0.281403921272252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,24106,0.00349587468075596,0.00324836944935369,-0.00287092943997727,0.00986267880148919,0.281851421096246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29462,0.00689449618458546,0.00641159099472662,-0.00567222216507872,0.0194612145342496,0.282241400987501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,24800,0.00245793464219855,0.00228976052898148,-0.00202999599460516,0.00694586527900225,0.283081434468142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,29720,-0.00332041066807335,0.00309640098442939,-0.00938935659755495,0.00274853526140826,0.28357373270331
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,24224,0.0033971969508628,0.00317304190163054,-0.00282196517633306,0.00961635907805867,0.28434039225735
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24800,0.00184070743323015,0.00173381386515529,-0.00155756774247422,0.00523898260893452,0.288403917160584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24096,0.00530553519795355,0.00499767154523726,-0.00448990103071149,0.0151009714266186,0.288427315834806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,24011,0.00341242752886433,0.00323542462132626,-0.00292900472893513,0.0097538597866638,0.291569609917169
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,29473,0.00481842044018889,0.00457128089570128,-0.00414129011538562,0.0137781309957634,0.291862480619259
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,24961,0.00220785734272374,0.00210521173729578,-0.00191835766237599,0.00633407234782348,0.294299739730629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24096,0.00444470268043309,0.0042431737820808,-0.00387191793244528,0.0127613232933115,0.294881919459748
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24899,-0.0033971944491122,0.00324417632944074,-0.00975578005481605,0.00296139115659166,0.295032725206771
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28926,0.00257805304928767,0.0024673082937137,-0.00225787120639118,0.00741397730496652,0.296084929776795
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,29376,-0.00289830386747692,0.00277519941203937,-0.00833769471507408,0.00254108698012025,0.296328025623047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24106,0.00338983601897366,0.00324850760649,-0.00297723888974674,0.00975691092769406,0.296724639024732
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NPHS2,Podocin,24224,0.00729393332598917,0.00700235352522548,-0.00643067958345276,0.0210185462354311,0.297588898601433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24796,0.00270343042053382,0.00259973998453858,-0.0023920599491618,0.00779892079022944,0.298403511838505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,28769,-0.00502229780839897,0.00483430760911062,-0.0144975407222558,0.00445294510545785,0.29886617475975
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28911,-0.00365703094295017,0.00352177333175177,-0.0105597066731836,0.0032456447872833,0.299089715140249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,23965,0.00287019337508543,0.00276851705446152,-0.00255610005165916,0.00829648680183001,0.299874077651079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,24190,0.00488595460895815,0.00471477967533152,-0.00435501355469163,0.0141269227726079,0.30006975882857
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,24011,0.00325861125581698,0.00315136687157763,-0.00291806781247518,0.00943529032410914,0.301132059095745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24096,0.00758771695686565,0.00733889536426977,-0.0067965179571031,0.0219719518708344,0.301191192454563
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,24106,0.0045759353148211,0.00442706788901712,-0.00410111774765246,0.0132529883772947,0.301321114879163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28911,0.00304987143706001,0.0029521747100651,-0.00273639099466758,0.0088361338687876,0.301568959800544
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,28769,0.0033181704652686,0.00321366380846707,-0.00298061059932685,0.00961695152986406,0.30183751346842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,24440,0.0016118999688078,0.00156239980484365,-0.00145040364868575,0.00467420358630134,0.302231263259254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,24440,0.00290313821250173,0.00281700191947534,-0.00261818554966993,0.00842446197467339,0.302749293185581
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28926,-0.0046651677668188,0.00453273138851822,-0.0135493212883145,0.0042189857546769,0.303385955971681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29561,0.00231642490203928,0.00227172481691672,-0.00213615573911749,0.00676900554319605,0.307890156524165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24863,0.00251987104687442,0.00247415806822336,-0.00232947876684336,0.00736922086059219,0.30846163311683
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24011,-0.00254937132049446,0.00250653558401984,-0.00746218106517335,0.00236343842418443,0.309121052628475
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24376,0.00364084177193394,0.00358738715666824,-0.00339043705513581,0.0106721205990037,0.310163238857633
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,29213,-0.00356821185641642,0.0035197226584956,-0.0104668682670678,0.00333044455423495,0.310697846811584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28911,-0.00578389236999686,0.00570718259907261,-0.0169699702641792,0.00540218552418546,0.310858088694891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28792,-0.0032826028718259,0.00327078719822812,-0.00969334578035302,0.00312814003670122,0.31557387221425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24224,0.00370127812056632,0.00369018527093545,-0.00353148501046717,0.0109340412515998,0.315867970909376
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24190,0.00530865944028663,0.00531323831012548,-0.00510528764755932,0.0157226065281326,0.317737741103055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29438,0.00242001027188763,0.00243128829746915,-0.0023453147911519,0.00718533533492716,0.31956876064862
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,28769,0.00355653591624284,0.00358938582485097,-0.00347866030046507,0.0105917321329507,0.321768123977022
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24096,0.00475346843869196,0.00480213956809257,-0.00465872511476947,0.0141656619921534,0.322250201245586
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24840,-0.00181179446589561,0.00183116018934397,-0.00540086843700979,0.00177727950521857,0.322465212551774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24917,0.00178113362818306,0.00180061466819303,-0.00174807112147527,0.00531033837784139,0.32258425504708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24863,0.00456102251676448,0.0046171795870067,-0.00448864947376865,0.0136106945072976,0.323241923263805
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,24376,-0.00384259737980515,0.00389326946322797,-0.011473405527732,0.00378821076812167,0.323659942997001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24800,-0.00338196748565749,0.00342874789926238,-0.0101023133682117,0.00333837839689677,0.323967873221777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29344,-0.00298258944183331,0.00302641850771409,-0.00891436971695291,0.0029491908332863,0.324377900548047
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,29584,-0.00228077102090794,0.00231524848748182,-0.00681865805637229,0.00225711601455642,0.324578826837415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,24096,-0.00413231925268206,0.00419894928618724,-0.012362259853609,0.00409762134824493,0.325060631371094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24106,0.00657576322358108,0.00668431018423226,-0.00652548473751414,0.0196770111846763,0.32524295120672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24863,0.00179194420978595,0.00182471996526318,-0.00178450692212988,0.00536839534170178,0.326090725485255
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24376,0.00833253233118674,0.00850236146497396,-0.00833209614016221,0.0249971608025357,0.327083188793626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24106,-0.00414930631908959,0.00425874379382963,-0.0124964441549957,0.00419783151681648,0.329915960169263
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29429,0.00792359604197614,0.00813544445590165,-0.0080218750915911,0.0238690671755434,0.330084497492924
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,29034,-0.00452799902494852,0.00465165999513821,-0.0136452526154194,0.00458925456552238,0.330354836022863
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,29344,-0.00201111510495345,0.00206680124872165,-0.00606204555244789,0.00203981534254099,0.330533074723443
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24224,0.00134422552735467,0.00138146866810274,-0.00136345306212671,0.00405190411683604,0.330542692588671
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,24224,0.00571771595789665,0.00592395543115651,-0.00589323668717011,0.0173286686029634,0.334461542914099
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,29409,-0.00591800326305214,0.00614743959895833,-0.0179669848770105,0.00613097835090619,0.335717189713113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,28717,-0.00587582477854086,0.00612248136304401,-0.0178758882501071,0.0061242386930254,0.337207777294192
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,29395,-0.00570207719288964,0.00594324034039791,-0.0173508282600695,0.00594667387429026,0.337353950889341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28792,-0.00367563450905339,0.00384832274174798,-0.0112183470828794,0.00386707806477266,0.339521820734838
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24011,0.00261805417927327,0.00274567967873508,-0.00276347799104749,0.00799958634959403,0.340337435536229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CFB,Complement factor B,24533,0.00211531682029201,0.00222233562257115,-0.00224046099994745,0.00647109464053146,0.341185488063363
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29158,-0.0061795442499361,0.00649224973261484,-0.0189043537258612,0.00654526522598898,0.341189052449914
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28769,-0.00347914511684747,0.00365697678171675,-0.0106468196090123,0.00368852937531737,0.341423592718089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24096,0.00397492413767718,0.0041804367250843,-0.00421873184348805,0.0121685801188424,0.341695427620215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29429,-0.00587596232634588,0.00620271233631962,-0.0180332785055323,0.00628135385284058,0.343482795650813
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24096,0.00275309505398076,0.00291573861926916,-0.00296175263978678,0.00846794274774831,0.345067351952521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24106,0.00282570600595055,0.00299341463012403,-0.00304138666909255,0.00869279868099365,0.345192328661206
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HLA_E,,29429,0.00185014038769519,0.00196316639056524,-0.00199766573781267,0.00569794651320305,0.345981971803298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,29438,0.00483002940034495,0.0051269865862014,-0.00521886430860979,0.0148789231092997,0.346159629651467
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24224,0.00590428794591262,0.00627029727060848,-0.00638549470447999,0.0181940705963052,0.346392486420942
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28911,0.00196321191731322,0.00208766612177251,-0.00212861368136091,0.00605503751598734,0.347027480115746
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27934,0.00253877690730272,0.0027082518412135,-0.00276939670147574,0.00784695051608117,0.348549248212245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,28842,-0.00566163313112096,0.00604019606727614,-0.0175004174229822,0.00617715116074027,0.348598718577968
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24096,0.00312062015154712,0.00333304712252701,-0.00341215220860582,0.00965339251170006,0.349145413186483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24106,0.00622572595910837,0.00665957350597113,-0.00682703811259505,0.0192784900308118,0.34987314577568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28769,0.00191301586192269,0.00204838470727902,-0.00210181816434418,0.00592784988818956,0.350355920629094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29438,-0.00174855035410913,0.00187252038851116,-0.00541869031559101,0.00192158960737274,0.350417262821841
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,29158,-0.0047682984840015,0.00511615275935982,-0.0147959578923467,0.00525936092434375,0.351339790120515
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24840,-0.00286958118233373,0.00308126289889386,-0.0089088564641657,0.00316969409949823,0.351707282767381
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,29561,0.00262320787875512,0.00281698756012622,-0.00289808773909227,0.0081445034966025,0.351752390513843
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28792,0.00296147200164824,0.00318252966857863,-0.00327628614876587,0.00919923015206234,0.352099232188754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29689,0.00146689969234731,0.00157753451820817,-0.00162506796334069,0.00455886734803532,0.352446726300804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,24190,-0.00579602274272232,0.00623556321900921,-0.0180177266519804,0.00642568116653574,0.35263376239718
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,28911,0.00295788328195643,0.00318618489660357,-0.00328703911538655,0.00920280567929942,0.353235666019046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24863,-0.00415346306965557,0.00448106502433258,-0.0129363505173474,0.00462942437803628,0.353991642757733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,24011,0.00263962956961642,0.00285152745498668,-0.00294936424215748,0.00822862338139033,0.354616575596936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24106,-0.00319168518788346,0.00345167781206724,-0.00995697369953525,0.00357360332376834,0.35514349399623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24190,0.00647952682588021,0.00700836503795794,-0.00725686864851735,0.0202159223002778,0.355213497013922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24610,-0.00400561257281394,0.0043461752294071,-0.0125241160224519,0.00451289087682397,0.356724990239761
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,24800,-0.00482263618919972,0.0052437685420836,-0.0151004225316836,0.00545515015328414,0.357744258484804
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24224,-0.00183279737478054,0.00199336567900156,-0.00573979410562361,0.00207419935606252,0.357870115303217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29473,-0.00357555316246636,0.00389254165180011,-0.0112049347999946,0.00405382847506185,0.358330580439194
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,24440,-0.00181992880607669,0.00198339517599118,-0.00570738335101941,0.00206752573886603,0.35884651606378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBN1,Drebrin,24224,-0.00317682642370412,0.00347434119977154,-0.00998653517525633,0.0036328823278481,0.360532615351923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,29720,0.00369999339159045,0.00404890664262742,-0.0042358636279593,0.0116358504111402,0.360816058586142
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24788,-0.0058103739278353,0.00638939929808493,-0.0183335965520818,0.00671284869641115,0.363159908915115
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C3,Complement C3,23774,0.00286885668305881,0.00315524027618073,-0.00331541425825542,0.00905312762437304,0.363235016113723
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24224,0.00300808186081914,0.00331652110127905,-0.0034922994976878,0.00950846321932608,0.364416267426498
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24933,0.00372106989955386,0.00410728856123917,-0.00432921568047492,0.0117713554795826,0.364961820852079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24224,0.00250531785199047,0.00276718867463136,-0.00291837195028699,0.00792900765426793,0.365280663496275
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,24190,-0.00316185244960016,0.00351009096001087,-0.0100416307312215,0.00371792583202115,0.36770931996427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,24631,0.00605009757719191,0.00671738476570296,-0.00711597656358589,0.0192161717179697,0.367776522922268
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29429,-0.00225669406761774,0.00250569828984344,-0.00716786271571088,0.00265447458047539,0.367795207571163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24863,-0.00517620818779572,0.0057683119275112,-0.0164820995657177,0.00612968319012624,0.369539631160495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,24011,0.00187256743798118,0.00208782507719405,-0.00221956971331916,0.00596470458928152,0.369782012163068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,24011,0.00708552589401153,0.00791489099606806,-0.00842766045828187,0.0225987122463049,0.370681366311868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,24190,-0.00366103563475868,0.00409217595031909,-0.0116817004973841,0.00435962922786674,0.370986986309175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24106,-0.00219230484288974,0.00246202723150772,-0.00701787821664487,0.00263326853086538,0.373234789263011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,24224,-0.00287793858191169,0.00324339485234255,-0.00923499249250309,0.00347911532867971,0.374913885239769
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,29756,-0.00360038940168973,0.00406187341151879,-0.0115616612882666,0.00436088248488709,0.375416505241197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,24106,0.00221333843075561,0.00249780793537238,-0.00268236512257426,0.00710904198408547,0.375565839403252
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24840,-0.00397264823032871,0.00448528676792654,-0.0127638102954647,0.0048185138348073,0.3757842131387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24440,0.0023296742614536,0.00263296807541499,-0.00283094316635978,0.00749029168926698,0.376268279761582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28769,0.00288240007073065,0.00326010840210153,-0.00350741239738835,0.00927221253884966,0.376626738901175
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24106,0.00237690203393932,0.0027105033264419,-0.0029356844858868,0.00768948855376545,0.380537341722089
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28926,-0.00546579586301064,0.00625021927581334,-0.0177162256436048,0.00678463391758351,0.381855103910575
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24235,0.00565866261664885,0.00647507729147342,-0.00703248887463906,0.0183498141079368,0.382173592835847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24914,0.00645585596923366,0.0074025454844242,-0.00805313318023777,0.0209648451187051,0.38315515721256
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24190,0.00421713168692739,0.00484470882856156,-0.00527849761705327,0.013712760990908,0.384056986264367
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24746,0.0023668763651964,0.00273429822718255,-0.0029923481600814,0.0077261008904742,0.386704345729125
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28792,0.00238100211333387,0.00276365186074047,-0.00303575553371745,0.0077977597603852,0.388946785472421
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NCLN,Nicalin,28926,0.00305438004120287,0.00354564664541608,-0.00389508738381265,0.0100038474662184,0.389000072501048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,29203,0.00265238089168692,0.00308154701968699,-0.00338745126689959,0.00869221305027343,0.389393670636188
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28792,0.00174645050829602,0.0020301006378077,-0.00223254674180707,0.00572544775839911,0.389643094562695
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24224,-0.00224744279521143,0.00261250672664017,-0.00736795597942615,0.00287307038900329,0.389652619082739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,24096,0.00377696154432033,0.00439745496116047,-0.0048420501795542,0.0123959732681949,0.39040580946174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24440,-0.00405485141266111,0.00472768195133387,-0.0133211080372755,0.00521140521195328,0.391076064832993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29599,-0.00189529099788249,0.00221629527101115,-0.00623922972906435,0.00244864773329936,0.392468519596095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,23897,0.00253675802187228,0.00297327452157072,-0.00329086004040632,0.00836437608415089,0.39356438169722
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,23386,-0.00141154356415454,0.00165516405189835,-0.0046556651058753,0.00183257797756623,0.393772374820512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24440,0.00452083371964402,0.00530461123862737,-0.00587620430806563,0.0149178717473537,0.394085925210652
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29576,0.00381752795829627,0.00449695308122729,-0.00499650008090922,0.0126315559975018,0.395935832738209
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,24917,-0.00412004260309449,0.00485688825947823,-0.0136395435916718,0.00539945838548285,0.396285457045365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28792,-0.00707577657475135,0.0083474867824217,-0.0234368506682979,0.00928529751879518,0.396638007083738
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29211,0.00334964374531926,0.00395324085552261,-0.00439870833150506,0.0110979958221436,0.396826024272143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24440,0.00499680848588987,0.00590215849372143,-0.00657142216180414,0.0165650391335839,0.397222524910488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28926,0.00372973532925159,0.00441804142824411,-0.00492962587010686,0.01238909652861,0.398561508970348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24204,-0.00323475698369642,0.00384780472447421,-0.0107764542436659,0.00430694027627304,0.400537793394378
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,24096,0.00360730997751686,0.00429578654373835,-0.00481243164821029,0.012027051603244,0.401066931860036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28792,0.00248344389072099,0.00296247402792168,-0.00332300520400551,0.00828989298544748,0.401868835827297
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28926,-0.00199442737438649,0.00240394099714753,-0.00670615172879566,0.00271729698002267,0.406744083343145
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29429,0.00677824283525608,0.00820487183030731,-0.00930330595214625,0.0228597916226584,0.408740365233299
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,28769,0.00289019388748983,0.00350407728598786,-0.00397779759304637,0.00975818536802603,0.409486974559416
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24096,0.00335590036385363,0.00407172754538915,-0.0046246856251091,0.0113364863528164,0.409836528520402
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,28717,-0.00201436000852295,0.00245135117566347,-0.00681900831282336,0.00279028829577746,0.411234804000199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,24863,-0.00424768663148576,0.00517302850932316,-0.0143868225097592,0.00589144924678764,0.411584754619027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24800,-0.00957909749863772,0.0116740799308301,-0.0324602941630648,0.0133020991657894,0.411913886633281
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,29473,-0.00378181089458065,0.00462062836418047,-0.0128382424883744,0.00527462069921308,0.4130997849922
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28926,0.00308536453929749,0.0037727623986267,-0.00430924976201084,0.0104799788406058,0.413478220779232
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24190,0.00201072919867789,0.00246404565763382,-0.00281880029028439,0.00684025868764017,0.414492405383644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAYN,Layilin,29158,-0.00192859295021999,0.00236435017584002,-0.00656271929486643,0.00270553339442645,0.414680217168856
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,24011,0.00225011178266743,0.0027742294457442,-0.00318737793099121,0.00768760149632606,0.417329893316483
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24788,0.00305775045281093,0.00377645523030087,-0.00434410179857877,0.0104596027042006,0.41812729774245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24190,-0.00422979801580632,0.00522649589621396,-0.0144737299723857,0.00601413394077304,0.418351133453812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29815,0.00150413023390317,0.00185955015167061,-0.00214058806337123,0.00514884853117758,0.418597651535833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,24224,0.00238232809352728,0.0029498725439023,-0.00339942209252123,0.00816407827957579,0.41932666862108
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPL,Periplakin,24224,0.00178458576578589,0.00221447536972201,-0.00255578595886926,0.00612495749044103,0.420324033461254
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24800,0.00141365859673068,0.00176205342545608,-0.00203996611716324,0.00486728331062461,0.422399234309741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24190,0.00199662020067826,0.00248960039654574,-0.0028829965765514,0.00687623697790792,0.422569976397449
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24800,-0.00232289687514035,0.00289717407522126,-0.00800135806257401,0.00335556431229332,0.422687787421854
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29689,-0.00366277733686286,0.0045827225008443,-0.0126449134385177,0.00531935876479197,0.424147260047273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24235,-0.00524489932370802,0.0065752274824134,-0.0181323451892383,0.00764254654182225,0.425066516542073
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,24011,-0.00336296829966521,0.00422007847159953,-0.0116343221040003,0.00490838550466986,0.425518678862425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28769,0.00190268399149637,0.00239236985590541,-0.00278636092607823,0.00659172890907097,0.426437739803359
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28769,-0.00453621450884548,0.00571000653656163,-0.0157278273205063,0.00665539830281531,0.426950272957314
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24011,0.00340965942401653,0.00429847904457626,-0.00501535950335293,0.011834678351386,0.427654806050326
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29576,-0.00147779092869075,0.00186626707918614,-0.00513567440389559,0.00218009254651409,0.428458452932171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29689,0.00686010194206618,0.0086864581447333,-0.0101653560216111,0.0238855599057434,0.429682003134063
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,29429,0.00348522177444652,0.00441335701099753,-0.00516495796710864,0.0121354015160017,0.429710185103887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24863,-0.0025015175559835,0.0031985542126098,-0.00877068381269869,0.0037676487007317,0.434176430538092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,24917,0.00279000261501541,0.0035689292800367,-0.00420509877385651,0.00978510400388734,0.434370235831349
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28792,0.00187371816989853,0.0023980999429255,-0.00282655771823545,0.0065739940580325,0.434612223745087
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEO1,Neogenin,24863,0.00115845253478876,0.0014845307699027,-0.00175122777422053,0.00406813284379805,0.435192739626678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,24376,0.00203870569258435,0.00262584770308082,-0.00310795580545405,0.00718536719062276,0.437520936123646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24917,0.00323729340429366,0.00417458390186584,-0.00494489104336339,0.0114194778519507,0.438065270895214
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,24011,-0.003829171330027,0.00494741438764701,-0.0135261035298151,0.00586776086976115,0.438953644891476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,24011,-0.00379103927168389,0.004901326060518,-0.0133976383502992,0.0058155598069314,0.439250615801199
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,24190,-0.00312672103195859,0.00404409834763344,-0.0110531537933201,0.00479971172940295,0.439437310011013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,29429,-0.00162801034172108,0.00211423739700215,-0.00577191563984529,0.00251589495640313,0.441292736658217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28792,-0.00241065566283994,0.00313765097717231,-0.00856045157809767,0.00373914025241779,0.442315578708038
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24440,0.00349219668415141,0.004550243555114,-0.00542628068387204,0.0124106740521749,0.442806764452131
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,29429,0.00179621893051763,0.00234964234665473,-0.00280908006892563,0.0064015179299609,0.444596421727554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,24190,0.00310411711976499,0.00408937025534231,-0.00491104858070593,0.0111192828202359,0.447818254193037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29344,0.00274591153443572,0.00362329517773504,-0.00435574701392496,0.0098475700827964,0.448547323341751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24440,0.00324140174001675,0.00428307955124827,-0.00515343418042986,0.0116362376604634,0.44918158995204
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,24190,0.00310574837234567,0.00410571848972248,-0.00494145986751038,0.0111529566122017,0.449390077565102
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24011,0.00170977278991499,0.00226885594817233,-0.00273718486850278,0.00615673044833275,0.451106647061422
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24788,-0.00359700163926248,0.00478759144774196,-0.0129806808768367,0.00578667759831175,0.452468685990149
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24440,0.00249781367172166,0.00334861298429403,-0.00406546777749464,0.00906109512093797,0.45571998508293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,24011,0.00349987608885447,0.00469275561537907,-0.0056979249172885,0.0126976770949974,0.455793105358991
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OGN,Mimecan,29438,0.00212220844860175,0.00284886796750065,-0.00346157276769952,0.00770598966490302,0.456319726081849
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29641,0.00114074346853618,0.00153556190201972,-0.00186895785942248,0.00415044479649484,0.457558158226955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPGN,Epigen,24788,-0.00241530258493594,0.00325227695855487,-0.00878976542370348,0.0039591602538316,0.457700817294462
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24840,0.00210793440907469,0.00284303322473147,-0.00346441071139898,0.00768027952954837,0.458434595996414
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24190,0.00348049551301016,0.00472389128761504,-0.00577833141071531,0.0127393224367356,0.461259834904607
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29669,0.00332737512656285,0.00452149804014128,-0.00553476103211405,0.0121895112852398,0.461796742592044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,29429,-0.00258203222954785,0.00352457773027612,-0.00949020458088906,0.00432614012179335,0.46382097647319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29668,0.0021011909731995,0.00286859081423207,-0.00352124702269537,0.00772362896909437,0.463880249374865
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24190,0.00270036271770814,0.00369788752114576,-0.00454749682373756,0.00994822225915384,0.465247707353229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,24011,-0.00362988412972915,0.00497495047080425,-0.0133807870525055,0.00612101879304718,0.465622147060231
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24011,-0.00205532995748413,0.00281717971342821,-0.00757700219580342,0.00346634228083515,0.465660153009399
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,28926,0.00240599930728606,0.00330316217963833,-0.00406819856480507,0.00888019717937718,0.466379113581171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24917,-0.00483071810140604,0.00663553771483596,-0.0178363720224845,0.00817493581967244,0.466616128017332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24788,-0.00256578987047512,0.00355172930866803,-0.00952717931546446,0.00439559957451423,0.470051837865266
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24376,-0.00180569387421342,0.00250002170923396,-0.00670573642431198,0.00309434867588515,0.470134640922682
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24190,0.00245476602607559,0.0034107552808132,-0.00423031432431829,0.00913984637646947,0.471708477196806
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,24011,0.00293106544560724,0.00409869918427298,-0.00510238495556781,0.0109645158467823,0.47454129824772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,24106,0.00193648908511135,0.0027166965666737,-0.0033882361855691,0.00726121435579181,0.47597010245726
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,24172,0.00209628401212006,0.00295670637414047,-0.00369886048119527,0.00789142850543539,0.478335685666621
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TTN,Titin,24106,-0.00321979226383732,0.00455626629892461,-0.0121500742097295,0.00571048968205491,0.479776288711171
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24800,-0.00256427427191924,0.0036315419485716,-0.00968209649111957,0.00455354794728109,0.480125310864327
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,28926,0.0014502962267111,0.00205905524472563,-0.00258545205295112,0.00548604450637333,0.481220307636495
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24011,0.00233944972643969,0.00332485616261435,-0.00417726835228443,0.00885616780516382,0.481673575532549
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28926,-0.00176873812618566,0.00252324498265738,-0.00671429829219413,0.00317682203982281,0.483322657189873
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24096,-0.00282842884734481,0.00403820761868098,-0.0107433157799595,0.00508645808526991,0.483673753914305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24106,-0.00185588394989911,0.00265791926790361,-0.0070654057149902,0.00335363781519197,0.485029525695056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24759,0.00331542919723958,0.00474859523031949,-0.00599181745418662,0.0126226758486658,0.485063953558678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29689,0.00220931369900495,0.00318190375316233,-0.00402721765719322,0.00844584505520311,0.487476290129883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24224,-0.00171772243560551,0.00247812706232904,-0.00657485147777043,0.00313940660655942,0.488219878289971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,24011,0.0012201213814905,0.00176535706155891,-0.00223997845916497,0.00468022122214596,0.489479800876612
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24129,0.00184912488114383,0.00267780931725043,-0.00339938138066701,0.00709763114295468,0.489863555888699
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,29513,0.00211264389655146,0.00306173874253874,-0.00388836403882446,0.00811365183192739,0.490190544597444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NENF,Neudesin,24788,0.00513413341220577,0.00744911747297268,-0.00946613683482068,0.0197344036592322,0.490686839018981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24190,0.00251593995169385,0.00365063565347052,-0.00463930592910837,0.00967118583249607,0.49071749903521
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,28926,-0.00226634701545504,0.00329086766105609,-0.00871644763112498,0.0041837536002149,0.491031668376354
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,24106,0.00235301193310809,0.00342098046538966,-0.00435210977905564,0.00905813364527183,0.491574022891915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24011,0.00157834161285936,0.00230792433832209,-0.00294519009025194,0.00610187331597066,0.494058008422517
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',24106,0.00199290082514539,0.00291683884737418,-0.00372410331570799,0.00770990496599878,0.494461803302881
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24224,0.00418547695327166,0.00614895707209699,-0.00786647890803844,0.0162374328145818,0.496080004202861
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28792,0.00146906017128983,0.00215838322112576,-0.00276137094211665,0.00569949128469632,0.496111173971137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24190,0.00218391649590134,0.00321666612430738,-0.00412074910774112,0.0084885820995438,0.497183718973796
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24863,-0.00174613984827929,0.00259522981839077,-0.00683279029232519,0.00334051059576662,0.501063822222783
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,24106,-0.00268516630099301,0.00399949343293586,-0.0105241734295473,0.00515384082756128,0.501987085216702
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24840,0.00481390292082962,0.00717415276723799,-0.00924743650295685,0.0188752423446161,0.502222650737473
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24800,0.0046741410041898,0.00698850131872251,-0.00902332158050632,0.0183716035888859,0.503608178381847
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28792,0.00208807866893547,0.00312207563094587,-0.00403118956771844,0.00820734690558938,0.503621384210424
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24863,-0.0051185878650996,0.00771210500412742,-0.0202343136731894,0.00999713794299015,0.506883203239929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,28926,0.00174581248592816,0.00264065156854409,-0.00342986458841826,0.00692148956027457,0.508534576533377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,24190,-0.00218860016643284,0.00331083370696952,-0.0086778342320931,0.00430063389922742,0.50859167231333
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24840,-0.00148660224275395,0.00224953474362731,-0.00589569034026348,0.00292248585475558,0.508715442248808
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,24933,0.00397554865190732,0.00601641503511883,-0.00781662481692559,0.0157677221207402,0.508757181850887
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28769,-0.00648500857654658,0.00983904871582484,-0.0257695440595633,0.0127995269064701,0.509830857806101
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,29539,0.00132771654419458,0.00201568912408083,-0.00262303413900386,0.00527846722739301,0.510099267347058
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29576,-0.00578328205633745,0.00878126349547214,-0.0229945585074628,0.0114279943947879,0.510162040556485
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,23965,-0.00158030070961345,0.00240786270869439,-0.00629971161865444,0.00313911019942755,0.511631968772391
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTTG1,Securin,24440,0.00183352479457536,0.00280936825399787,-0.00367283698326048,0.00733988657241119,0.513990242296436
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24224,0.0039669429665787,0.00614344733387671,-0.00807421380781966,0.0160080997409771,0.518467231085574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29668,0.00132996255731083,0.002060848026411,-0.00270929957445472,0.00536922468907639,0.51870718769688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,29561,0.0024497585441126,0.00379704812293786,-0.00499245577684561,0.00989197286507082,0.518819132363335
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,28792,-0.00293307953228382,0.00454977064214476,-0.0118506299908876,0.00598447092631991,0.519149207121858
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,24440,0.00150244483656835,0.00233323036064824,-0.0030706866703022,0.00607557634343891,0.519624702312493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29344,-0.00199644422582075,0.00311294228864349,-0.00809781111156198,0.00410492265992048,0.521308942187055
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,24933,0.00396958476837592,0.00618967434349657,-0.00816217694487735,0.0161013464816292,0.521318301313173
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24440,-0.00314664234806946,0.00490888143698801,-0.0127680499645659,0.00647476526842704,0.521522165675762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24917,-0.00388714998692365,0.0060642802680165,-0.015773139312236,0.00799883933838868,0.521534331013134
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,24224,0.000941314587230978,0.00146982490440121,-0.0019395422253954,0.00382217139985736,0.521901522795821
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,29449,0.00114245298661717,0.00178445944031574,-0.00235508751640168,0.00463999348963602,0.522032247288547
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,28792,-0.00320942783646896,0.00503004427917535,-0.0130683146236526,0.00664945895071474,0.523445163539337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29731,-0.00200644511294419,0.00314737171263785,-0.00817529366971437,0.004162403443826,0.523805022210243
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MDK,Midkine,29450,-0.00217938948806875,0.00343882054819548,-0.0089194777625319,0.0045606987863944,0.526241896509096
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24011,0.00131296669629764,0.00207344997598043,-0.002750995256624,0.00537692864921928,0.526590761731599
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,24011,0.00229794994203465,0.00363157690125116,-0.00481994078441762,0.00941584066848692,0.526890414451091
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24840,-0.00249139435091219,0.00394090355631713,-0.0102155653212938,0.00523277661946939,0.527269459291368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,24302,-0.00357742674308775,0.00568877674532446,-0.0147274291639237,0.00757257567774819,0.52944863188706
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,29429,-0.00273845305348356,0.00435660225343004,-0.0112773934702065,0.00580048736323932,0.529631942803118
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24863,0.00324180672180828,0.00518080031380252,-0.00691256189324465,0.0133961753368612,0.531494691719926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24011,0.00228316597837832,0.00366785958120803,-0.00490583880078942,0.00947217075754605,0.533632788596217
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28657,0.0024114265057129,0.00389412294610806,-0.0052210544686589,0.0100439074800847,0.5357581469228
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29273,0.00115051433135367,0.0018618810638737,-0.00249877255383879,0.00479980121654612,0.536625525232597
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,24190,0.00274653436438818,0.00444600423315958,-0.0059676339326046,0.011460702661381,0.536743704669823
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,29781,0.00366760551419946,0.00593731918404282,-0.00796954008652447,0.0153047511149234,0.536764128729757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24011,-0.00387120497959232,0.00627560952427437,-0.0161713996471701,0.00842898968798544,0.53732950972122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24376,-0.00286131883142946,0.00464220521587684,-0.0119600410545481,0.00623740339168914,0.537655709407988
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24011,0.00600047276293906,0.00974110781880981,-0.0130920985619282,0.0250930440878063,0.537903726616205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24440,-0.00127952224934874,0.00208274186335778,-0.00536169630152999,0.00280265180283251,0.538993030778512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,29291,-0.00128116594263312,0.0020891827378877,-0.00537596410889301,0.00281363222362677,0.539723841119757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,24642,-0.00181258660598193,0.00296907489632376,-0.00763197340277649,0.00400680019081264,0.541543775085993
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29391,-0.00169302083317718,0.00277465111189758,-0.00713133701249643,0.00374529534614208,0.541751064208165
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24106,-0.00168884512987876,0.00276805251535119,-0.0071142280599671,0.00373653780020958,0.541787851253826
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24788,0.00358604362365898,0.00588821013199799,-0.00795484823505709,0.015126935482375,0.542516103833332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,24933,-0.00103831693076957,0.00171254548041811,-0.00439490607238907,0.00231827221084992,0.544320846625428
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,24224,-0.00159812291661054,0.00264379047981625,-0.0067799522570504,0.00358370642382931,0.545529108859915
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,24190,0.00274462657240095,0.00454170993502956,-0.00615712490025698,0.0116463780450589,0.545639447836662
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24440,-0.00179069100454572,0.00296333522625822,-0.00759882804801183,0.0040174460389204,0.545661589386046
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,24800,-0.00249719114239881,0.00413677381216526,-0.0106052678142427,0.00561088552944509,0.54607744561112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,24106,0.00136687829427476,0.00227087675667964,-0.00308404014881734,0.00581779673736686,0.547235353915936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,29408,0.00518004007602806,0.0086638134586542,-0.0118010343029342,0.0221611144549903,0.549915424557903
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24224,-0.00305055957543777,0.00510618339303354,-0.0130586790257835,0.00695755987490798,0.55022952057423
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,29473,-0.00145503373621309,0.00244054239762396,-0.00623849683555605,0.00332842936312988,0.551051034804387
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24225,-0.00156796085491857,0.00263481519960181,-0.00673219864613812,0.00359627693630098,0.551786673060554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29689,0.00316101643814059,0.00532588078347809,-0.00727770989747646,0.0135997427737577,0.552837766701191
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,28926,0.00250218269148904,0.00423000632943964,-0.00578862971421266,0.0107929950971907,0.554168869267955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,29720,-0.00127123612630329,0.00214938807162994,-0.00548403674669798,0.0029415644940914,0.554229508880441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24840,-0.00102499270320251,0.00173935638763887,-0.0044341312229747,0.00238414581656967,0.555669269367212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,24961,0.00103097015732327,0.00175138831308254,-0.00240175093631852,0.00446369125096505,0.556095504917749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29576,0.00470035093402304,0.00807430143077747,-0.0111252798703008,0.0205259817383469,0.560478733665186
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24096,-0.00214202704131039,0.00368579125835479,-0.00936617790768577,0.005082123825065,0.56113941667961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24190,0.00331211656164564,0.00570446025741018,-0.00786862554287832,0.0144928586661696,0.561502847050555
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,29473,-0.00152591196485419,0.00263036696827428,-0.00668143122267178,0.0036296072929634,0.561842369505848
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LGMN,Legumain,29576,0.00140518627194969,0.00242442330088325,-0.00334668339778148,0.00615705594168085,0.56219144545088
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28769,0.00225651047472947,0.00390132957623646,-0.00539009549469399,0.00990311644415294,0.563001833517609
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,24224,0.00242563552974222,0.00423555462572317,-0.0058760515366752,0.0107273225961596,0.56686380481945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,24224,-0.00190448567046394,0.00334727310916694,-0.00846514096443114,0.00465616962350326,0.569384273079779
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,24224,0.00212164037435993,0.00373065382616783,-0.00519044112492902,0.00943372187364888,0.569561831176971
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,24190,-0.00135259128319122,0.00239702972665987,-0.00605076954744456,0.00334558698106212,0.572570145420029
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28911,-0.00127403163137048,0.00226211781471957,-0.00570778254822084,0.00315971928547988,0.573301002483068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24011,0.00320061364446736,0.00569283013329692,-0.00795733341679461,0.0143585607057293,0.573972502338932
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24440,0.00314987246512648,0.00566160587458447,-0.00794687504905908,0.014246619979312,0.577972117271426
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,24235,-0.00234333472973691,0.00424367290050307,-0.0106609336147229,0.0059742641552491,0.580819891455456
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24863,0.00280431788155886,0.0051276499295756,-0.0072458759804093,0.012854511743527,0.584451524702523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24106,0.00175811580459316,0.00321563475588022,-0.00454452831693207,0.00806075992611839,0.584562505944003
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24190,-0.00190174404721663,0.00348578145420728,-0.00873387569746289,0.00493038760302963,0.585365349686794
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24440,-0.00314346518994308,0.00577875869723585,-0.0144698322365253,0.00818290185663918,0.586467818030629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28926,-0.004324848544837,0.00799522347250135,-0.0199954865509396,0.0113457894612657,0.588560662294657
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24917,-0.00266335035917482,0.00497992116470735,-0.0124239958420012,0.00709729512365157,0.592780645216392
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24224,-0.00317575833141262,0.00597171835626676,-0.0148803263096955,0.00852880964687023,0.594869575226114
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24235,0.00220931648120305,0.00415734635539042,-0.00593908237536218,0.0103577153377683,0.595129392083262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,24190,-0.00226219146135263,0.00427358030313514,-0.0106384088554975,0.00611402593279224,0.596572125129427
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,24096,0.00268793833997267,0.00508204597306291,-0.00727287176723063,0.012648748447176,0.596873659604985
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,28792,0.00495113343202941,0.00937908383705732,-0.0134318708886029,0.0233341377526618,0.597579099828545
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24800,-0.00312419604373385,0.00601557621918241,-0.0149147254333314,0.00866633334586369,0.603520571927708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29576,-0.00305603090789484,0.00591783785576241,-0.0146549931051892,0.00854293128939949,0.605571914915407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24190,-0.00136051231781566,0.0026467575693014,-0.00654815715364641,0.00382713251801508,0.607235840110751
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24235,-0.00136992322378192,0.00268882128696766,-0.00664001294623853,0.00390016649867469,0.610414577137789
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24224,0.00109788050804229,0.00215511744113971,-0.00312614967659154,0.00532191069267613,0.610455811181749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29213,0.00122452704130732,0.00240564104024069,-0.00349052939756443,0.00593958348017906,0.610739825907742
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24224,0.00209286008964925,0.00411551312116573,-0.00597354562783558,0.0101592658071341,0.611086645712496
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29689,-0.00103191928987585,0.00203491521825571,-0.00502035311765704,0.00295651453790534,0.612083671104001
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,29213,0.00117340466681344,0.00231604169884939,-0.00336603706293137,0.00571284639655824,0.612409656308917
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,24096,0.00163513736117617,0.00323552353720448,-0.00470648877174461,0.00797676349409695,0.613303430333262
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,28769,-0.00132786683228285,0.00262780007131701,-0.00647835497206419,0.00382262130749848,0.613341471460504
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24224,0.0022462939436196,0.00444638643164932,-0.00646862346241308,0.0109612113496523,0.613426204109478
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,29689,-0.000769218799629097,0.00152760265675381,-0.00376332000686656,0.00222488240760836,0.614583912793353
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24863,0.00336130793294136,0.00672449659534581,-0.00981870539393642,0.0165413212598191,0.617177973797437
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,24840,-0.00313397375635074,0.00627391498156649,-0.0154308471202211,0.00916289960751958,0.617414412921929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24863,0.0011423898501236,0.00229124763782667,-0.00334845552001668,0.00563323522026387,0.618073682367644
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24190,-0.00139289889453613,0.00279816604455129,-0.00687730434185667,0.0040915065527844,0.618636638212222
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,29308,-0.00130324860282152,0.00261870819143581,-0.0064359166580357,0.00382941945239266,0.618721442636112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,28645,0.00102641065451703,0.00206587931300506,-0.0030227127989729,0.00507553410800695,0.619305981174953
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24399,0.00183173638234148,0.00368866280938832,-0.00539804272405963,0.00906151548874258,0.619485872676419
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24440,-0.00177093462950814,0.00360307388102594,-0.00883295943631898,0.0052910901773027,0.623072594443982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24190,0.00140159043033306,0.00288313832381565,-0.00424936068434561,0.00705254154501173,0.626876847482585
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24440,0.00149926536653263,0.0030882230386329,-0.00455365178918786,0.00755218252225313,0.627341434352385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,29678,0.00197171804324293,0.00409169279943431,-0.00604799984364831,0.00999143593013418,0.629892472136377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28926,-0.00190090792381413,0.00394629271595335,-0.00963564164708269,0.00583382579945444,0.630026552769212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24011,-0.0016147488448569,0.00335249913184719,-0.00818564714327739,0.0049561494535636,0.630055254919617
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,24933,0.00143177502929321,0.00297534217552315,-0.00439989563473217,0.00726344569331858,0.630368942846681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSG,Basigin,29755,-0.000665442295910618,0.00139009292164339,-0.00339002442233167,0.00205913983051043,0.632153120774493
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24106,-0.00148528305583405,0.0031112108092094,-0.00758325624188447,0.00461269013021637,0.633083700887696
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,29689,-0.000861407346260787,0.00180730782310477,-0.00440373067954613,0.00268091598702456,0.633632980969432
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,24190,-0.0026619720100808,0.00561889670536283,-0.0136750095525919,0.00835106553243036,0.635679971670745
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,24011,0.0017044229590831,0.00359913304789302,-0.00534987781478721,0.00875872373295342,0.635814542695298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29389,-0.000961273559116602,0.00203355244861854,-0.00494703635840894,0.00302448924017573,0.63642606600961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,23796,0.00125231639861524,0.00265259752317357,-0.00394677474680496,0.00645140754403544,0.636852988314556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24788,0.00244722047308072,0.00519509703949507,-0.00773516972432962,0.0126296106704911,0.637599553702921
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,24863,-0.00503463552411792,0.0107309260360559,-0.0260672505547875,0.0159979795065517,0.638951780195992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24106,0.00189239055039671,0.00403592157035567,-0.0060180157275004,0.00980279682829383,0.639154759173556
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24106,0.00356526895162482,0.00768968993888317,-0.0115065233285862,0.0186370612318358,0.642907912718212
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24800,-0.00284132014502068,0.00612937518231623,-0.0148548955023605,0.00917225521231912,0.642968610223977
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,24840,0.000832209868503477,0.00179564281357546,-0.00268725004610443,0.00435166978311139,0.643038244032883
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24440,0.00249935700044161,0.00540208822920223,-0.00808873592879477,0.013087449929678,0.643608650899522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29429,0.0026425037097741,0.00575326544281426,-0.00863389655814185,0.01391890397769,0.646018536193737
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24096,0.00238262202913325,0.00518780124287114,-0.00778546840689418,0.0125507124651607,0.646041589173056
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24917,-0.000943455244036714,0.00205715903874311,-0.00497548695997321,0.00308857647189978,0.646510737003512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24917,-0.000850300290644896,0.00186219495283243,-0.00450020239819646,0.00279960181690667,0.647954039495777
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24416,0.00308615880208992,0.006817911900542,-0.0102769485229724,0.0164492661271522,0.650801540413069
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24788,-0.00139284793180613,0.00307865760853857,-0.00742701684454173,0.00464132098092947,0.650970015416244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24106,-0.00203887838214373,0.00454663083276697,-0.010950274814367,0.00687251805007953,0.653841735259646
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,29438,0.0036680737568236,0.00819775089981706,-0.0123995180068178,0.019735665520465,0.654554345581211
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28792,0.0026237784574869,0.00588214572267094,-0.00890522715894814,0.0141527840739219,0.655558669314923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24235,0.000952935003291464,0.00214109048217103,-0.00324360234176376,0.00514947234834669,0.656273191817937
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24011,0.00172853448026544,0.00389402293471985,-0.00590375047178547,0.00936081943231635,0.657123027613163
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRL,Prolactin,29689,0.00227559520833941,0.00512839631152772,-0.00777606156225492,0.0123272519789337,0.65724499833501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24106,0.00119245760039194,0.00269173921592393,-0.00408335126281896,0.00646826646360283,0.657765109838205
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,24788,0.00157766628580173,0.00357687492719571,-0.00543300857150187,0.00858834114310532,0.659163324286672
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,24224,0.00183099448750511,0.00415840852715584,-0.00631948622572034,0.00998147520073057,0.659715549745122
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24933,0.00184783867236585,0.00422054280659778,-0.0064244252285658,0.0101201025732975,0.661520459738248
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24788,0.00104182397565776,0.00238193552653924,-0.00362676965635914,0.00571041760767467,0.661835636769949
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24946,0.000949217645876946,0.00217765714385355,-0.00331899035607601,0.0052174256478299,0.662920756716998
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24440,-0.00255065997749738,0.0058675957304272,-0.0140511476091347,0.00894982765413994,0.663782045002765
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29438,0.00128083262179636,0.00298105868178614,-0.00456204239450448,0.0071237076380972,0.667448339725525
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24224,-0.000907848827128023,0.00211388413899611,-0.0050510617395604,0.00323536408530435,0.667585385561458
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28769,0.00183845220851655,0.0042844429689844,-0.00655905601069288,0.010235960427726,0.667854052430899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24376,-0.00175361009994359,0.00408814002836076,-0.00976636455553068,0.0062591443556435,0.667962971507004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,24235,0.000522702613874949,0.00121891974595156,-0.0018663800881901,0.00291178531594,0.668054783428537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24235,-0.00244767849241537,0.00575447879696061,-0.0137264569344582,0.00883109994962743,0.670583943146036
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,29344,-0.0054422918451168,0.0127998346516359,-0.0305299677623232,0.0196453840720896,0.670705270564948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28792,0.00135673813495229,0.00320941322257167,-0.00493371178128819,0.00764718805119277,0.672490220735612
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24224,-0.00184404717386417,0.00436500568904799,-0.0103994583243982,0.00671136397666988,0.672691894326571
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,24235,-0.00245653723092324,0.00581792622238703,-0.0138596726268018,0.00894659816495535,0.672856598436716
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24096,0.00155294907522699,0.00368281153534411,-0.00566536153404746,0.00877125968450144,0.673266113364673
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24235,0.00119802410247265,0.00284200177072628,-0.00437229936815086,0.00676834757309617,0.673362834802505
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28911,-0.00172701664537426,0.00409926074888392,-0.00976156771318674,0.00630753442243823,0.673539503610925
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,28825,0.00139144481364277,0.00330334081653329,-0.00508310318676247,0.00786599281404801,0.673595020662944
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28769,-0.00140825895692748,0.0033446104606079,-0.00796369545971897,0.00514717754586401,0.673719377302907
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29213,-0.00172483803099683,0.00412498466815773,-0.00980980798058598,0.00636013191859233,0.675844833260494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24185,-0.00100716468445532,0.00242889454919851,-0.00576779800088441,0.00375346863197377,0.678394718139494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24235,0.00178855717677964,0.00433035002427718,-0.00669892887080363,0.0102760432243629,0.679589524327361
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,29438,0.000698438853248932,0.00169130132639641,-0.00261651174648803,0.00401338945298589,0.679639337703869
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,28769,-0.00137462367062381,0.00333028622385466,-0.00790198466937894,0.00515273732813132,0.679782297275012
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,28911,0.00212048684499373,0.00517782507989522,-0.00802805031160091,0.0122690240015884,0.68215207076909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,24416,0.00274016678967743,0.00669278014474402,-0.0103776822940208,0.0158580158733757,0.682234099931035
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,29708,0.000587864467795002,0.0014366907963307,-0.00222804949301316,0.00340377842860317,0.682410865077595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,28769,-0.00164905871930513,0.00404380253603854,-0.00957491168994067,0.0062767942513304,0.683424267750782
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28792,0.00152897673218677,0.00375926569680915,-0.00583918403355918,0.00889713749793271,0.684215074277319
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24800,0.00270006417879874,0.00664080021703115,-0.0103159042465823,0.0157160326041798,0.684314731141494
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24011,-0.00158301794651811,0.00391373840574199,-0.00925394522177241,0.00608790932873619,0.68586544662146
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,24788,-0.0012101540060845,0.00300981158706111,-0.00710938471672429,0.00468907670455528,0.687636208668961
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24863,0.00120952793703109,0.00301314199024343,-0.00469623036384603,0.00711528623790822,0.68811621613773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,24788,0.00120943438622367,0.00303359422520614,-0.00473641029518037,0.00715527906762772,0.690132189629465
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24440,0.00173684166009245,0.00438203216054602,-0.00685194137457776,0.0103256246947627,0.691846401210002
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,24106,-0.00128322818230468,0.00324639751290467,-0.00764616730759783,0.00507971094298846,0.692641536541309
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24840,0.00639198095653481,0.0161990441288982,-0.0253581455361057,0.0381421074491753,0.693148878305316
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,24106,-0.00136431841393479,0.00346025688527524,-0.00814642190907426,0.00541778508120468,0.693376040438966
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24910,0.000660077592809026,0.00168262548098385,-0.00263786834991933,0.00395802353553738,0.694847115277923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24800,-0.00140305806697975,0.00358251038135494,-0.00842477841443542,0.00561866228047593,0.695326831807371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24917,-0.000749373912962512,0.00192864383024126,-0.00452951582023538,0.00303076799431035,0.697612630021774
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24011,0.00245902220768975,0.00634482032524485,-0.00997682562979015,0.0148948700451696,0.698342354304429
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,29531,-0.00150024442727983,0.00387790199867916,-0.00910093234469098,0.00610044349013131,0.698855148802486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24376,-0.00223886660931659,0.00580126884154102,-0.013609353538737,0.00913162032010381,0.699554061599014
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,28769,-0.00160065247614736,0.00416006714352149,-0.00975438407744949,0.00655307912515476,0.700413622527688
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24096,0.000979790091600639,0.00257091477762142,-0.00405920287253735,0.00601878305573863,0.703128233175271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,29213,-0.00090980352098803,0.00240725906292255,-0.00562803128431623,0.00380842424234017,0.705476670098909
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24933,0.000643685420884229,0.00171938454249986,-0.00272630828241551,0.00401367912418396,0.708132491621707
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24011,-0.000805175026432825,0.00216324788445728,-0.00504514087996909,0.00343479082710344,0.709742358337476
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23033,-0.00132750305093182,0.00359420327137431,-0.00837214146282546,0.00571713536096183,0.711873561379229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,28926,-0.000786731300026621,0.00213990832130046,-0.00498095160977552,0.00340748900972228,0.713139007475293
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24917,-0.0018267153418445,0.00500457588661196,-0.0116356840796039,0.00798225339591493,0.715107772516492
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24863,0.000585157728377037,0.00161327816642187,-0.00257686747780982,0.00374718293456389,0.716822018286631
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,24224,-0.000793771029007004,0.00219224002543202,-0.00509056147885376,0.00350301942083976,0.717293786328648
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24106,-0.000974025585210343,0.00270150434954747,-0.00626897411032339,0.0043209229399027,0.718439533978371
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,24106,0.0021788681183485,0.00612731078453974,-0.00983066101934939,0.0141883972560464,0.722143696586244
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24376,-0.000688304628364761,0.00193974082259726,-0.00449019664065539,0.00311358738392587,0.722709830015773
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,28911,-0.00116025907713826,0.00329726048058346,-0.00762288961908185,0.00530237146480532,0.72492648959011
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24788,0.000871666154409965,0.0024961857636771,-0.00402085794239715,0.00576419025121708,0.7269427097629
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24440,0.00131497156212833,0.00378431141787958,-0.00610227881691564,0.00873222194117231,0.728233927599415
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24440,0.00103374278782935,0.00297905545114925,-0.00480520589642319,0.00687269147208188,0.728591648624348
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24440,-0.00126929535478223,0.00366691501612363,-0.00845644878638453,0.00591785807682008,0.729234461666898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29748,0.00122495375464883,0.00354371183797122,-0.00572072144777476,0.00817062895707242,0.729593414734288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24440,-0.000889777382965441,0.00258338358100893,-0.00595320920174294,0.00417365443581205,0.730530967355867
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24788,0.00142116175476854,0.00413764350573621,-0.00668861951647443,0.00953094302601151,0.731246850079981
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24788,0.00224493145362605,0.0065839231027444,-0.010659557827753,0.0151494207350051,0.733127777996955
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB2,Calretinin,28769,0.000705537765120105,0.00207012012772452,-0.00335189768521995,0.00476297321546016,0.733241792857417
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28911,0.00179727631204839,0.0052927917182083,-0.00857659545563987,0.0121711480797367,0.73418241041945
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,28847,0.00166099132080221,0.00496425299609179,-0.0080689445515377,0.0113909271931421,0.73793653275095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24106,0.00112157010177544,0.00336918931669847,-0.00548204095895356,0.00772518116250443,0.739220064632574
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24190,-0.000850593273123283,0.00256811836010605,-0.00588410525893113,0.00418291871268457,0.740486740602093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24190,0.00232424365836011,0.00703239168996206,-0.0114592440539655,0.0161077313706857,0.74102095236926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,29689,0.000701725599680821,0.00212987926021943,-0.00347283775034926,0.0048762889497109,0.741804820826174
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24788,0.00122935238251332,0.00373199146693967,-0.00608535089268844,0.00854405565771508,0.741849187749762
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24011,-0.000590667156511205,0.00179899338269878,-0.00411669418660081,0.0029353598735784,0.742663490567137
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24376,-0.00263079084334629,0.00805071541374454,-0.0184101930542856,0.013148611367593,0.743839156035593
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,24011,0.000983162049936358,0.00300900495011796,-0.00491448765229485,0.00688081175216756,0.743867450469811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,24933,-0.00193706334324338,0.00593959421676856,-0.0135786680081098,0.009704541321623,0.744330842797394
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,24224,-0.00104801253268329,0.00322991984664095,-0.00737865543209955,0.00528263036673297,0.745584931410784
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28792,0.00165660109893441,0.00510743151454321,-0.00835396466957029,0.0116671668674391,0.745674583861626
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,28926,0.00121959301181078,0.00377140108103246,-0.00617235310701283,0.00861153913063439,0.746410349114541
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24096,0.00257347969676609,0.00802947099619671,-0.0131642834557795,0.0183112428493117,0.74858887891733
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24440,0.00143004669321818,0.00449708045355351,-0.0073842309957467,0.0102443243821831,0.750491853855433
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28926,0.00140772222093519,0.00444317432853719,-0.0073008994629977,0.0101163439048681,0.751376372941031
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,24011,0.00135544295216546,0.00431161561170774,-0.0070953236467817,0.00980620955111262,0.753242709415337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,28911,-0.00177864002663014,0.00571540791191068,-0.0129808395339751,0.00942355948071478,0.755650151608855
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,28926,0.00171859075778279,0.00554487895859356,-0.00914937200106059,0.0125865535166262,0.756607312835078
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,24011,0.00140393684811827,0.00458518576400116,-0.007583027249324,0.0103909009455605,0.759462838214757
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BSND,Barttin,24011,-0.000703113158271021,0.00229896138525341,-0.00520907747336771,0.00380285115682567,0.759729518909693
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,24011,-0.000845068689344546,0.00277953327651279,-0.00629295391130962,0.00460281653262052,0.761105701757885
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24011,0.000539994074123166,0.00177690674297061,-0.00294274314209923,0.00402273129034557,0.761210093480714
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,29169,0.00119740671469628,0.00394741840679582,-0.00653953336262353,0.00893434679201609,0.761633544919786
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,28926,-0.000894499563734722,0.00295246802808424,-0.00668133689877984,0.00489233777131039,0.761917401257298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24235,0.000973199308584389,0.00325543116798102,-0.0054074457806584,0.00735384439782718,0.76498353568342
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24096,0.001052737942378,0.00361290864765718,-0.00602856300703008,0.00813403889178607,0.770761393864776
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24106,0.000661468220867714,0.00228427777220604,-0.00381571621265613,0.00513865265439156,0.772144394352115
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,24106,0.00117386037096689,0.00407497933772042,-0.00681309913096513,0.00916081987289891,0.773299189462051
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28493,0.00166712878572657,0.00579850189051672,-0.00969793491968619,0.0130321924911393,0.77372373908068
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24788,0.00104680669007431,0.00367465707336131,-0.00615552117371386,0.00824913455386249,0.775744635324249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,24376,0.00223343993180734,0.00784044491924172,-0.0131338321099064,0.0176007119735211,0.775752768998143
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24096,0.000965716797450628,0.00340600460698291,-0.00571005223223589,0.00764148582713714,0.7767702550126
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28911,-0.0011713244841006,0.00413870520999273,-0.00928318669568635,0.00694053772748515,0.777165730503133
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24106,-0.000647295614607082,0.00229272428493969,-0.00514103521308888,0.00384644398387471,0.777695996937245
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24800,0.000540954679107035,0.00191732641244167,-0.00321700508927864,0.00429891444749271,0.77783843665602
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,29344,-0.000362474732387513,0.00129378114393554,-0.00289828577450117,0.00217333630972614,0.779351388513859
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,24235,-0.00133969199308363,0.00478220565239987,-0.0107128150717874,0.00803343108562012,0.779371703285768
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28296,0.000716230858537445,0.00255909029326608,-0.00429958611626407,0.00573204783333896,0.779573817180767
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24011,0.00121022802062531,0.00432880576398397,-0.00727423127678327,0.00969468731803388,0.779805618202721
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28533,-0.00230453353231986,0.00825976786826284,-0.018493678554115,0.0138846114894753,0.7802414313763
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28342,-0.000595223363745131,0.00213477360582297,-0.00477937963115815,0.00358893290366789,0.780382919925092
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,24190,-0.00142186726118473,0.00511883239379028,-0.0114547787530137,0.00861104423064422,0.781189919182095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,24440,-0.00135246638759222,0.00487519641028964,-0.0109078513517599,0.00820291857657547,0.781461643436708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24106,-0.000871354141757537,0.00317943842972544,-0.0071030534640194,0.00536034518050433,0.78404152801772
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,24106,0.00088405579626801,0.00322805724035675,-0.00544293639483122,0.00721104798736724,0.784189788863187
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,28926,0.000592961060391824,0.00216889792075392,-0.00365807886428586,0.0048440009850695,0.784553244978139
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24376,-0.00160458516287917,0.00590965230788491,-0.0131875036863336,0.00997833336057526,0.785993892720659
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29164,-0.000718659386597244,0.00271092151851077,-0.00603206556287835,0.00459474678968386,0.79093598062441
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24224,-0.000836933382162746,0.00319570729388407,-0.00710051967817552,0.00542665291385002,0.793406161697815
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24961,0.000330868909344529,0.00126455911316452,-0.00214766695245793,0.00280940477114699,0.793595270675103
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28911,-0.00047765253572996,0.00184792642892262,-0.0040995883364183,0.00314428326495838,0.796038109245229
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,24190,-0.000889218683452923,0.00344106573881261,-0.00763370753152565,0.0058552701646198,0.796089809780522
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,24376,-0.000594656758235728,0.00232393097937193,-0.00514956147780472,0.00396024796133326,0.798042568807552
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,28865,-0.0008643925263706,0.00338203125562593,-0.00749317378739741,0.00576438873465621,0.798274021897929
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29781,0.000605133235460638,0.00236834573962862,-0.00403682441421146,0.00524709088513273,0.798331894328461
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24224,-0.000771204577289566,0.00302033172246718,-0.00669105475332524,0.0051486455987461,0.798464447740891
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28926,-0.000500342230162174,0.00196534230643642,-0.00435241315077757,0.00335172869045322,0.799047201843444
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,29378,-0.000495875326884029,0.00195544482703259,-0.00432854718786791,0.00333679653409985,0.799816440187557
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29486,-0.000675011512149553,0.00269034490043193,-0.00594808751699613,0.00459806449269702,0.801892030695842
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,28911,-0.000457378216475894,0.00185997287527751,-0.00410292505201982,0.00318816861906803,0.805756859354663
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24440,-0.00107840452534094,0.0044003625631461,-0.0097031151491073,0.00754630609842542,0.806402940072368
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29438,-0.00047439179904871,0.00194020044440815,-0.00427718467008869,0.00332840107199127,0.806840201883958
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,29669,0.000849058909347021,0.00351008565645663,-0.00603070897730797,0.00772882679600201,0.808866124487249
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29537,0.00083850806192813,0.00347227363320469,-0.00596714825915307,0.00764416438300933,0.809179564618258
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24235,0.00430637677069609,0.0178716619098089,-0.0307220805725294,0.0393348341139216,0.809587242309703
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,24190,-0.000472937759389276,0.0019671818670884,-0.00432861421888254,0.00338273870010399,0.810011483476643
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24376,0.00182332348318113,0.00758994265213791,-0.0130529641150092,0.0166996110813714,0.81015484118223
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,24440,0.000872823298007697,0.00363577285345647,-0.00625329149476698,0.00799893809078237,0.810281564112749
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,24096,0.000802374325818078,0.00334816764938928,-0.0057600342669849,0.00736478291862106,0.810606892902701
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24235,0.00045565502617824,0.00190355043891026,-0.00327530383408587,0.00418661388644235,0.810819837005595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24788,0.000723463200949397,0.00304313485654005,-0.00524108111786909,0.00668800751976789,0.812087700465568
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24440,0.000645634289638679,0.00272567107571146,-0.00469668101875579,0.00598794959803315,0.812758326486037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,23857,0.00129515408380337,0.00547117871668978,-0.0094283562009086,0.0120186643685153,0.812873689563377
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,24440,-0.00136743741010073,0.00581164068185793,-0.0127582531465423,0.0100233783263408,0.813983428625013
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,24011,0.00094727431752658,0.0040389645437191,-0.00696909618816286,0.00886364482321601,0.814572478949155
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,24106,0.00117075351970105,0.0050100869179153,-0.00864901683941293,0.010990523878815,0.815235957578566
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,24190,0.000531028679340941,0.00227879613611099,-0.00393541174743659,0.00499746910611847,0.815739805133938
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29429,0.000736751372592819,0.0032310452565598,-0.00559609733026439,0.00706960007545003,0.819630248146956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,28792,-0.00123233359714919,0.00545153219791021,-0.0119173367050532,0.00945266951075482,0.82116203414407
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,28792,0.000473942680764685,0.00210658379645328,-0.00365496156028373,0.0046028469218131,0.821995153443048
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24840,-0.00070298681999782,0.00314418389096261,-0.00686558724628453,0.00545961360628889,0.8230834461296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24190,0.000540514728662258,0.00242395087105577,-0.00421042897860705,0.00529145843593157,0.823545839894658
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28911,0.000731356247045889,0.00330779355346584,-0.00575191911774716,0.00721463161183894,0.825015404518004
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAX,Protein max,28769,0.00156364408805479,0.00712445510559739,-0.0124002879189161,0.0155275760950257,0.826281139566507
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24096,0.00122322447647936,0.00569465854497127,-0.00993830627166433,0.012384755224623,0.829923453253156
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24011,0.000605394998646188,0.00282756659452783,-0.00493663552662836,0.00614742552392074,0.830467312225113
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,28926,0.00133115794176157,0.00622184713235604,-0.0108636624376563,0.0135259783211794,0.830588340852889
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28911,-0.00134025827607947,0.0062855970054107,-0.0136600284066844,0.0109795118545255,0.831151502645153
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NEB,Nebulin,24106,0.000545540169155787,0.00257228733201245,-0.00449614300158862,0.00558722333990019,0.83204354395298
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,24190,-0.000937007390780553,0.00443333925873605,-0.00962635233790322,0.00775233755634211,0.832612230785538
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,24756,-0.000406263966404067,0.00192266171823526,-0.00417468093414517,0.00336215300133704,0.832652672766279
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28792,0.000720905754498948,0.00342159831479548,-0.00598542694250019,0.00742723845149809,0.833128570505764
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,24190,0.000598338365331696,0.00284131445096655,-0.00497063795856274,0.00616731468922613,0.833212848447453
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24863,-0.0017997211240288,0.00855604280220728,-0.0185695650163551,0.0149701227682975,0.833400113091824
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,24749,0.000732545675332649,0.00350640008114666,-0.0061399984837148,0.00760508983438009,0.834514955939992
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24917,-0.000555409584506569,0.00266990187812045,-0.00578841726562266,0.00467759809660952,0.835210198940587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24096,0.000433318510294996,0.00217875602829974,-0.0038370433051725,0.0047036803257625,0.842355596765759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28911,0.000770482705484692,0.00389612510670657,-0.00686592250366018,0.00840688791462957,0.84323724586739
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MB,Myoglobin,29815,-0.000689654973949863,0.00355244429626239,-0.00765244579462415,0.00627313584672442,0.846071235518584
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,28769,-0.000726765029744959,0.0037719052329159,-0.00811969928626012,0.00666616922677021,0.847212125791027
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,24106,0.000594420959472918,0.00313003281424411,-0.00554044335644555,0.00672928527539138,0.849382150500954
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,28911,0.000910059364595511,0.0048365409372169,-0.00856956087234962,0.0103896796015406,0.850749984664271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29429,-0.00103209332199311,0.00552807402902299,-0.0118671184188782,0.00980293177489196,0.851896874049595
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24376,-0.00117953576438229,0.00642944122527599,-0.0137812405659232,0.0114221690371586,0.854439790243386
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24235,0.000309015458843883,0.00168839550005624,-0.00300023972126634,0.0036182706389541,0.854781388099435
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24863,0.0014281887845548,0.00782136635225855,-0.013901689265872,0.0167580668349816,0.855112642719305
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29390,-0.00134359107967394,0.00740680491385327,-0.0158609287108264,0.0131737465514785,0.85605522344026
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,24224,0.000334553323894202,0.00184601268881203,-0.00328363154617737,0.00395273819396578,0.856188376080147
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29720,-0.000476326017007564,0.00264875741825522,-0.0056678905567878,0.00471523852277267,0.85728726627332
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24096,0.000484206965458565,0.00272364794913393,-0.00485414301484393,0.00582255694576106,0.858898163273508
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24190,0.000594211300665528,0.00334822498879005,-0.00596830967736297,0.00715673227869402,0.859140289463512
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24497,0.000506557612966034,0.00288693375702023,-0.00515183255079361,0.00616494777672568,0.860715236338645
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24011,-0.00051915626462285,0.00300187972700938,-0.00640284052956124,0.00536452800031554,0.862697119763451
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24190,-0.000588898492332173,0.00341437681191778,-0.00728107704369102,0.00610328005902668,0.863064670902503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24235,-0.000698347616757029,0.00424778014300661,-0.00902399669704998,0.00762730146353592,0.869415307650837
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,24190,-0.000251974545314324,0.00155360413651239,-0.00329703865287861,0.00279308956224997,0.871159875529025
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24224,0.000318669944650785,0.00197524785516814,-0.00355281585147878,0.00419015574078035,0.871833563191044
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28769,-0.000856276246957203,0.00532502997271261,-0.0112933349934739,0.00958078249955951,0.872250364606008
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,28926,0.000447189036504219,0.00278906080611513,-0.00501937014348144,0.00591374821648988,0.872616905387497
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24724,-0.000478818730455187,0.00300081005683966,-0.00636040644186092,0.00540276898095055,0.873226506546956
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24011,0.000638386418808539,0.00402490414280409,-0.00725042570108748,0.00852719853870456,0.873978194428564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29473,-0.00091688503933493,0.00585568267784997,-0.0123940230879209,0.010560253009251,0.875576636510583
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,24800,0.00273904916857513,0.0175561347576641,-0.0316709749564465,0.0371490732935968,0.876021175038296
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29815,0.000322392746944632,0.00215572504084561,-0.00390282833311276,0.00454761382700202,0.881119182063095
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24106,0.000573647111432478,0.00384830550529717,-0.00696903167894998,0.00811632590181494,0.88150370341271
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,29429,0.000585781308175121,0.0039685228999767,-0.00719252357577921,0.00836408619212945,0.882654031902086
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24106,0.000597645186060639,0.00413784075314752,-0.0075125226901085,0.00870781306222978,0.88515892204295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24190,0.000544526956432866,0.00377997771701401,-0.00686422936891459,0.00795328328178032,0.885457766041615
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24224,0.000227440460031738,0.00158147694488117,-0.00287225435193536,0.00332713527199884,0.885647578342162
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,29368,-0.000645041479879568,0.00451299931935455,-0.00949052014581448,0.00820043718605534,0.886346711011835
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CALB1,Calbindin,29344,-0.000408343167409943,0.00295772481594645,-0.00620548380666497,0.00538879747184509,0.890194031793079
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29415,-0.000853671938328667,0.00643968904794583,-0.0134754624723025,0.0117681185956452,0.894538989353601
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24190,-0.000562357661329922,0.004471633246699,-0.00932675882485997,0.00820204350220012,0.899922054919503
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24863,-0.000408733778686247,0.00330428672522899,-0.00688513576013506,0.00606766820276257,0.901555367138523
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28792,0.000644889098853452,0.00523496359720507,-0.00961563955166849,0.0109054177493754,0.901958422028246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29213,-0.000861878149912038,0.00707671351606682,-0.014732236641403,0.0130084803415789,0.903065588776288
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24224,-0.000494972692145623,0.00419695664763841,-0.0087210077215169,0.00773106233722565,0.906119268829537
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SCIN,Adseverin,24096,-0.000583271531626703,0.0049828291070082,-0.0103496165813628,0.00918307351810938,0.906816416426488
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29781,-0.000363461391166751,0.0031381795610294,-0.00651429333078438,0.00578737054845088,0.907796628685936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24106,0.000477414592695327,0.0041858857563064,-0.00772692148966522,0.00868175067505588,0.909196395812623
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24190,-0.000377482706345232,0.00332904174471554,-0.0069024045259877,0.00614743911329723,0.909721674799564
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,24224,-0.000313412223849514,0.00276768688173239,-0.00573807851204499,0.00511125406434596,0.909841406048802
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,29344,0.000312037350408886,0.00283374463453446,-0.00524210213327866,0.00586617683409643,0.912319048745267
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,29306,0.000259064425385686,0.00235944880985905,-0.00436545524193805,0.00488358409270942,0.912569769740227
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28769,-0.000240791645931964,0.00220715073905455,-0.00456680709447888,0.00408522380261496,0.913126990549845
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,29689,-0.000465223254861951,0.00442873342915433,-0.00914554077600443,0.00821509426628053,0.916339565798531
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24224,0.000608490746854615,0.0058913904286636,-0.010938634493326,0.0121556159870353,0.917737839590215
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24096,0.000571804138109084,0.00574479660872621,-0.0106879972149943,0.0118316054912124,0.92071490776596
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24011,0.000171087918901308,0.00172495369185159,-0.00320982131712781,0.00355199715493042,0.920992955316919
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24440,0.000403738097680026,0.0040812116254441,-0.00759543668819042,0.00840291288355047,0.921197806495812
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29720,0.000221965758210933,0.00227661369105487,-0.0042401970762566,0.00468412859267847,0.922331413977728
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,24440,0.000383761004593432,0.00403125124930996,-0.00751749144405408,0.00828501345324095,0.924159531838295
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,24961,-0.000176383243421979,0.00185984808983388,-0.00382168549949638,0.00346891901265242,0.924444704708708
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,24376,0.000688190945746597,0.00733258648181763,-0.013683678558616,0.0150600604501091,0.925226083114373
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,23908,0.000220074029231193,0.00234681504679532,-0.00437968346248764,0.00481983152095003,0.925288187320678
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24106,-0.000411369473103864,0.00446595534572012,-0.0091646419507153,0.00834190300450757,0.926609572176403
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24917,-0.000437045685865852,0.0047970965217264,-0.0098393548684496,0.00896526349671789,0.927408864347811
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,28769,-0.00041527096310318,0.00457467952726745,-0.00938164283654738,0.00855110091034102,0.927671238108689
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,29438,0.000277444669548961,0.00310458504390201,-0.00580754201649898,0.0063624313555969,0.928791569072285
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,29344,-0.000498116446883776,0.00557403029978884,-0.0114232158344699,0.0104269829407024,0.928793413607216
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,28874,-0.000258334450583219,0.0028950780076172,-0.00593268734551293,0.00541601844434649,0.928897920389964
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,29344,-0.000192374197875504,0.00220798128848325,-0.00452001752330267,0.00413526912755166,0.930571370488717
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,24106,-0.000227025432052057,0.002607498851818,-0.00533772318161534,0.00488367231751123,0.930619488739197
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24011,0.000322384599689308,0.00373314022605017,-0.00699457024336903,0.00763933944274765,0.93118296346385
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,24788,0.000473310681690089,0.00550864247252936,-0.0103236285644675,0.0112702499278476,0.931529535093341
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,29164,0.000268221790657077,0.00312953314921509,-0.00586566318180451,0.00640210676311866,0.931700207224741
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,24224,0.000123983403185326,0.00148400976851734,-0.00278467574310866,0.00303264254947931,0.933417920149898
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,28752,-0.000615793125968352,0.00743278996639285,-0.0151840614600983,0.0139524752081616,0.933972835162755
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24106,-0.000216640300814964,0.00267238260158014,-0.00545451019991203,0.0050212295982821,0.935389860519582
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,29328,0.000184128028167345,0.0023163855849769,-0.00435598771838739,0.00472424377472208,0.93664392987851
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24106,0.000260369195508685,0.00327605459404287,-0.00616069780881535,0.00668143619983271,0.936654321076684
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,24224,-0.000207632318853252,0.00275515459513383,-0.00560773532531557,0.00519247068760906,0.939927789571112
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,24917,-0.000135457441690712,0.00179953389378824,-0.00366254387351566,0.00339162899013424,0.939997609796913
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23970,0.000246213928914046,0.00328601089733893,-0.00619436742987026,0.00668679528769835,0.940272695599833
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,24096,-0.000186900221690969,0.00254869703308106,-0.00518234640652985,0.00480854596314791,0.94154279582398
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,24106,-0.000247830735441224,0.00344858850358558,-0.00700706420246896,0.00651140273158651,0.942710419881037
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24440,0.000217198095022177,0.00303361761412101,-0.00572869242865501,0.00616308861869936,0.942923167947286
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,24032,-0.000246296479776992,0.00372847604953458,-0.00755410953686477,0.00706151657731079,0.947332026005935
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29344,0.000194723029037482,0.00304237347561034,-0.00576832898315878,0.00615777504123374,0.94896775091948
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24190,-0.000180852071787851,0.00283524265523229,-0.00573792767604313,0.00537622353246743,0.949140231064899
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29815,-0.000107014345873741,0.00168900670717517,-0.00341746749193706,0.00320343880018958,0.949480791133831
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24106,0.000212592366758938,0.00341684493648269,-0.00648442370874714,0.00690960844226502,0.950389019991411
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24224,0.000154684197616095,0.00253652033438093,-0.00481689565777053,0.00512626405300272,0.951373383745282
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,24800,-0.00014764425234723,0.00242246512493505,-0.00489567589721992,0.00460038739252547,0.951401163398246
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24440,0.000286550963580213,0.00478249068108032,-0.00908713077133722,0.00966023269849764,0.952222485243801
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24933,-0.000164886714324752,0.00282868943146785,-0.00570911800000173,0.00537934457135223,0.953517422321093
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24096,0.000225909376681712,0.00392121059822466,-0.00745966339583863,0.00791148214920205,0.954058048723635
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29269,-0.000100759873561719,0.00177104228830712,-0.00357200275864367,0.00337048301152023,0.954630834913754
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,24224,-0.000173220204857158,0.0030975956078478,-0.00624450759623885,0.00589806718652454,0.955405315818893
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24440,0.000199435969871626,0.00362569635927027,-0.00690692889429811,0.00730580083404136,0.95613393233972
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24190,0.000138608714891078,0.00255842791942863,-0.00487591000718904,0.00515312743697119,0.956794354382594
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29576,0.000240576164317351,0.00451629764908622,-0.00861136722789165,0.00909251955652635,0.957518379663302
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,28926,0.000101336277706946,0.00193740449781876,-0.00369597653801783,0.00389864909343172,0.958285892746788
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28769,-0.00010356639391651,0.00202878236772738,-0.00407997983466218,0.00387284704682916,0.959287189884094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,29367,0.000203395737537086,0.00427319184525988,-0.00817206027917227,0.00857885175424644,0.962036884148656
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,24190,-0.0001554451815608,0.00328354819985087,-0.0065911996532685,0.0062803092901469,0.962242151627704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24847,0.000202598455672914,0.00439198794334649,-0.0084056979132862,0.00881089482463203,0.963207722326323
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29576,-8.20651883670171e-05,0.00182278438946355,-0.00365472259171557,0.00349059221498154,0.964090169373107
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,24863,-0.000112366818873137,0.00253329209301979,-0.00507761932119192,0.00485288568344565,0.964620954306425
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24011,-0.000143942117697666,0.00331294805446936,-0.0066373203044576,0.00634943606906227,0.965344499977681
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,24376,0.000274514340503835,0.00632704215333607,-0.0121264882800349,0.0126755169610425,0.965393022767982
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,29561,-0.000109670427388157,0.00255220316564917,-0.00511198863206053,0.00489264777728421,0.965725033592067
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,24840,6.52026487835968e-05,0.00152772533874816,-0.00292913901516279,0.00305954431272998,0.965957314868868
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SAG,S-arrestin,24096,-0.000152745313783955,0.0035812751338874,-0.00717204457620325,0.00686655394863534,0.965980016455273
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24788,0.000176204326771655,0.00422566769713143,-0.00810610435960594,0.00845851301314925,0.966739324976923
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29438,-0.000112033643178519,0.00286020307725153,-0.00571803167459152,0.00549396438823448,0.968755260086554
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24788,-0.00012068228018543,0.00329790193638186,-0.00658457007549387,0.00634320551512301,0.970809298883704
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,24224,-0.000101074772561825,0.00291388041507683,-0.00581228038611242,0.00561013084098877,0.972329338783926
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24011,-0.000118727566775184,0.00346494281868674,-0.0069100154914012,0.00667256035785083,0.972665819984337
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28792,9.12617407036498e-05,0.00317482329028341,-0.00613139190825183,0.00631391538965913,0.977067802639632
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29344,0.00018054853973685,0.00636954623757487,-0.0123037620859099,0.0126648591653836,0.977386713284983
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24190,0.000155542822570363,0.00573310004776921,-0.0110813332710573,0.011392418916198,0.978355739753587
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29781,3.85042491292648e-05,0.00159376980832012,-0.00308528457517817,0.0031622930734367,0.980725761435976
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24840,-8.053316246925e-05,0.003715268816788,-0.00736246004337374,0.00720139371843524,0.982706368941486
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29720,-4.20031225831265e-05,0.0021819157361306,-0.0043185579653991,0.00423455172023284,0.984641344970365
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,28792,8.50890011457876e-05,0.00700232256743125,-0.0136394632310195,0.013809641233311,0.990304796863434
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24224,3.24374875779539e-05,0.0027425129791508,-0.00534288795155761,0.00540776292671351,0.990563217011501
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,24224,2.85048828086303e-05,0.00256338412660623,-0.00499572800533957,0.00505273777095683,0.991127782186019
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24840,-2.36053311114081e-05,0.00264885857903713,-0.00521536814602418,0.00516815748380136,0.992889809051936
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28714,-2.31972743398998e-05,0.00324802021651247,-0.00638931689870433,0.00634292235002454,0.99430162768759
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,24440,2.19343059125644e-05,0.00407518890044166,-0.00796543593895309,0.00800930455077822,0.995705529034094
NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24235,2.74835869594276e-06,0.0033536220649878,-0.00657035088868014,0.00657584760607203,0.99934612486166
